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ABSTRACT 
 
JUSTIN ANDREW McDONOUGH: Investigation of the Twin-arginine Translocation 
Pathway in Mycobacteria 
(Under the direction of Miriam Braunstein) 
 
Mycobacterium tuberculosis is an intracellular pathogen that resides primarily in host 
macrophages.  Proteins that reside on the surface of the bacillus or are secreted into 
environment are ideally positioned to interact with host cell components and are therefore 
candidate virulence factors and immunogenic antigens.  These proteins are actively 
transported from the cytoplasm to the cell envelope or extracellular space by specific export 
pathways.  In this work, we describe the initial characterization of the twin-arginine 
translocation (Tat) export pathway in mycobacteria.  The Tat pathway exports folded 
proteins, including virulence factors, in a number of bacteria.  Proteins targeted for Tat-
export carry N-terminal signal sequences that have a conserved twin-arginine motif, referred 
to as R-R-x-φ-φ (φ = uncharged residue).  We provide evidence that the Tat pathway is 
functional in Mycobacterium smegmatis and required for the export of mycobacterial β-
lactamases, including BlaC of M. tuberculosis.  We demonstrate that BlaC can be used as a 
reporter to exclusively identify Tat-exported fusion proteins that promote resistance to the β-
lactam antibiotic carbenicillin.  We describe using the BlaC reporter with a M. tuberculosis 
genomic expression library to identify random Tat signal sequence-BlaC fusions that 
promote Tat export in M. smegmatis.  Using this approach, we identified eleven M. 
tuberculosis Tat signal sequences shown to direct the export of the BlaC reporter through the 
Tat pathway, including the known phospholipase C virulence factors.  In addition, we 
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identified a protein lacking the typical twin-arginine motif, suggesting that our current 
understanding of what defines a Tat signal sequence is limited, and demonstrating the 
effectiveness of our experimental system.  We describe ongoing evaluation to determine the 
specificity and requirements for export of the authentic full length M. tuberculosis proteins.  
Finally, we demonstrate the novel finding that BlaC can be used as a reporter for the 
identification of proteins exported by M. tuberculosis during growth in macrophages.  This 
may lead to the identification of a subset of proteins exported exclusively within the 
intracellular environment.  This work has important implications in determining the role that 
protein export plays in M. tuberculosis, as well as increasing the understanding of how the 
Tat pathway functions in bacteria. 
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CHAPTER 1 
 
INTRODUCTION 
 
Tuberculosis disease. 
 Tuberculosis (TB) is an infectious disease caused by bacteria of the Mycobacterium 
tuberculosis complex.  Each year, 1.7 million people die from TB, making it the leading 
cause of death worldwide from a bacterial infectious disease (61).  It is estimated that up to 
one-third of the world’s population, around two billion people, are infected with M. 
tuberculosis.  The majority of people infected with M. tuberculosis are asymptomatic.  
However, five to ten percent of this population will progress to active, symptomatic disease 
over the course of a person’s lifetime (61).  Coinfection with HIV greatly increases the risk 
of developing TB to ten percent annually.  If left untreated, half of the people with active 
disease will die from TB.  Most TB deaths occur in developing countries where poor socio-
economic conditions and HIV/AIDS incidence contribute to the transmission and 
effectiveness of TB disease. 
TB can cured by antibiotic treatment; however, the therapy is long (6-12 months) and 
involves a combination of antibiotics such as isoniazid and rifampin, to ensure the most 
effective treatment and to reduce the risk of drug-resistance.  However, inadequate treatment, 
poor quality drugs, and the inability to maintain an appropriate drug regimen, has led to the 
emergence of drug-resistant strains of M. tuberculosis (33).  Multidrug-resistant tuberculosis 
(MDR-TB) refers to strains that are resistant to at least two (isoniazid and rifampin) of the 
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primary antibiotics used to treat TB.  These strains are difficult to treat, but not impossible, 
with the use of second line drugs.  Recently, a second category of extensively drug-resistant 
strains (XDR-TB) emerged and is named so due to resistance to the primary drugs, isoniazid 
and rifampin, as well as many second-line drugs (61).  Because XDR-TB is resistant to both 
first and second line drugs, it is virtually untreatable and therefore requires an urgent global 
response. 
TB is primarily a disease of the lungs (pulmonary TB), although other parts of the 
body can be affected, such as the lymph nodes, kidneys, bones, joints, etc (extrapulmonary 
TB).  The disease is transmitted when a person with active pulmonary TB coughs, sneezes, or 
talks thereby expelling aerosolized droplet nuclei carrying the bacilli, which can then be 
inhaled by another person.  Upon inhalation, the bacteria are internalized primarily by 
alveolar macrophages where they survive and replicate.  Here the bacteria elicit an immune 
response that can ultimately lead to containment of the infection or progression to active TB 
(46).  This complex relationship between host and pathogen is not yet understood. 
 
Protein export in M. tuberculosis. 
The surface and secreted proteins of M. tuberculosis are attractive candidates for 
virulence factors and immunogenic antigens due to their exposure to the host cell 
environment (26).  These proteins utilize specific transport pathways to cross the barriers 
imposed by the bacterial cytoplasmic membrane or cell wall (collectively termed the cell 
envelope) to reach their final location, and are therefore referred to as exported proteins.  
Exported proteins are ideally positioned to sense the environment, interact with the host, and 
protect the bacillus from host defenses during infection thereby promoting intracellular 
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survival.  In addition, exported proteins can be antigens presented to the immune system 
during infection that elicit a host immune response.  Together, exported proteins have 
important roles in bacterial physiology and pathogenesis and are of interest as targets for the 
development of drugs, vaccines, and diagnostics for TB. 
Both surface and secreted proteins cross the cytoplasmic membrane and, depending 
on their final destination, may also navigate the cell wall.  The mycobacterial cell wall is a 
unique, complex, and highly impermeable structure (20).  At its core is a network of 
covalently linked peptidoglycan, arabinogalactan, and long chain (C60-C90) mycolic acids.  
Beyond the core structure is an outer layer of “free” lipids that is further capped by an 
exopolysaccharide capsule.  This novel cell wall architecture is sure to present special 
challenges to protein transport and may necessitate mycobacterial-specific pathways. 
The protein transport pathways of M. tuberculosis are of great interest due to their 
ability to export these important proteins.  Our current understanding of protein export in M. 
tuberculosis remains limited (26, 31).  However, the availability of the complete genome 
sequence of M. tuberculosis and the development of genetic tools to work with mycobacteria 
have stimulated research efforts to understand these complex pathways (6, 13).  Two 
conserved protein export systems have been identified: the general secretion (Sec) pathway 
and the twin-arginine translocation (Tat) pathway.  Together, these two systems probably 
account for the majority of protein transport across the cytoplasmic membrane.  More 
specialized transport systems that act on select subsets of proteins also exist in M. 
tuberculosis: the SecA2-dependent system and the ESAT-6 secretion system (ESX-1). 
In this Chapter, I describe the recent advances made identifying and understanding 
the protein transport pathways of M. tuberculosis, with emphasis on the twin-arginine 
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translocation (Tat) pathway, which is the focus of the research discussed herein.  The Tat 
pathway is essential for exporting virulence factors in a number of bacterial pathogens (10, 
11, 19, 28, 40, 45, 59).  Upon initiation of this study, the Tat export pathway had not been 
characterized in mycobacteria.  However, the M. tuberculosis genome sequence revealed 
homologs to components of the Tat translocase and putative Tat-exported proteins (13, 18), 
including known virulence factors (42).  As described in Chapters 2-4, we investigated the 
Tat pathway of mycobacteria.  We showed it to be functional in M. smegmatis and we have 
identified a set of the M. tuberculosis exported Tat substrates.  In the process, we developed 
an enzymatic reporter, based on the Tat-exported β-lactamase of M. tuberculosis that can be 
used in a genetic selection to assay for Tat-dependent export in mycobacteria.  In addition to 
being a useful tool for testing the export of predicted Tat substrates, the reporter can also be 
used to select M. tuberculosis sequences that promote Tat-dependent export from a reporter 
fusion library.  A significant feature of this reporter library system is that it can provide 
information as to the specific sequences required for targeting to the Tat apparatus.  This has 
an advantage over bioinformatic predictions of putative Tat substrates, which rely on 
information from a relatively small dataset of experimentally proven Tat substrates which do 
not include mycobacterial examples, and therefore may yield inaccurate predictions. 
Much of the work described in the following chapters was carried out in the fast-
growing, saprophytic organism Mycobacterium smegmatis.  Although M. smegmatis is not a 
human pathogen, it is a useful genetic model to study some aspects of mycobacterial 
physiology, and can be a starting point for subsequent work in the slow-growing, pathogenic 
M. tuberculosis (43).  It also provides a convenient model to study mycobacteria without 
constraints imposed by biosafety level 3 containment. 
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Sec Pathway 
 The general secretion (Sec) pathway is a conserved protein export system of bacteria.  
Years of study, primarily in Escherichia coli, provide an advanced understanding of this 
pathway (for a comprehensive review and detailed references see 16, 35).  The Sec pathway 
transports proteins from the cytosol across the cytoplasmic membrane to the cell envelope.  
These proteins may be further secreted into the extracellular space through subsequent action 
of Sec-independent mechanisms. 
At the core of the Sec machinery is the Sec translocase composed of the integral 
membrane proteins SecY, SecE, and SecG, which serve as the channel through which 
proteins cross the cytoplasmic membrane.  Peripherally associated with the Sec translocase is 
the multifunctional SecA protein.  SecA binds to cytoplasmic precursors of exported proteins 
and to associated chaperones, such as SecB, that maintain these precursors in a translocation-
competent unfolded state.  SecA binds to membrane phospholipids and to the integral 
membrane components of the translocase.  SecA is also an ATPase that provides energy for 
translocation.  Through cycles of ATP binding and hydrolysis, SecA undergoes 
conformational changes that drive stepwise export of the precursor through the Sec channel 
and across the membrane.  Because many Sec-exported proteins play essential roles in cell 
physiology, the central components of the Sec apparatus (SecY, SecE, and SecA) are 
essential for bacterial viability.  Other proteins that are not required for Sec export but 
increase efficiency of the process (SecG, SecDF, YajC) are not essential. 
Sec exported proteins are synthesized as precursors that have N-terminal signal 
peptides required for transport (41).  Typically, the signal peptide is 18-30 amino acids long 
with a tripartite structure: a positively charged N-region, a hydrophobic H-region, and a C-
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region with a cleavage site.  During or immediately following translocation of the protein, a 
signal peptidase cleaves the signal peptide to produce the mature protein.  For standard Sec 
signal peptides, cleavage is performed by signal peptidase I (LepB) and the cleavage site 
(often denoted A-X-A) has short-chain amino acids at the -1 and -3 positions relative to the 
first amino acid of the cleaved mature protein.  The conserved elements of Sec signal 
peptides enable bioinformatic prediction of Sec-exported proteins. 
The Sec pathway also exports lipoproteins that, by virtue of a covalently attached 
lipid, remain anchored to the cell envelope.  Bacterial lipoproteins are synthesized with N-
terminal signal peptides that are similar in overall structure to standard Sec signal peptides, 
but possess a lipobox motif (L-A/S-G/A-C+1) in the C-region (2).  The lipobox serves as both 
the site of lipid modification at the invariant cysteine and the site of signal peptide cleavage, 
immediately prior to the invariant cysteine.  The requirement for a lipobox in relation to the 
other signal peptide elements enables bioinformatic prediction of lipoproteins.  In contrast to 
standard Sec signal peptides, lipoprotein signal peptides are cleaved by the lipoprotein-
specific signal peptidase II, LspA (for a review of lipoprotein processing see 62).  In Gram-
positive and Gram-negative bacteria, lipoproteins are found in the cytoplasmic membrane.  In 
Gram-negative bacteria, lipoproteins can also be routed to the outer membrane through a 
process involving the Lol sorting system (reviewed in 56). 
In conjunction with additional factors, the Sec pathway also participates in the signal 
recognition particle (SRP)-mediated process of positioning integral membrane proteins in the 
cytoplasmic membrane (reviewed in 14).  Bacterial SRP, a protein-RNA complex comprised 
of the Ffh protein and ffs (a 4.5S RNA), recognizes transmembrane domains as they emerge 
from the ribosome and delivers them to the SRP receptor protein FtsY, which in turn directs 
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the complex to the Sec translocase for export across the membrane.  The membrane protein 
YidC aids in the stable integration of the transmembrane domain into the lipid bilayer of the 
membrane.  This SRP/Sec/YidC-dependent pathway is used by many membrane proteins; 
however, there are also examples of transmembrane proteins localized in a Sec-independent 
but YidC-dependent manner (58). 
 
Sec Pathway in M. tuberculosis 
M. tuberculosis appears to have a functional Sec pathway (Fig. 1.1).  The M. 
tuberculosis genome contains open reading frames (ORFs) predicted to encode orthologs of 
the Sec pathway components (7, 13).  Genomic analysis also reveals the unusual presence of 
two SecA homologs: SecA1 and SecA2.  The only Sec factor not obvious in the 
mycobacterial genomes is the SecB chaperone; however, SecB is not present in all bacteria 
(53).  Consistent with the lack of SecB is the observation that the M. tuberculosis SecAs lack 
consensus SecB-binding sites. 
The identification of surface and secreted proteins synthesized with recognizable Sec 
signal peptides provides further support for a functional Sec pathway in M. tuberculosis (26).  
In addition, application of bioinformatic methods to identify Sec signal peptides and 
transmembrane domains in the ORFs of the M. tuberculosis genome predict as much as 23% 
of the M. tuberculosis genome encodes Sec-exported proteins.  This prediction is on the order 
of that proposed for E. coli and most other bacteria (23, 48, 52, 55). 
So far, the only Sec proteins directly investigated in mycobacteria are SecA1 and 
SecA2.  The presence of two SecAs in M. tuberculosis appears to be a property shared with 
all mycobacterial species including non-pathogenic M. smegmatis (8, 13), as well as some  
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Figure 1.1.  Sec and Tat export systems of Mycobacterium tuberculosis. 
Protein export across the cytoplasmic membrane in M. tuberculosis.  A) Proposed export 
through the Sec pathway in M. tuberculosis.  Unfolded proteins with signal peptides (open 
box) are recognized by SecA1 and transported through the SecYEG channel.  After transport 
across the membrane, the signal peptide is cleaved and the proteins fold.  SecA2 is not shown 
in this diagram.  B) Proposed export through the Tat pathway in M. tuberculosis.  Folded 
precursor proteins with Tat signal peptides are delivered to TatBC and transported through 
the TatA channel. 
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Gram positive bacteria (5, 12, 30).  Both SecA1 and SecA2 are highly homologous to SecA 
of other bacteria and both include predicted ATP binding sites.  However, of the two 
proteins, SecA1 shares more sequence similarity with the singular and essential SecA of 
other bacteria.  Furthermore, only SecA1 is essential (8, 51).  Finally, the N-domain of M. 
tuberculosis SecA1 is functional in E. coli as a chimeric protein composed of the N-domain 
of SecA1 and the C-domain of E. coli SecA (36).  These findings lead to the conclusion that 
SecA1 is the “housekeeping” SecA with a major function in transporting proteins beyond the 
cytoplasm including proteins involved in essential activities.  Interestingly, SecA2 cannot 
fulfill the essential role of SecA1.  Even when secA2 is overexpressed from a plasmid, the 
chromosomal copy of secA1 in M. smegmatis cannot be deleted (8).  This indicates that 
SecA1 and SecA2 are not functionally equivalent or redundant.  SecA2 in mycobacteria is 
involved in the export of a subset of proteins including lipoproteins with N-terminal signal 
sequences and secreted proteins that lack recognizable signal sequences (8, 9, 21).  SecA2 in 
M. tuberculosis is required for virulence and modulation of the host immune response (9, 
27). 
 
Lipoprotein Processing and Export in M. tuberculosis 
Young and Garbe (1991) were the first to demonstrate the presence of lipoproteins in 
M. tuberculosis (65).  More recently, bioinformatic analysis revealed 99 proteins with 
predicted Sec signal sequences and lipobox motifs in the M. tuberculosis genome (55).  
Demonstration of lipid modification is lacking for the majority of assumed mycobacterial 
lipoproteins and some may be misidentified.  M. tuberculosis has a functional lipoprotein 
signal peptidase LspA as demonstrated by the accumulation of modified but uncleaved 
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lipoprotein precursors in a M. tuberculosis lspA mutant (4, 49).  Testing of M. tuberculosis 
lspA mutants in mice and macrophages further showed that lipoprotein processing is 
important for M. tuberculosis virulence and stimulation of the host Toll-like receptor 2 
signaling pathway, an important arm of innate immunity (4, 49). 
The final location of lipoproteins in mycobacteria is an unresolved issue.  
Mycobacterial lipoproteins may remain anchored to the cytoplasmic membrane or reach 
more external locations such as the outer lipid layer of the cell wall in a manner akin to Lol 
sorting of lipoproteins in Gram-negative bacteria.  There are no obvious orthologs of the Lol 
system in mycobacteria.  However, the crystal structure of M. tuberculosis LppX, which 
functions in the transport of phthiocerol dimycocerosate lipid to the cell surface, is 
structurally similar to E. coli LolA and LolB (54).  This raises the possibility that functional 
homologs of Lol exist in M. tuberculosis.  Additionally, there are a small number of 
lipoproteins reported in M. tuberculosis culture filtrates (44); however, it remains to be 
demonstrated that these secreted species are still lipidated and not trimmed free of the lipid 
moiety. 
 
Tat Pathway 
The twin-arginine translocation (Tat) pathway is a more recently identified system for 
protein export in bacteria (for comprehensive reviews and references see 29, 50).  In contrast 
to the Sec pathway, not all bacteria have a recognizable Tat pathway (18, 64).  Like the Sec 
pathway, the Tat pathway exports proteins across the cytoplasmic membrane.  The proteins 
may be further secreted beyond the cell envelope by a subsequent system (59).  Although 
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there are similarities between the Tat and Sec pathways, Tat-mediated export is Sec-
independent and has the distinct mechanism of translocating folded proteins. 
The majority of research on the Tat pathway has been performed in E. coli (29, 50).  
In E. coli, the Tat translocation apparatus is composed of integral membrane proteins TatA, 
TatB, and TatC.  Some bacteria have an additional TatA homolog with overlapping 
functions, designated TatE.  TatA/E and TatB are similar in structure; both are small with a 
single N-terminal transmembrane domain and an amphipathic tail.  TatC is a larger protein 
with six transmembrane domains.  In vitro, TatA forms large homo-oligomeric rings of 
varying size with a central cavity (22).  This led to the hypothesis that TatA complexes 
represent the membrane-spanning channel through which Tat substrates are translocated.  
The size variation in TatA complexes could account for the wide variety of folded proteins 
that transit the Tat channel, which includes multiprotein and cofactor-bound complexes. 
The current model for Tat export is as follows (22, 29, 50) (Fig. 1.1B).  A folded Tat 
precursor is targeted to a TatBC complex via the Tat signal peptide (1).  After initial 
recognition, TatA channels are recruited to the complex and the folded precursor is passed 
along to the channel and transported across the membrane.  The proton motive force provides 
energy for this process.  Protein folding is a prerequisite for Tat export (17), and some 
cofactor-bound Tat precursors have cognate cytoplasmic chaperones that prevent targeting to 
the Tat pathway until cofactor insertion and/or folding is complete (25, 37, 38).  Some 
bacteria lack a tatB ortholog (18).  In these cases, TatA appears to fulfill the function of 
TatB, making the minimum functional Tat components TatA and TatC. 
Proteins exported by the Tat pathway are synthesized as precursors with N-terminal 
signal peptides that have similar tripartite structures to Sec signal peptides.  This includes the 
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presence of a recognition site that is cleaved during export to generate the mature protein.  In 
Tat precursors the standard A-X-A cleavage site is also cleaved by the LepB peptidase (63).  
There are also Tat signal peptides with lipoboxes and LspA cleavage sites (60).  However, 
there has yet to be direct demonstration of lipidation or LspA cleavage of a Tat exported 
protein.  Additionally, there are examples of Tat substrates that are cytoplasmic membrane 
proteins.  In E. coli, there are examples of proteins transported to the cytoplasmic membrane 
in a Tat-dependent fashion but remain integrated into the membrane via the C-terminus of the 
protein (24).  There are also examples of Fe/S-containing Rieske proteins that are directed to 
the membrane by N-terminal Tat signal sequences but since the signal sequence is not 
cleaved they remain integral membrane proteins (3, 15, 34). 
The major distinction between Sec and Tat signal peptides is the presence of a 
consensus twin-arginine motif in the charged N-region, designated R-R-x-φ- φ (φ = 
uncharged residue) (reviewed in 29, 50).  The twin-arginines ‘RR’ is an important feature of 
the signal peptide since conservative substitution with twin-lysines ‘KK’ prevents export.  
However, the requirement for ‘RR’ is not absolute since exceptions to this rule exist and 
there are other features believed to help define a Tat signal peptide.  Because Tat substrates 
must be folded prior to export, the ability of the mature domain of the precursor to fold in the 
cytoplasm also plays a role in determining whether a protein can be exported by the Tat 
pathway (17).  In connection with this data, it was reported recently that some E. coli twin-
arginine signal sequences direct the export of an unfolded reporter to the Sec pathway and a 
folded reporter to the Tat pathway, and therefore represent a category of signal sequences 
that are promiscuous for export (57). 
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Tat pathway in M. tuberculosis 
M. tuberculosis has a functional Tat pathway (Figure 1.1).  The genome of M. 
tuberculosis contains orthologs of tatABC (13).  The tatA and tatC genes are in an operon 
and cotranscribed (47).  The tatB gene is distantly located from the tatAC operon.  ORFs 
predicted to encode proteins with Tat signal peptides are also present in the genome (18).  
The application of bioinformatics-based Tat substrate recognition programs to the M. 
tuberculosis genome is discussed in Chapter 3. 
The M. tuberculosis tatABC genes appear to be essential under standard laboratory 
conditions.  Disruption of tatAC or tatB in M. tuberculosis was unsuccessful unless a second 
copy of the genes was being expressed from the chromosome (47).  These findings are 
consistent with transposon site hybridization (TraSH) analysis of M. tuberculosis that 
reported tatC as essential for optimal growth (51).  In other bacteria, tat mutants often 
display growth defects; however, M. tuberculosis is the first reported example where the Tat 
pathway is essential for in vitro growth.  The basis of the essential nature of the M. 
tuberculosis Tat pathway is not clear.  Mislocalization of Tat substrates involved in nutrient 
uptake seems the likely explanation, since several putative M. tuberculosis Tat substrates are 
homologous to periplasmic substrate-binding proteins of ABC transporters (18). 
In M. smegmatis, tatABC genes are also present and have the same genomic 
arrangement as in M. tuberculosis.  In M. smegmatis it is possible to construct individual 
deletion mutants of tatA, tatB, and tatC; although, these mutants have in vitro growth defects 
(32, 39).  The characterization of the Tat pathway in M. smegmatis is discussed in greater 
detail in Chapter 2 of this work.  In addition, Posey et al. (39) independently reported results 
with M. smegmatis ∆tat mutants that confirmed our results and also identified some 
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additional properties.  M. smegmatis tat mutants have several additional phenotypes: 
hypersensitivity to sodium dodecyl sulfate, changes in colony morphology, inability to use 
succinate as a sole carbon source, and increased sensitivity to β-lactam antibiotics.  The 
pleiotropic effects of the tat mutations suggest that the mycobacterial Tat pathway exports 
multiple substrates.  Comparative 2D-PAGE of M. smegmatis culture filtrate proteins 
revealed five proteins that were tat-dependent for secretion (39).  Tat substrates are also 
likely to exist in the cell envelope. 
Several lines of evidence demonstrate that export of the M. smegmatis β-lactamase 
(BlaS) is Tat-dependent and that the β-lactam sensitivity phenotype of M. smegmatis tat 
mutants is due to a defect in BlaS export.  Because β-lactams target the cell wall, β-
lactamases must be exported to protect the cell.  Culture filtrates produced from M. 
smegmatis tat mutants contain significantly less β-lactamase, as shown by 2D-PAGE 
analysis and by in vitro enzyme activity assay (32, 39).  Further, M. smegmatis BlaS as well 
as the M. tuberculosis β-lactamase BlaC have predicted Tat signal peptides.  Experiments in 
which the M. tuberculosis BlaC is expressed in a blaS β-lactamase mutant of M. smegmatis 
or a tatA/blaS double mutant show that BlaC can protect from β-lactams only in the presence 
of a functional Tat pathway (32).  Site-directed mutagenesis experiments further demonstrate 
that this ability depends on the ‘RR’ dipeptide in the twin-arginine motif of BlaC.  These 
experiments strongly suggest that M. tuberculosis BlaC, like M. smegmatis BlaS, is exported 
by the Tat pathway and that the Tat pathway is required for the β-lactam resistance of M. 
tuberculosis. 
One can exploit the Tat-export specific properties of BlaC as a reporter tool for study 
and identification of M. tuberculosis proteins with Tat signal peptides.  A truncated ‘BlaC 
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lacking its native Tat signal peptide is not exported and does not protect against β-lactams.  
However, fusion of a Tat signal peptide to the N-terminus of ‘BlaC promotes export as 
measured by β-lactam resistance, and this export requires a functional Tat pathway since 
protection from β-lactams is not seen in M. smegmatis tat mutants (32).  The utilization of 
the ‘BlaC reporter to identify M. tuberculosis Tat-exported fusion proteins is discussed at 
greater length in Chapter 3. 
The Tat pathway functions in several bacterial pathogens and contributes to virulence 
(reviewed in 29).  Pseudomonas aeruginosa uses the Tat pathway for export of the 
phospholipase C virulence factor PlcH across the cytoplasmic membrane.  It is likely that the 
Tat pathway also contributes to the virulence of M. tuberculosis.  The cell wall-localized 
phospholipase C proteins (Plc) of M. tuberculosis have predicted Tat signal peptides.  These 
Plc enzymes are virulence factors in M. tuberculosis (42).  Using the ‘BlaC reporter, the PlcB 
signal peptide was shown to export functional β-lactamase in a Tat and twin ‘RR’-dependent 
manner (32).  This indicates that the PlcB signal peptide of M. tuberculosis is functional in 
Tat export.  Furthermore, export of a functional PlcB fusion to β-lactamase protected M. 
tuberculosis from β-lactam antibiotics during growth in macrophages, indicating that this 
reporter can report on proteins exported within host cells.  This will be discussed in greater 
detail in Chapter 4 of this work.  Of the other predicted Tat exported proteins in M. 
tuberculosis, the majority are uncharacterized.  Interestingly, a M. tuberculosis mutant of 
Rv2525c, which encodes a predicted Tat exported protein, exhibits increased virulence in 
macrophages and in SCID mice (47). 
 
 
 
 
 16 
Summary 
Over recent years, our understanding of the protein transport systems operating in M. 
tuberculosis has greatly improved.  This success was largely driven by the ability to construct 
mutant strains of M. tuberculosis and test individual gene products for roles in protein 
transport.  We anticipate that future research will extend these efforts, combine them with 
sophisticated biochemical characterization of the pathways, and uncover additional pathways 
that transport proteins across the novel mycobacterial cell wall. 
In the following chapters, we describe the initial characterization of the Tat pathway 
in M. smegmatis and demonstrate that mycobacterial β-lactamases are native Tat-exported 
proteins (Chapter 2).  We describe the development of a β-lactamase reporter for Tat-
dependent export in mycobacteria (Chapter 2).  We demonstrate the use of this reporter to 
identify M. tuberculosis signal sequences capable of promoting Tat export of the reporter 
(Chapter 3).  We also describe ongoing evaluation of the export of the respective full length 
M. tuberculosis proteins from the signal sequences we identified (Chapter 3).  We conclude 
with the development and application of a β-lactamase reporter system that works to identify 
Tat proteins exported during growth of M. tuberculosis within macrophages (Chapter 4).  
Together this represents the first steps in determining the role that the Tat pathway plays in 
processes essential for growth of M. tuberculosis in vitro and intracellularly.  These studies 
may pave the way for the development of newer effective anti-TB therapies and better 
diagnostics to report on infection.  Additionally, the ability of the Tat translocase to export 
folded proteins and complexes may be exploited for the improved secretion of protective 
antigens and heterologous proteins. 
 
 17 
References 
 
1. Alami, M., I. Luke, S. Deitermann, G. Eisner, H. G. Koch, J. Brunner, and M. 
Muller. 2003. Differential interactions between a twin-arginine signal peptide and its 
translocase in Escherichia coli. Mol Cell 12:937-46. 
 
2. Babu, M. M., M. L. Priya, A. T. Selvan, M. Madera, J. Gough, L. Aravind, and 
K. Sankaran. 2006. A database of bacterial lipoproteins (DOLOP) with functional 
assignments to predicted lipoproteins. J Bacteriol 188:2761-73. 
 
3. Bachmann, J., B. Bauer, K. Zwicker, B. Ludwig, and O. Anderka. 2006. The 
Rieske protein from Paracoccus denitrificans is inserted into the cytoplasmic 
membrane by the twin-arginine translocase. FEBS J 273:4817-30. 
 
4. Banaiee, N., E. Z. Kincaid, U. Buchwald, W. R. Jacobs, Jr., and J. D. Ernst. 
2006. Potent inhibition of macrophage responses to IFN-gamma by live virulent 
Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but 
dependent on TLR2. J Immunol 176:3019-27. 
 
5. Bensing, B. A., and P. M. Sullam. 2002. An accessory sec locus of Streptococcus 
gordonii is required for export of the surface protein GspB and for normal levels of 
binding to human platelets. Mol Microbiol 44:1081-94. 
 
6. Braunstein, M., S. S. Bardarov, and W. R. J. Jacobs. 2002. Genetic methods for 
deciphering virulence determinants of Mycobacterium tuberculosis, p. 67-99. In V. L. 
Clark and P. M. Bavoil (ed.), Methods in Enzymology, vol. 358. Academic Press, 
London. 
 
7. Braunstein, M., and J. T. Belisle. 2000. Genetics of protein secretion, p. 203-220. In 
G. F. Hatfull and W. R. J. Jacobs (ed.), Molecular genetics of mycobacteria. ASM 
Press. 
 
8. Braunstein, M., A. M. Brown, S. Kurtz, and W. R. Jacobs, Jr. 2001. Two 
nonredundant SecA homologues function in mycobacteria. J Bacteriol 183:6979-90. 
 
9. Braunstein, M., B. J. Espinosa, J. Chan, J. T. Belisle, and W. R. Jacobs, Jr. 2003. 
SecA2 functions in the secretion of superoxide dismutase A and in the virulence of 
Mycobacterium tuberculosis. Mol Microbiol 48:453-64. 
 
10. Bronstein, P. A., M. Marrichi, S. Cartinhour, D. J. Schneider, and M. P. DeLisa. 
2005. Identification of a twin-arginine translocation system in Pseudomonas syringae 
pv. tomato DC3000 and its contribution to pathogenicity and fitness. J Bacteriol 
187:8450-61. 
 
 18 
11. Caldelari, I., S. Mann, C. Crooks, and T. Palmer. 2006. The Tat pathway of the 
plant pathogen Pseudomonas syringae is required for optimal virulence. Mol Plant 
Microbe Interact 19:200-12. 
 
12. Chen, Q., H. Wu, and P. M. Fives-Taylor. 2004. Investigating the role of secA2 in 
secretion and glycosylation of a fimbrial adhesin in Streptococcus parasanguis 
FW213. Mol Microbiol 53:843-56. 
 
13. Cole, S. T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S. V. 
Gordon, K. Eiglmeier, S. Gas, C. E. Barry, 3rd, F. Tekaia, K. Badcock, D. 
Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. 
Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, and B. G. 
Barrell. 1998. Deciphering the biology of Mycobacterium tuberculosis from the 
complete genome sequence. Nature 393:537-44. 
 
14. Dalbey, R. E., and M. Chen. 2004. Sec-translocase mediated membrane protein 
biogenesis. Biochim Biophys Acta 1694:37-53. 
 
15. De Buck, E., L. Vranckx, E. Meyen, L. Maes, L. Vandersmissen, J. Anne, and E. 
Lammertyn. 2007. The twin-arginine translocation pathway is necessary for correct 
membrane insertion of the Rieske Fe/S protein in Legionella pneumophila. FEBS Lett 
581:259-64. 
 
16. de Keyzer, J., C. van der Does, and A. J. Driessen. 2003. The bacterial translocase: 
a dynamic protein channel complex. Cell Mol Life Sci 60:2034-52. 
 
17. DeLisa, M. P., D. Tullman, and G. Georgiou. 2003. Folding quality control in the 
export of proteins by the bacterial twin-arginine translocation pathway. Proc Natl 
Acad Sci U S A 100:6115-20. 
 
18. Dilks, K., R. W. Rose, E. Hartmann, and M. Pohlschroder. 2003. Prokaryotic 
utilization of the twin-arginine translocation pathway: a genomic survey. J Bacteriol 
185:1478-83. 
 
19. Ding, Z., and P. J. Christie. 2003. Agrobacterium tumefaciens twin-arginine-
dependent translocation is important for virulence, flagellation, and chemotaxis but 
not type IV secretion. J Bacteriol 185:760-71. 
 
20. Draper, P., and M. Daffe. 2005. The cell envelope of Mycobacterium tuberculosis 
with special reference to the capsule and outer permeability barrier, p. 261-273. In S. 
T. Cole, K. D. Eisenach, D. N. McMurray, and W. R. J. Jacobs (ed.), Tuberculosis 
and the Tubercle Bacillus. ASM Press, Washington, DC. 
 
21. Gibbons, H. S., F. Wolschendorf, M. Abshire, M. Niederweis, and M. 
Braunstein. 2007. Identification of two Mycobacterium smegmatis lipoproteins 
exported by a SecA2-dependent pathway. J Bacteriol. 189:5090-100. 
 19 
 
22. Gohlke, U., L. Pullan, C. A. McDevitt, I. Porcelli, E. de Leeuw, T. Palmer, H. R. 
Saibil, and B. C. Berks. 2005. The TatA component of the twin-arginine protein 
transport system forms channel complexes of variable diameter. Proc Natl Acad Sci 
U S A 102:10482-6. 
 
23. Gomez, M., S. Johnson, and M. L. Gennaro. 2000. Identification of secreted 
proteins of Mycobacterium tuberculosis by a bioinformatic approach. Infect Immun 
68:2323-7. 
 
24. Hatzixanthis, K., T. Palmer, and F. Sargent. 2003. A subset of bacterial inner 
membrane proteins integrated by the twin-arginine translocase. Mol Microbiol 
49:1377-90. 
 
25. Hatzixanthis, K., D. J. Richardson, and F. Sargent. 2005. Chaperones involved in 
assembly and export of N-oxide reductases. Biochem Soc Trans 33:124-6. 
 
26. Kurtz, S., and M. Braunstein. 2005. Protein secretion and export in Mycobacterium 
tuberculosis, p. 71-138. In T. Parish (ed.), Mycobacterium molecular biology. 
Horizon bioscience, Norfolk, UK. 
 
27. Kurtz, S., K. P. McKinnon, M. S. Runge, J. P. Ting, and M. Braunstein. 2006. 
The SecA2 secretion factor of Mycobacterium tuberculosis promotes growth in 
macrophages and inhibits the host immune response. Infect Immun 74:6855-64. 
 
28. Lavander, M., S. K. Ericsson, J. E. Broms, and A. Forsberg. 2006. The twin 
arginine translocation system is essential for virulence of Yersinia 
pseudotuberculosis. Infect Immun 74:1768-76. 
 
29. Lee, P. A., D. Tullman-Ercek, and G. Georgiou. 2006. The bacterial twin-arginine 
translocation pathway. Annu Rev Microbiol 60:373-395. 
 
30. Lenz, L. L., and D. A. Portnoy. 2002. Identification of a second Listeria secA gene 
associated with protein secretion and the rough phenotype. Mol Microbiol 45:1043-
56. 
 
31. McDonough, J. A., and M. Braunstein. 2007. Protein transport in Mycobacterium 
tuberculosis. In S. H. Kaufmann and E. J. Rubin (ed.), MTB Handbook Volume 1: 
Molecular Genetics and Biochemistry, vol. In press. Wiley-VCH Verlag Press. 
 
32. McDonough, J. A., K. E. Hacker, A. R. Flores, M. S. Pavelka, Jr., and M. 
Braunstein. 2005. The twin-arginine translocation pathway of Mycobacterium 
smegmatis is functional and required for the export of mycobacterial beta-lactamases. 
J Bacteriol 187:7667-79. 
 
 20 
33. Meya, D. B., and K. P. McAdam. 2007. The TB pandemic: an old problem seeking 
new solutions. J Intern Med 261:309-29. 
 
34. Molik, S., I. Karnauchov, C. Weidlich, R. G. Herrmann, and R. B. Klosgen. 
2001. The Rieske Fe/S protein of the cytochrome b6/f complex in chloroplasts: 
missing link in the evolution of protein transport pathways in chloroplasts? J Biol 
Chem 276:42761-6. 
 
35. Mori, H., and K. Ito. 2001. The Sec protein-translocation pathway. Trends 
Microbiol 9:494-500. 
 
36. Owens, M. U., W. E. Swords, M. G. Schmidt, C. H. King, and F. D. Quinn. 2002. 
Cloning, expression, and functional characterization of the Mycobacterium 
tuberculosis secA gene. FEMS Microbiol Lett 211:133-41. 
 
37. Palmer, T., F. Sargent, and B. C. Berks. 2005. Export of complex cofactor-
containing proteins by the bacterial Tat pathway. Trends Microbiol 13:175-80. 
 
38. Perez-Rodriguez, R., A. C. Fisher, J. D. Perlmutter, M. G. Hicks, A. Chanal, C. 
L. Santini, L. F. Wu, T. Palmer, and M. P. Delisa. 2007. An essential role for the 
DnaK molecular chaperone in stabilizing over-expressed substrate proteins of the 
bacterial twin-arginine translocation pathway. J Mol Biol. 367:715-30. 
 
39. Posey, J. E., T. M. Shinnick, and F. D. Quinn. 2006. Characterization of the twin-
arginine translocase secretion system of Mycobacterium smegmatis. J Bacteriol 
188:1332-40. 
 
40. Pradel, N., C. Ye, V. Livrelli, J. Xu, B. Joly, and L. F. Wu. 2003. Contribution of 
the twin arginine translocation system to the virulence of enterohemorrhagic 
Escherichia coli O157:H7. Infect Immun 71:4908-4916. 
 
41. Pugsley, A. P. 1993. The complete general secretory pathway in gram-negative 
bacteria. Microbiol Rev 57:50-108. 
 
42. Raynaud, C., C. Guilhot, J. Rauzier, Y. Bordat, V. Pelicic, R. Manganelli, I. 
Smith, B. Gicquel, and M. Jackson. 2002. Phospholipases C are involved in the 
virulence of Mycobacterium tuberculosis. Mol Microbiol 45:203-17. 
 
43. Reyrat, J. M., and D. Kahn. 2001. Mycobacterium smegmatis: an absurd model for 
tuberculosis? Trends Microbiol 9:472-4. 
 
44. Rosenkrands, I., A. King, K. Weldingh, M. Moniatte, E. Moertz, and P. 
Andersen. 2000. Towards the proteome of Mycobacterium tuberculosis. 
Electrophoresis 21:3740-56. 
 
 21 
45. Rossier, O., and N. P. Cianciotto. 2005. The Legionella pneumophila tatB gene 
facilitates secretion of phospholipase C, growth under iron-limiting conditions, and 
intracellular infection. Infect Immun 73:2020-32. 
 
46. Russell, D. G. 2007. Who puts the tubercle in tuberculosis? Nat Rev Microbiol 5:39-
47. 
 
47. Saint-Joanis, B., C. Demangel, M. Jackson, P. Brodin, L. Marsollier, H. Boshoff, 
and S. T. Cole. 2006. Inactivation of Rv2525c, a substrate of the twin arginine 
translocation (Tat) system of Mycobacterium tuberculosis, increases {beta}-lactam 
susceptibility and virulence. J Bacteriol 188:6669-79. 
 
48. Saleh, M. T., M. Fillon, P. J. Brennan, and J. T. Belisle. 2001. Identification of 
putative exported/secreted proteins in prokaryotic proteomes. Gene 269:195-204. 
 
49. Sander, P., M. Rezwan, B. Walker, S. K. Rampini, R. M. Kroppenstedt, S. 
Ehlers, C. Keller, J. R. Keeble, M. Hagemeier, M. J. Colston, B. Springer, and E. 
C. Bottger. 2004. Lipoprotein processing is required for virulence of Mycobacterium 
tuberculosis. Mol Microbiol 52:1543-52. 
 
50. Sargent, F., B. C. Berks, and T. Palmer. 2006. Pathfinders and trailblazers: a 
prokaryotic targeting system for transport of folded proteins. FEMS Microbiol Lett 
254:198-207. 
 
51. Sassetti, C. M., D. H. Boyd, and E. J. Rubin. 2003. Genes required for 
mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48:77-84. 
 
52. Schneider, G. 1999. How many potentially secreted proteins are contained in a 
bacterial genome? Gene 237:1113-1121. 
 
53. Scott, J. R., and T. C. Barnett. 2006. Surface proteins of gram-positive bacteria and 
how they get there. Annu Rev Microbiol 60:397-423. 
 
54. Sulzenbacher, G., S. Canaan, Y. Bordat, O. Neyrolles, G. Stadthagen, V. Roig-
Zamboni, J. Rauzier, D. Maurin, F. Laval, M. Daffe, C. Cambillau, B. Gicquel, 
Y. Bourne, and M. Jackson. 2006. LppX is a lipoprotein required for the 
translocation of phthiocerol dimycocerosates to the surface of Mycobacterium 
tuberculosis. EMBO J 25:1436-44. 
 
55. Sutcliffe, I. C., and D. J. Harrington. 2004. Lipoproteins of Mycobacterium 
tuberculosis: an abundant and functionally diverse class of cell envelope components. 
FEMS Microbiol Rev 28:645-59. 
 
56. Tokuda, H., and S. Matsuyama. 2004. Sorting of lipoproteins to the outer 
membrane in E. coli. Biochim Biophys Acta 1693:5-13. 
 
 22 
 
57. Tullman-Ercek, D., M. P. Delisa, Y. Kawarasaki, P. Iranpour, B. Ribnicky, T. 
Palmer, and G. Georgiou. 2007. Export pathway selectivity of Escherichia coli 
twin-arginine translocation signal peptides. J Biol Chem. 282:8309-16. 
 
58. van der Laan, M., N. P. Nouwen, and A. J. Driessen. 2005. YidC--an evolutionary 
conserved device for the assembly of energy-transducing membrane protein 
complexes. Curr Opin Microbiol 8:182-7. 
 
59. Voulhoux, R., G. Ball, B. Ize, M. L. Vasil, A. Lazdunski, L. F. Wu, and A. 
Filloux. 2001. Involvement of the twin-arginine translocation system in protein 
secretion via the type II pathway. EMBO J 20:6735-41. 
 
60. Widdick, D. A., K. Dilks, G. Chandra, A. Bottrill, M. Naldrett, M. Pohlschroder, 
and T. Palmer. 2006. The twin-arginine translocation pathway is a major route of 
protein export in Streptomyces coelicolor. Proc Natl Acad Sci U S A. 103:17927-32. 
 
61. WorldHealthOrganization 2007, posting date. WHO Information tuberculosis fact 
sheet. [Online.] 
 
62. Wu, C. H. 1996. Biosynthesis of lipoproteins, p. 1005-1014. In F. C. Neidhart (ed.), 
Escherichia coli and Salmonella typhimurium. ASM Press, Washington, DC. 
 
63. Yahr, T. L., and W. T. Wickner. 2001. Functional reconstitution of bacterial Tat 
translocation in vitro. EMBO J 20:2472-9. 
 
64. Yen, M. R., Y. H. Tseng, E. H. Nguyen, L. F. Wu, and M. H. Saier, Jr. 2002. 
Sequence and phylogenetic analyses of the twin-arginine targeting (Tat) protein 
export system. Arch Microbiol 177:441-50. 
 
65. Young, D. B., and T. R. Garbe. 1991. Lipoprotein antigens of Mycobacterium 
tuberculosis. Res Microbiol 142:55-65. 
 
  
 
 
 
CHAPTER 2 
 
The Twin-arginine Translocation (Tat) Pathway of Mycobacterium smegmatis is 
Functional and Required for the Export of Mycobacterial β-Lactamases 
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The twin-arginine translocation (Tat) pathway exports folded proteins across the 
bacterial cytoplasmic membrane and is responsible for the proper extracytoplasmic 
localization of proteins involved in a variety of cellular functions, including pathogenesis.  
The Mycobacterium tuberculosis and Mycobacterium smegmatis genomes contain open 
reading frames with homology to components of the Tat export system (TatABC) as well as 
potential Tat-exported proteins possessing N-terminal signal sequences with the 
characteristic twin-arginine motif.  Due to the importance of exported virulence factors in the 
pathogenesis of M. tuberculosis and the limited understanding of mycobacterial protein 
export systems, we sought to determine the functional nature of the Tat export pathway in 
mycobacteria.  Here we describe phenotypic analyses of ∆tatA and ∆tatC deletion mutants of 
M. smegmatis which demonstrated that tatA and tatC encode components of a functional Tat 
system capable of exporting characteristic Tat substrates.  Both mutants displayed a growth 
defect on agar medium and hypersensitivity to SDS.  The mutants were also defective in the 
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export of active β-lactamases of M. smegmatis (BlaS) and M. tuberculosis (BlaC), both of 
which possess twin-arginine signal sequences.  The Tat-dependent nature of BlaC was 
further revealed by mutation of the twin-arginine motif.  Finally, we demonstrated that 
replacement of the native signal sequence of BlaC with the predicted Tat signal sequences of 
M. tuberculosis phospholipase C proteins (PlcA and PlcB) resulted in the Tat-dependent 
export of an enzymatically active ‘BlaC.  Thus, ‘BlaC can be used as a genetic reporter for 
Tat-dependent export in mycobacteria.   
 
Introduction 
 
 Tuberculosis (TB), caused by the bacillus Mycobacterium tuberculosis, remains a 
global health problem accounting for over two million deaths annually (23).  The ability to 
survive in host phagocytes is a poorly understood virulence property of M. tuberculosis.  The 
M. tuberculosis proteins exported to the bacterial cell surface or secreted by the bacillus are 
ideally positioned to interact with host cell components and include virulence factors that 
promote intracellular survival. 
 Our understanding of how exported mycobacterial proteins are transported beyond 
the cytoplasmic membrane is limited (42).  In bacteria, the well-characterized general 
secretion (Sec) pathway transports unfolded proteins across the cytoplasmic membrane to 
their final destination (for reviews, see 19, 56).  Proteins targeted to this system contain 
specific N-terminal signal sequences (ss) that consist of a positively-charged region followed 
by a stretch of hydrophobic residues and end with a short uncharged polar region.  Upon 
export, the signal sequence is cleaved yielding the mature protein.  The Sec pathway is also 
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involved in the insertion of some integral membrane proteins and in these cases the signal 
sequences are not always cleaved (18).  Numerous Sec proteins are required for the operation 
of this pathway including SecA, which provides the energy to move unfolded proteins 
through the Sec pore (19, 56).  Mycobacteria possess a functional Sec pathway and the 
unusual property of possessing two SecA proteins (11, 12). 
  Recent studies reveal that many bacteria also utilize a twin-arginine translocation 
(Tat) pathway to transport proteins across the cytoplasmic membrane.  The Tat pathway 
operates independently of the Sec pathway and is distinguished by the ability to translocate 
proteins in a folded state.  Although studies in Escherichia coli provide the majority of 
information regarding the Tat pathway (for reviews, see 13, 59), the list of prokaryotic 
organisms experimentally shown to possess a functional Tat export pathway is expanding 
and includes Gram-positive bacteria such as Bacillus subtilis and Streptomyces spp., (40, 66, 
67).  In addition, the Tat pathway was shown to function in some bacterial pathogens and to 
contribute to virulence in Pseudomonas aeruginosa, Agrobacterium tumefaciens, 
enterohemorrhagic E. coli O157:H7, and Legionella pneumophila (22, 55, 60, 79). 
Substrates of the Tat pathway are synthesized as precursor proteins containing N-
terminal signal sequences with the same overall structure as Sec signal sequences.  The major 
distinction between Sec and Tat signal sequences is the presence of a characteristic twin-
arginine motif in the charged region of Tat signal sequences, defined as R-R-x-φ-φ (φ = 
uncharged residue) (4, 6).  The importance of the twin arginines ‘RR’ to Tat export was 
shown by conservative substitution with twin lysines ‘KK’ in Tat signal sequences, which 
eliminates the export of many native Tat substrates and Tat-dependent reporter proteins (17, 
30, 73).  However, the requirement for twin arginines in a Tat-exported protein is not 
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absolute since there are reported examples of Tat substrates that lack a characteristic ‘RR’ 
signature (33, 36).  Additional elements such as the degree of hydrophobicity in the region 
following the R-R-x-φ-φ  motif and the presence of a positively-charged residue near the end 
of the signal sequence may also play a role in Tat-dependent export (17). 
 In E. coli, the Tat translocation apparatus is composed of the TatA, TatB, and TatC 
proteins (63).  E. coli has an additional TatA homologue, designated TatE, which has 
overlapping functions with TatA.  TatA and TatB are similar in structure, with each having a 
single transmembrane domain and a cytoplasmic tail (64).  A number of GC-rich Gram-
positive bacteria lack tatB (21), and in these bacteria TatA likely fulfills the function of both 
TatA and TatB.  TatC is a more complex protein containing four to six transmembrane 
domains (9, 28).  Current models suggest that TatC and TatB are involved in the initial 
recognition and delivery of Tat substrates to the protein conducting channel, composed of an 
oligomer of TatA (5, 27).  In all reported cases, deletions of tatA, tatB, or tatC yield viable 
mutants with defects in the export of Tat signal sequence-containing proteins (9, 22, 40, 63, 
66, 79). 
We describe here analysis of the Tat pathway in the fast-growing nonpathogen M. 
smegmatis, often used as a genetic model for investigating physiologic properties of 
mycobacteria.  We demonstrate that the Tat pathway is functional in M. smegmatis.  
Furthermore, we show that an intact Tat system is required for optimal growth of M. 
smegmatis in vitro and for the export of active mycobacterial β-lactamases.  We also 
demonstrate the potential for using a truncated β-lactamase (‘BlaC) lacking its native Tat 
signal sequence as a reporter for Tat-dependent exported proteins, including virulence factors 
of M. tuberculosis. 
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Materials and Methods 
 
Bacterial strains and culture methods. 
The strains used during this work are listed in Table 2.1.  E. coli strains DH5α, 
TOP10 (Invitrogen), EP1300 (Epicentre), and EZ (Qiagen) were used for DNA cloning 
procedures.  Luria-Bertani (LB) medium (Fisher) was used for culturing of E. coli and 
antibiotics were added at the following concentrations:  150 µg/ml, hygromycin B (Roche 
Applied Science); 100 µg/ml, ampicillin; or 40 µg/ml, kanamycin (Acros Chemicals).  
Middlebrook 7H9 or 7H10 medium (Difco; BD Biosciences) was used for the culturing of M. 
smegmatis and M. tuberculosis.  For growth of M. smegmatis, Middlebrook medium was 
supplemented with 0.5% glycerol and 0.2% dextrose.  For growth of M. tuberculosis, 
Middlebrook medium was supplemented with 0.5% glycerol and 1× ADS (0.5% bovine 
serum albumin, fraction V [Roche]; 0.2% dextrose; and 0.85% NaCl).  When necessary, 
media was supplemented with 0.05-0.1% Tween-80 (Fisher).  Antibiotics were added to 
Middlebrook media at the following concentrations:  50 µg/ml, hygromycin B; 50 µg/ml, 
carbenicillin; or 20 µg/ml, kanamycin.  When necessary, sucrose was added to 7H10 plates at 
a concentration of 4.5%.  L-lysine at 40 and 80 µg/ml was added to agar and liquid media, 
respectively, for growth of M. smegmatis strains PM759 and JM578. 
 
Molecular biology procedures. 
Standard molecular biology techniques were employed as previously described (61).  
The Expand high fidelity PCR system (Roche) was used in all PCR reactions from 
chromosomal DNA and dimethyl sulfoxide at 5.0% was included in select PCR reactions.   
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TABLE 2.1. Strains used in this study 
 
Strain Description Reference 
E. coli   
  K-12 DH5α F- [φ80d∆lacZM15] ∆(lacZYA-argF) U169 deoR recA1 endA1 
hsdR17 glnV44 thi-1 gyrA96 relA1 
Gibco-BRL 
  TOP10 F- mcrA [φ80d∆lacZM15] ∆(mrr-hsdRMS-mcrBC) ∆lacX74 deoR 
recA1 endA1 araD139 ∆(ara, leu)7697 galU galK rpsL nupG 
Invitrogen 
  EP1300 F- mcrA [φ80d∆lacZM15] ∆(mrr-hsdRMS-mcrBC) ∆lacX74 recA1 
endA1 araD139 ∆(ara, leu)7697 galU galK λ- rpsL nupG trfA 
Epicentre 
  Qiagen EZ [F'::Tn10(Tcr) proA+B+ lacIqZ∆M15] recA1 end A1 hsdR17 (rK12 
–
 mK12
+) lac glnV44 thi-1 gyrA96 relA1 
Qiagen 
   
M. smegmatis   
  mc2155 ept-1 (70) 
  MB679 mc2155::pKEH4, tatA single-crossover strain This work 
  JM499 mc2155::pJM112, tatC single-crossover strain This work 
  MB692 mc2155, ∆tatA This work 
  JM567 mc2155, ∆tatC This work 
  PM759 mc2155, ∆blaS1 ∆lysA4 rpsL6 (25) 
  JM575 PM759::pKEH4, tatA single-crossover strain This work 
  JM578 PM759, ∆tatA This work 
   
M. tuberculosis   
  H37Rv Virulent (2) 
  PM638 H37Rv, ∆blaC1 (25) 
 
DNA sequencing was performed by the UNC-CH Automated DNA Sequencing Facility. 
 
Construction of ∆tat suicide plasmids. (i) ∆tatA suicide plasmid pKEH4. 
Genomic sequence immediately upstream and downstream of the tatA gene, including 
the 5’ and 3’ termini of tatA were amplified from M. smegmatis genomic DNA using the 
following primers:  tatAUpstream1 (5’- AGATATCCTCCGCAGGCGTGGATCAT), 
tatAUpstream2 (5’- ACATATGGGTTACCTCCAGAACGTCGGTG), tatADownstream1 
(5’- TCATATGCAGTCCACGGACCGGCACAC), and tatADownstream2 (5’- 
CGACTTCCAGCAGCACCGTCA) (underlined residues denote the NdeI-XbaI restriction 
sites).  The PCR products were cloned into the pCR2.1 vector (Invitrogen) to generate 
pKEH1 and pKEH2.  The NdeI-XbaI fragment from pKEH2 containing the downstream tatA 
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flank was cloned into NdeI-XbaI cut pKEH1.  The resulting plasmid, pKEH3, contained a 
221-bp unmarked in-frame deletion of tatA.  The 1.7-kbp tatA deletion fragment was then cut 
out of pKEH3 by EcoRV and cloned into the EcoRV site on counterselectable suicide vector 
pYUB657 (51), generating pKEH4.  DNA inserts in the above plasmids were sequenced and 
determined to be error-free. 
(ii) ∆tatC suicide plasmid pJM112.  Genomic sequence immediately upstream and 
downstream of the tatC gene, including the 5’ and 3’ termini of tatC were amplified from M. 
smegmatis genomic DNA using the following primers:  SmTatC1 (5’- 
GCGTGGATGTTCGACTACTACC), SmTatC2 (5’- 
AAGCTTGTTGCGAAGCTCGTGGAGGTG), SmTatC3 (5’- 
AAGCTTCTCAACGACCGCAGGAAGGC), and SmTatC4 (5’- 
GCAGGTGCAGGATGACCTCTTC) (underlined residues denote the HindIII restriction 
sites).  The PCR products were cloned into the pCC1 vector using the CopyControl PCR 
cloning kit (Epicentre) to generate pJM104 and pJM105.  A 753-bp HindIII fragment from 
pJM104 containing the upstream tatC flank was cloned into pJM105 cut with HindIII.  The 
resulting plasmid, pJM110, contained a 690-bp unmarked in-frame deletion of the tatC gene.  
The 1.3-kbp tatC deletion fragment was then cut out of pJM110 by BamHI and cloned into 
the BglII site on counterselectable suicide vector pYUB657 (51), producing pJM112.  DNA 
inserts were sequenced and determined to be error-free. 
 
Two-step allelic exchange to create ∆tat mutants of M. smegmatis. 
To construct the ∆tatA mutants, pKEH4 was electroporated into mc2155 as described 
previously (50, 51) and hygromycin-resistant transformants were selected.  Individual 
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transformants were subjected to Southern analysis and shown to contain the suicide vector 
integrated into the tatA region of the chromosome by means of a single-crossover event.  One 
of these strains, MB679, was employed in the subsequent steps.  For the second homologous 
recombination event, MB679 was grown to saturation in 7H9 medium with hygromycin.  
This culture was then subcultured at a 1:100 dilution into the same medium lacking 
hygromycin and incubated overnight.  Dilutions were plated onto 7H10 plates containing 
4.5% sucrose to select for sucrose-resistant colonies.  Sucrose-resistant strains were patched 
onto 7H10 plates containing hygromycin.  Strains that were both sucrose-resistant and 
hygromycin-sensitive were analyzed by PCR and Southern analysis for a deletion at the tatA 
locus.  The same procedure was performed in the ∆blaS PM759 background to generate a 
∆blaS ∆tatA deletion strain.  To obtain ∆tatC mutants, pJM112 was electroporated into 
mc2155 and hygromycin-resistant transformants were confirmed to be the result of a single-
crossover event by Southern analysis.  One of these clones, JM499, was used for the 
subsequent work presented in this report.  The second homologous recombination event was 
selected by using the protocol described above for MB679. 
 
Southern analysis. 
To analyze tatA recombinants, genomic DNA was isolated from M. smegmatis strains 
as previously described (10) and digested with NdeI-FspI.  The probe used was a 910-bp SalI 
fragment of pJM120 containing tatC of M. smegmatis.  To analyze tatC recombinants, 
genomic DNA was isolated and digested with FspI.  The probe used was a 753-bp HindIII 
fragment obtained from pJM104 that contains tatA of M. smegmatis.  Southern analysis was 
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performed as previously described (61), and probes were labeled with [32P]dCTP using the 
Ready-to-Go Labeling kit (Amersham). 
 
Antimicrobial susceptibility testing. 
The replica-inoculating MIC method used was adapted from a previously described 
protocol (71).  Mid-exponential-phase M. smegmatis cultures were diluted ten-fold in 7H9 
liquid medium and spotted using a multi-pronged replica-inoculating device onto 7H10 agar 
plates containing 2-fold dilutions of carbenicillin.  Culture dilutions containing an estimated 
102 to 104 colony-forming units (CFU) of M. smegmatis resulted in confluent growth on agar 
plates lacking carbenicillin.  For plates containing antibiotic, the lowest concentration of 
carbenicillin that inhibited growth completely after incubation for four days was designated 
the minimum inhibitory concentration (MIC).  Each MIC determination was performed in 
triplicate.  For determining sensitivity to sodium dodecyl sulfate (SDS), mid-exponential-
phase M. smegmatis cultures were diluted ten-fold in 7H9 liquid medium and spotted using a 
multi-pronged replica-inoculating device onto 7H10 agar plates containing 0.0025% SDS. 
 
Preparation of culture filtrates and whole-cell extracts from M. smegmatis for nitrocefin 
analysis. 
To obtain cell-free culture filtrates, exponential-phase M. smegmatis cultures were 
diluted to an optical density (OD600) = 0.1 and allowed to grow at 37ºC for two generations.  
When the culture reached an OD600 = 0.4, 500 µl was applied to a 0.2 µm NANOSEP 
centrifugal filter (Pall Filtron) and the culture filtrate was harvested by centrifugation at 
13,000 rpm.  Alternatively, culture filtrates were harvested using a 0.22 µm Millex-GV 
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syringe-driven filter unit (Millipore).  Whole cell extracts were prepared from the remaining 
culture by harvesting 10 ml of culture by centrifugation and the pellets stored at -20ºC.  At a 
later time, the pellets were resuspended in 200 µl of 1×PBS with protease inhibitors (10 
µg/ml aprotinin, 10 µg/ml E-64, 10 µg/ml leupeptin, 500 µg/ml Pefabloc SC, 10 µg/ml 
pepstatin A) to which 0.4 g of 106 µm glass beads (Sigma) was added.  The cells and beads 
were then vortexed twice for 5 min at 4ºC with a 5 min rest on ice.  200 µl of 1×PBS with 
protease inhibitors was added, followed by vortexing, and centrifugation for 10 minutes at 
4°C.  Culture filtrates and cell extracts were assayed for total protein content using the 
bicinchoninic acid (BCA) protein quantification kit (Pierce). 
 
Nitrocefin assays. 
The β-lactamase activity of M. smegmatis whole-cell extracts and culture filtrates was 
determined using the chromogenic β-lactam nitrocefin (46), as previously described (25).  
Assays were performed on triplicate wells set up from a single culture, and β-lactamase 
activity, expressed as A486 min-1 mg total protein-1, was reported as an average with standard 
deviation.  Each experiment was repeated three times and a representative experiment is 
presented. 
 
Construction of ‘blaC fusion plasmids. 
(i) ss-plcA. Genomic sequence encoding the predicted signal sequence of M. 
tuberculosis plcA was amplified from M. tuberculosis genomic DNA using the following 
primers:  plcA-1 (5’- TGGCCAGC-CGTCGAGAGTTTTTGACAAAG) (underlined residues 
denote the MscI restriction site) and plcA-3 (5’- GGATC-CGCCGTAGGCCTTTTCAATCA) 
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(underlined residues denote the BamHI restriction site).  The 104-bp PCR product was cloned 
into the pCR2.1 vector (Invitrogen) to generate pJM128.  A 96-bp MscI-BamHI fragment 
from pJM128 was cloned into pMV261 cut with MscI-BamHI.  The resulting plasmid, 
pJM129, contained the predicted signal sequence of plcA cloned downstream of the hsp60 
promoter. 
(ii) ss-plcB. Genomic sequence encoding the predicted signal sequence of M. tuberculosis 
plcB was amplified from M. tuberculosis genomic DNA using the following primers:  plcB-1 
(5’- ATGGCC-ACCCGCCGACAATTTTTTGC) (underlined residues denote the MscI 
restriction site) and plcB-3 (5’- GGATCC-TCCGTAGGCTTTTTCGATA) (underlined 
residues denote the BamHI restriction site).  The 104-bp PCR product was cloned into the 
pCR2.1 vector (Invitrogen) to generate pMB221.  A 104-bp MscI-BamHI fragment from 
pMB221 was cloned into pMV261 cut with MscI-BamHI.  The resulting plasmid, pMB222, 
contained the predicted signal sequence of plcB cloned downstream of the hsp60 promoter.  
(iii) ss-mpt63. Genomic sequence containing the 5’ region of the mpt63/Rv1926c gene was 
amplified from M. tuberculosis genomic DNA using the following primers:  Rv1926c-5 (5’- 
CTGCGCAT-GAAGCTCACCACAATGATCAAG) (underlined residues denote the FspI 
restriction site) and Rv1926c-6 (5’- AGGATCC-AGCCAACGCGACCGGTGCCGCAAAG) 
(underlined residues denote the BamHI restriction site).  The 94-bp PCR product was cloned 
into the pDRIVE vector (Qiagen) to generate pMB226.  A 94-bp FspI-BamHI fragment from 
pMB226 was cloned into pMV261 cut with MscI-BamHI.  The resulting plasmid, pMB228, 
contained the predicted signal sequence of mpt63 cloned downstream of the hsp60 promoter.  
(iv) ‘blaC.  Sequence encoding a truncated version of M. tuberculosis blaC lacking its 
predicted signal sequence (‘blaC) was amplified from pMP159 (25) using the following 
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primers:  blaCfor1 (5’- AGATCTGCG-CGTCCGGCATCGACAACCTTGC) and blaCrev 
(5’- AGATCT-CCACGAGCCTATGCAAGCACAC) (underlined residues denote the BglII 
restriction sites).  The 854-bp PCR product was cloned into the pCC1 vector (Epicentre) to 
generate pJM106.  A 848-bp BglII fragment from pJM106 was end-filled with Klenow and 
cloned into pMV261 cut with MscI.  The resulting plasmid, pJM113, contained the predicted 
mature sequence of blaC cloned downstream of the hsp60 promoter.  All other plasmids used 
in this work are described in Table 2.2.  Translational fusion plasmids were sequenced and 
shown to be error-free. 
 
Site-directed mutagenesis of ‘blaC fusion plasmids. 
Site-directed mutagenesis was employed to replace the twin-arginine residues of the M. 
tuberculosis PlcB signal sequence with twin-lysine residues.  pJM111 was used as the 
template in an inverse PCR using primers plcB-RR2KKfor (5’-
AAGCAATTTTTTGCCAAAGCCGCC) and plcB-RR2KKrev (5’-
CTTGGTGGCCATTGCGAAGTGATT) (underlined residues denote mutated bases).  The 
resulting PCR product was gel purified, 5’-phosphorylated using the End-It DNA End-Repair 
Kit (Epicentre), and self-ligated.  The resulting plasmid, pJM118, was sequenced to verify 
the presence of the mutated bases.  Likewise, to replace the twin-arginine residues of the 
BlaC signal sequence with twin-lysine residues, pMP327 was used as the template in an 
inverse PCR using primers blaC-RR2KKfor (5’-
AAGGAACTGCTGGTAGCGATGGCAATG) and blaC-RR2KKrev (5’- 
CTTACCGAATCCTCTGTTGCGCATGCC).  The resulting plasmid, pJM117, was 
sequenced to verify the presence of the mutated bases. 
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TABLE 2.2. Plasmids used in this study 
 
Plasmid Genotype Description Source 
pCC1 cat oriV ori2 CopyControl (single copy) blunt cloning vector Epicentre 
pCR2.1 bla aph ColE1 TA cloning vector Invitrogen 
pDRIVE bla aph ColE1 UA cloning vector Qiagen 
pMV261.kan aph Phsp60 oriM ColE1 Multicopy mycobacterial shuttle plasmid (75) 
pJSC77 aph Phsp60 -HA oriM ColE1 HA tag cloned into pMV261  (26) 
pMB198 hyg int attP ColE1 Single-copy mycobacterial shuttle plasmid (11) 
pYUB657 bla hyg Phsp60-sacB ColE1 Counterselectable suicide plasmid for mycobacteria (51) 
pJM104 cat oriV ori2 M. smegmatis tatC upstream flank cloned into pCC1 This work 
pJM105 cat oriV ori2 M. smegmatis tatC downstream flank cloned into pCC1 This work 
pJM110 cat ∆tatC (M. smegmatis) 
oriV ori2 
tatC upstream flank from pJM104 cloned adjacent to tatC 
downstream flank in pJM105 
This work 
pJM112 bla hyg Phsp60-sacB ∆tatC 
(M. smegmatis) ColE1 
1.3-kbp BamHI fragment containing ∆tatC from pJM110 
cloned into pYUB657 
This work 
pKEH1 bla aph ColE1 M. smegmatis tatA upstream flank cloned into pCR2.1 This work 
pKEH2 bla aph ColE1 M. smegmatis tatA downstream flank cloned into pCR2.1 This work 
pKEH3 bla aph ColE1 ∆tatA (M. 
smegmatis) 
tatA downstream flank from pKEH2 cloned adjacent to tatA 
upstream flank in pKEH1  
This work 
pKEH4 bla hyg Phsp60-sacB ∆tatA 
(M. smegmatis) ColE1 
1.7-kbp EcoRV fragment containing ∆tatA from pKEH3 
cloned into pYUB657 
This work 
pJM119 cat tatC (M. smegmatis) 
oriV ori2 
M. smegmatis tatC ORF cloned into pCC1 This work 
pJM120 aph Phsp60-tatC-HA (M. 
smegmatis) oriM ColE1 
M. smegmatis tatC ORF from pJM119 cloned into pJSC77; 
HA-tagged M. smegmatis tatC under control of hsp60 
promoter 
This work 
pMB234 bla aph tatA (M. 
smegmatis) ColE1 
M. smegmatis tatA ORF cloned into pCR2.1 This work 
pMB236 aph Phsp60-tatA (M. 
smegmatis) oriM ColE1 
M. smegmatis tatA ORF from pMB234 cloned into pMV261; 
M. smegmatis tatA under control of hsp60 promoter 
This work 
pJM124 hyg Phsp60-tatA (M. 
smegmatis) int attP ColE1 
Phsp60-tatA from pMB236 cloned into pMB198 This work 
pMP159 bla blaC (M. tuberculosis) 
ColE1 
Fragment containing blaC from MTCY49 in pKS+ (25) 
pMP327 aph PblaC-blaC (M. 
tuberculosis) oriM ColE1 
M. tuberculosis blaC from pMP159 cloned into pMV261; M. 
tuberculosis blaC under control of endogenous promoter 
This work 
pJM106 cat ‘blaC (M. tuberculosis) 
oriV ori2 
Predicted M. tuberculosis ‘blaC mature sequence cloned into 
pCC1 
This work 
pMM7-2 aph Phsp60-ssfbpB (M. 
tuberculosis) oriM ColE1 
M. tuberculosis fbpB signal sequence in pMV261 under 
control of hsp60 promoter 
(82) 
pJM109 aph Phsp60-ssfbpB-‘blaC 
(M. tuberculosis) oriM 
ColE1 
’blaC from pJM106 cloned into pMM7-2 This work 
pJM128 bla aph ColE1 Predicted M. tuberculosis plcA signal sequence cloned into 
pCR2.1  
This work 
pJM129 aph Phsp60-ssplcA (M. 
tuberculosis) oriM ColE1 
M. tuberculosis plcA signal sequence from pJM128 cloned 
into MscI-BamHI cut pMV261 
This work 
pJM130 aph Phsp60-ssplcA-‘blaC 
(M. tuberculosis) oriM 
ColE1 
’blaC from pJM106 cloned into pJM129 This work 
pMB221 bla aph ColE1 Predicted M. tuberculosis plcB signal sequence cloned into 
pCR2.1  
This work 
pMB222 aph Phsp60-ssplcB (M. 
tuberculosis) oriM ColE1 
M. tuberculosis plcB signal sequence from pMB221 cloned 
into MscI-BamHI cut pMV261 
This work 
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TABLE 2.2. (Continued) Plasmids used in this study 
 
pJM111 aph Phsp60-ssplcB-‘blaC (M. 
tuberculosis) oriM ColE1 
’blaC from pJM106 cloned into pMB222 This work 
pMB226 bla aph ColE1 
 
M. tuberculosis mpt63 signal sequence cloned into pDRIVE This work 
pMB227 aph Phsp60-ssmpt63 (M. 
tuberculosis) oriM ColE1 
M. tuberculosis mpt63 signal sequence from pMB226 cloned 
into MscI-BamHI cut pMV261 
This work 
pMB228 aph Phsp60-ssmpt63-‘blaC 
(M. tuberculosis) oriM 
ColE1 
’blaC from pJM106 cloned into pMB227 This work 
pJM113 aph Phsp60-‘blaC (M. 
tuberculosis) oriM ColE1 
’blaC from pJM106 cloned into MscI-linearized pMV261 This work 
pJM117 aph PblaC-(KK)blaC (M. 
tuberculosis) oriM ColE1 
M. tuberculosis ssblaC(KK) under control of endogenous 
promoter 
This work 
pJM118 aph Phsp60-ssplcB(KK)-
‘blaC (M. tuberculosis) 
oriM ColE1 
M. tuberculosis ssplcB(KK)-‘blaC under control of hsp60 
promoter 
This work 
 
Nucleotide sequence accession numbers. 
The DNA sequence of a 2018 bp cloned product containing the M. smegmatis tatA 
and tatC ORFs was submitted to GenBank and given the accession number AY998985. 
 
Results 
 
Identification of a putative Tat system in mycobacteria. 
The genome of M. tuberculosis strain H37Rv contains two distinct loci with open 
reading frames (ORFs) homologous to components of the bacterial Tat system.  M. 
tuberculosis TatA (Rv2094c), TatB (Rv1224), and TatC (Rv2093c) are 44%, 38%, and 43% 
similar at the amino-acid level to TatA, TatB, and TatC of E. coli (16).  The proximity of 
tatA and tatC (17-bp between ORFs) suggests that these genes are located in an operon.  The 
tatB gene is located approximately 1-Mbp away from tatAC.  Using sequence data obtained 
from The Institute for Genomic Research (http://www.tigr.org) we identified homologues of 
tatABC in the genome of M. smegmatis strain mc2155.  The organization of the tat genes is 
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conserved in all the available mycobacteria genome sequences including M. tuberculosis, M. 
bovis, M. leprae, M. avium, and M. smegmatis (http://www.tigr.org). 
 The M. tuberculosis genome also contains 31 ORFs with predicted Tat signal 
sequences, as identified by the TATFIND search algorithm (21).  The TATFIND algorithm is 
based on experimentally demonstrated Tat substrates and sequences of putative Tat 
substrates in halophilic archaea.  The list of TATFIND-predicted M. tuberculosis Tat 
substrates is available at the following URL:  
http://www.sas.upenn.edu/~pohlschr/tatprok.html.  Notable among the predicted M. 
tuberculosis Tat substrates are the virulence factor phospholipase C (PlcB) (58) and the 
major β-lactamase BlaC (25, 78).  Our inspection of the amino-terminus of the major β-
lactamase of M. smegmatis, BlaS (25, 44), also revealed a potential Tat signal sequence.  The 
identification of putative Tat components and Tat-exported substrates in mycobacteria 
strongly suggested the existence of a functional Tat pathway. 
 
M. smegmatis tatA and tatC deletion mutants have growth defects. 
To examine the functional nature of the predicted Tat pathway in mycobacteria, in-
frame and unmarked deletion alleles of the tatA and tatC genes were generated in M. 
smegmatis using a two-step allelic exchange strategy (10, 50).   
To construct the ∆tatA mutant, we electroporated the suicide plasmid pKEH4 
containing an in-frame unmarked deletion within M. smegmatis tatA into wild-type M. 
smegmatis mc2155.  This ∆tatA deletion allele is predicted to produce a truncated protein of 
34 amino acids (in comparison to the wild type protein of 106 amino acids).  Integration of 
pKEH4 at the tatA chromosomal locus via a single homologous recombination event yielded 
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the single-crossover strain MB679.  This single-crossover strain contained both a wild-type 
and a deleted copy of tatA along with intervening pKEH4 vector sequence carrying the 
selectable hygromycin-resistance gene and the counterselectable sacB marker.  Southern blot 
analysis confirmed successful construction of the single-crossover strain (Fig. 2.1). 
We employed the same strategy to construct a single-crossover strain for generation 
of a ∆tatC mutant using the suicide plasmid pJM112, which contained an in-frame deletion 
within M. smegmatis tatC.  This tatC deletion is predicted to produce a truncated protein of 
87 amino acids (in comparison to the wild type protein of 317 amino acids) which lacks the 
six transmembrane domains.  Southern blot analysis confirmed construction of the tatC 
single crossover strain JM499 (Fig. 2.1). 
 Our initial attempts to isolate secondary recombinants with tat deletions from the 
single-crossover strains yielded only wild-type alleles at both the tatA and tatC loci.  This 
strongly suggested that under the growth conditions tested, a tat deletion in M. smegmatis 
was lethal and that the Tat pathway was essential for growth.  However, further incubation 
for two additional days at 37°C yielded a population of slow-growing secondary 
recombinants.  These small colonies were subsequently proven to be tatA or tatC deletion 
mutants by PCR (data not shown) and Southern blot analysis (Fig. 2.1).  The ∆tatA and ∆tatC 
mutants represented 65% and 32% of the total secondary recombinants, respectively.  All of 
the ∆tatA and ∆tatC mutants obtained formed smaller single colonies on both minimal 7H10 
and rich LB agar media compared to wild-type M. smegmatis (Fig. 2.2a).  The M. smegmatis 
∆tatA mutant strain MB692 and ∆tatC mutant strain JM567 were used for all subsequent 
analyses (Table 2.1). 
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Fig. 2.1.  Southern analysis of tatA and tatC recombinants in M. smegmatis.  Panels: A, 
diagram of the mc2155 (wild-type) chromosomal tatAC locus; B, Construction of M. 
smegmatis ∆tatA allele.  i) tatA single-crossover strain MB679, ii) ∆tatA allele, iii) Southern 
blot of FspI/NdeI-digested genomic DNA.  Lanes: 1, mc2155; 2, MB679; 3, MB692 (∆tatA); 
4, wild-type recombinant.  C, Construction of M. smegmatis ∆tatC allele.  i) tatC single-
crossover strain JM499, ii) ∆tatC allele, iii) Southern blot of FspI-digested genomic DNA.  
Lanes: 1, mc2155; 2, JM499; 3, JM567 (∆tatC); 4, wild-type recombinant.  The FspI/NdeI 
restriction endonuclease sites are indicated, as well as the size of the DNA fragments 
detected by hybridization with the probe used (bold line).  Diagrams are not drawn to scale. 
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We compared growth of the ∆tat mutants to that of wild-type M. smegmatis in 
Middlebrook 7H9 liquid medium.  Growth of the mutants over time was determined by 
measuring the optical density (OD600) and by plating for colony-forming units (CFU).  The 
∆tatC mutant had lower OD600 readings than the wild-type strain throughout the growth 
curve (Fig. 2.2b).  However, there was no difference in the number of counted CFU during 
liquid growth between the ∆tatC mutant and wild-type M. smegmatis strains (Fig. 2.2c).  The 
same phenotypes were observed for the ∆tatA mutant (data not shown).  Thus, the ∆tat 
mutants appeared to replicate at the same rate as wild-type M. smegmatis in liquid medium, 
even though slower growing colonies were observed on agar medium.  The basis for the 
discrepancy between OD600 readings and viable CFU in culture is not clear. 
 Complementation analysis of the ∆tatA mutant (MB692) was performed with a 
single-copy plasmid pJM124 that expresses M. smegmatis tatA from the constitutive hsp60 
promoter.  For the ∆tatC mutant (JM567) the multicopy plasmid pJM120, which 
constitutively expresses M. smegmatis tatC from the hsp60 promoter, was used.  Introduction 
of these tat expression constructs into the respective ∆tat mutants successfully rescued the 
mutant phenotypes: small colony growth on agar and reduced OD600 readings during liquid 
culture (Fig. 2.2).  The complementation experiments demonstrated that the ∆tat mutations 
are responsible for the observed phenotypes and they indicate that both TatA and TatC of M. 
smegmatis are functional and required for optimal in vitro growth. 
 
M. smegmatis tat mutants are sensitive to SDS. 
Tat-deficient mutants of E. coli are hypersensitive to the detergent sodium dodecyl 
sulfate (SDS) (38, 72).  To determine if the M. smegmatis ∆tatA and ∆tatC mutants were  
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Fig. 2.2. The ∆tatA and ∆tatC mutants have growth defects.  (A) Single colonies of wild-
type (mc2155, pMB198), ∆tatA mutant (MB692, pMB198), and complemented ∆tatA 
attB::tatA (MB692, pJM124) strains are shown on 7H10 agar medium containing 0.1% 
tween-80, grown at 37ºC.  Not shown are the ∆tatC mutant and the complemented ∆tatC 
strain, which display the same growth phenotypes.  (B) Representative growth curves for 
wild-type (mc2155, pMV261), ∆tatC mutant (JM567, pMV261), and complemented ∆tatC 
(JM567, pJM120) strains in 7H9 liquid medium containing 0.1% tween-80, grown at 37ºC, is 
shown as the optical density at 600 nm.  (C) Viable count measurements from the same 
cultures shown in (B) as the log10 of viable CFU/ml. 
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similarly hypersensitive to SDS, we compared the ability of the mutant strains to grow on 
agar media containing SDS using a replica-inoculating protocol (described in Materials and 
Methods) (71).  The ∆tatA and ∆tatC mutants failed to grow in the presence of 0.0025% 
SDS, in contrast to growth observed for the wild-type strain (Fig. 2.3).  This was true even 
after extended incubation (data not shown). Growth of the ∆tat mutants on 0.0025% SDS 
was restored to wild-type levels when complemented with Tat proteins expressed in trans.  
The failure of the ∆tat mutants to grow on medium containing SDS was not a result of the 
general growth defect on agar medium, as the ∆tat mutants grew on agar media lacking SDS, 
albeit slower (Fig. 2.3).   
 
M. smegmatis tat mutants are sensitive to β-lactam antibiotics. 
Tat-deficient mutants of E. coli are also hypersusceptible to multiple antibiotics 
including the β-lactam ampicillin (72).  We similarly tested the ∆tatA and ∆tatC mutants of 
M. smegmatis for drug susceptibility.  β-lactam susceptibility was assayed by determining the 
minimal inhibitory concentration (MIC) of carbenicillin using a replica-inoculating protocol 
on 7H10 agar medium (described in Materials and Methods) (71).  In contrast to wild-type 
M. smegmatis which is intrinsically resistant to β-lactam antibiotics and had an MIC of >200 
µg/ml for carbenicillin, the MIC for the ∆tatA and ∆tatC mutants was 5 µg/ml.  The 
complemented strains were resistant to >200 µg/ml carbenicillin, indicating that increased 
susceptibility to carbenicillin of the mutants was due to the ∆tat mutations.  Similar results 
were obtained using a disk diffusion assay to test susceptibility to the β-lactams carbenicillin, 
ampicillin, and amoxicillin (data not shown).  In both the MIC and disk diffusion assays, the 
sensitivity of the ∆tat mutants was comparable to the sensitivity of a ∆blaS mutant lacking  
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Fig. 2.3. The ∆tatA and ∆tatC mutants are hypersensitive to SDS.  The following strains 
were grown in liquid media and approximately 103 CFU were spotted onto plates with and 
without 0.0025% SDS using a multi-pronged replica inoculating device as described in 
Materials and Methods: wild-type (mc2155, pMV261), ∆tatC mutant (JM567, pMV261), 
complemented ∆tatC strain (JM567, pJM120), ∆tatA mutant (MB692, pMB198), and 
complemented ∆tatA attB::tatA strain (MB692, pJM124). 
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the major M. smegmatis β-lactamase.   In contrast to the results with the β-lactam antibiotics, 
the ∆tatA and ∆tatC mutants exhibited no increased sensitivity to the other antibiotics tested 
(5 µg isoniazid, 25 µg rifampin, 25 µg ethambutol, 12.5 µg streptomycin, 20 µg tetracycline, 
and 20 µg vancomycin).  Thus, the β-lactam sensitive phenotype of the M. smegmatis ∆tat 
mutants is a specific phenomenon and not the result of a general increase in drug 
susceptibility.   
 
β-lactamase export requires the Tat pathway of M. smegmatis. 
The major β-lactamases BlaC and BlaS are required for the β-lactam resistance of 
both M. tuberculosis and M. smegmatis, respectively (25, 44, 78).  Since β-lactam antibiotics 
target extracytoplasmic cell wall biosynthetic enzymes, a β-lactamase must be exported to 
the cell envelope or extracellular environment in order to protect the bacterium.  Inspection 
of the N-terminus of BlaC and BlaS revealed a twin-arginine motif, suggesting that both 
enzymes are exported by the Tat pathway.  We hypothesized that the β-lactam sensitivity 
phenotype of the ∆tatA and ∆tatC mutants of M. smegmatis was due to a defect in export of 
the putative Tat substrate BlaS. 
It was previously reported that during liquid growth M. smegmatis releases β-
lactamase into the medium (57).  To test whether M. smegmatis β-lactamase export depends 
upon the Tat pathway, we assayed short-term cell-free culture filtrates from the ∆tat mutants 
for β-lactamase activity using the chromogenic β-lactam nitrocefin.   
Substantially less β-lactamase activity was observed in culture filtrates produced from 
the ∆tatA and ∆tatC mutants compared to wild-type M. smegmatis (Fig. 2.4a).  The ∆tat  
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Fig. 2.4. Nitrocefin assays on culture-filtrates and whole-cell extracts of M. smegmatis 
wild-type and ∆tatA and ∆tatC mutants.  Short-term culture filtrates (A) and whole-cell 
extracts (B) of log-phase M. smegmatis cultures were assayed for the ability to hydrolyze 
nitrocefin.  Strains used:  wild-type (mc2155, pMV261), ∆blaS (PM759, pMV261), ∆tatC 
mutant (JM567, pMV261), complemented ∆tatC strain (JM567, pJM120), ∆tatA mutant 
(MB692, pMB198), complemented ∆tatA attB::tatA strain (MB692, pJM124), and liquid 
culture medium (7H9).  Nitrocefin hydrolyzing activity was expressed as A486 min-1 mg total 
protein-1, and was standardized to PBS.  Shown is a representative assay reported as an 
average + standard deviation. 
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mutant levels were comparable to that observed with the ∆blaS mutant.  The low level of 
nitrocefin hydrolyzing activity detected in the ∆blaS and ∆tat strains was largely attributable 
to background from the 7H9 medium (Fig. 2.4a).  To rule out the possibility that the reduced 
β-lactamase activity in culture filtrates of the ∆tat mutants was due to reduced expression, we 
measured the nitrocefin hydrolyzing activity of whole-cell extracts of the strains.  This 
analysis revealed β-lactamase expression with more cell-associated activity for the ∆tat 
mutants in comparison to the ∆blaS mutant (Fig. 2.4b).  Further, a five-fold higher level of β-
lactamase activity was associated with whole-cell extracts of the ∆tat mutants compared to 
the wild-type strain.  This suggests that in the absence of Tat export β-lactamase accumulates 
with the cells of the ∆tat mutants and that β-lactamase activity is specifically reduced in the 
culture filtrates of the ∆tat mutants.  As seen in Fig. 2.4b, whole-cell extracts of the ∆blaS 
mutant did not exhibit a complete lack of nitrocefin hydrolyzing activity presumably due to 
the expression of the BlaE protein.  BlaE was recently shown to have a minor contribution to 
the total β-lactamase activity of M. smegmatis, without contributing significantly to 
resistance (25).  Examination of the BlaE protein sequence revealed a Sec-like signal 
sequence.  When complemented, the ∆tatC mutant showed wild-type β-lactamase activity in 
the culture filtrate.  Complementation of the ∆tatA mutant also resulted in an increase in 
culture filtrate β-lactamase activity, although to a reduced degree.  These results indicate a 
defect in β-lactamase export by the ∆tat mutants and serve to explain the increased β-lactam 
sensitivity observed in the absence of TatA and TatC.  
 
Export of active M. tuberculosis BlaC depends on the Tat pathway and a twin-arginine 
signal sequence. 
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The above results strongly suggest that the M. smegmatis β-lactamase is a Tat 
substrate.  Like BlaS, the major β-lactamase of M. tuberculosis (BlaC) has a predicted Tat 
signal sequence (Table 2.3).  To determine if BlaC is a Tat substrate, we tested for Tat-
dependent export of BlaC expressed in M. smegmatis ∆blaS, M. smegmatis ∆tatA∆blaS, and 
M. tuberculosis ∆blaC mutants. 
TABLE 2.3.  M. tuberculosis signal sequences fused to ‘BlaC 
 
Signal 
sequence 
origin 
Amino acid sequence 
 
BlaC 
 
MRNRGFGRRELLVAMAMLVSVTGCARHASGARP 
 
BlaC(KK) 
                            
MRNRGFGKKELLVAMAMLVSVTGCARHASGARP 
 
PlcA 
                                  
MASRREFLTKLTGAGAAAFLMDWAAPVIEKAYGGSARP 
 
PlcB 
                                  
MATRRQFFAKAAAATTAGAFMSLAGPIIEKAYGGSARP 
 
PlcB(KK) 
                                  
MATKKQFFAKAAAATTAGAFMSLAGPIIEKAYGGSARP 
 
Mpt63 
                                 
MGMKLTTMIKTAVAVVAMAAIATFAAPVALAGSARP 
 
FbpB 
 
MATDVSRKIRAWGRRLMIGTAAAVVLPGLVGLAGGAATAGAGSARP 
 
  Signal sequences of PlcA, and PlcB were predicted by SignalP (3). 
  Signal sequences of Mpt63 and FbpB were determined previously (35). 
  Underlined residues denote the start of ‘BlaC in the fusion constructs,  
  residues in italics are derived from the Hsp60 coding region. 
 
Unlike wild-type M. smegmatis and M. tuberculosis, the corresponding ∆bla mutants 
are sensitive to β-lactams, failing to grow on 7H10 agar medium containing 50 µg/ml of 
carbenicillin.  When the full-length M. tuberculosis BlaC was expressed from plasmid 
pMP327 in M. smegmatis ∆blaS and M. tuberculosis ∆blaC mutants the strains were resistant 
to carbenicillin (Table 2.4).  This β-lactam resistance was dependent on BlaC export since 
expression of a truncated ‘BlaC lacking the native signal sequence, from plasmid pJM113, in 
either M. smegmatis ∆blaS or M. tuberculosis ∆blaC did not allow growth on carbenicillin  
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TABLE 2.4.  Export of functional ‘BlaC is dependent on a twin-arginine signal sequence and an intact Tat 
pathway 
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   Carbenicillin Resistance 
mc2155 WT + + + + ND + + + + 
PM759 ∆blaS - + - - + + - - - 
M. smegmatis 
JM578 ∆tatA ∆blaS - - - - - - - - - 
 
H37Rv WT + + + + ND + + + + M. tuberculosis 
PM638 ∆blaC - + - - + + - - - 
*All strains carrying a vector were resistant to 20 µg/ml kanamycin as a result of the vector resistance marker.  
Carbenicillin resistance and sensitivity was determined by the presence (+) or absence (-) of single colony 
growth on 7H10 plates containing 50 µg/ml carbenicillin and 20 µg/ml kanamycin.  ND, not done. 
 
containing agar medium (Table 2.4).  Whole-cell extracts of M. smegmatis ∆blaS carrying 
pJM113 assayed for nitrocefin activity revealed a 20-fold higher β-lactamase activity 
compared to that of M. smegmatis ∆blaS confirming that truncated ‘BlaC was expressed in 
this strain (Fig. 2.5a). 
Based on the above results, we used β-lactam resistance as an indicator of the export 
of functional BlaC enzyme in the following experiments.  Unlike the results obtained when 
we expressed full-length BlaC in the ∆blaS M. smegmatis mutant, expression of full-length 
BlaC in a M. smegmatis ∆tatA∆blaS double mutant did not protect against β-lactams.  
Nitrocefin analysis on whole-cell extracts of M. smegmatis ∆tatA∆blaS carrying pMP327 
demonstrated that BlaC was expressed in this strain (Fig. 2.5b).  Thus, the Tat pathway also 
appears to function in BlaC export.   
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Fig. 2.5.  Nitrocefin assays on whole-cell extracts of M. smegmatis strains carrying ‘BlaC 
fusion constructs.  Whole-cell extracts of M. smegmatis cultures were assayed for the ability 
to hydrolyze nitrocefin.  (A) Assays were performed on M. smegmatis ∆blaS (strain PM759) 
strains carrying the following vectors:  pMV261 (empty), pMP327 (BlaC), pJM113 (‘BlaC), 
pJM117 (BlaC(KK)), pJM111 (ssPlcB-‘BlaC), pJM118 (ssPlcB(KK)-‘BlaC), pJM130 
(ssPlcA-‘BlaC), pMB228 (ssMpt63-‘BlaC), and pJM109 (ssFbpB-‘BlaC). (B) Assays were 
performed on M. smegmatis ∆tatA∆blaS (strain JM578) carrying pMV261 (empty), pMP327 
(BlaC), pJM111 (ssPlcB-‘BlaC), or pJM130 (ssPlcA-‘BlaC). Nitrocefin hydrolyzing activity 
was expressed as A486 min-1 mg total protein-1, and was standardized to PBS.  Shown is a 
representative assay reported as an average + standard deviation. 
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In addition, we tested the significance of the twin-arginine motif in the BlaC signal 
sequence to the export of BlaC using mutants in which the twin-arginines ‘RR’ were 
substituted with conservative twin-lysine ‘KK’ residues (Table 2.3).  Similar substitutions in 
Tat substrates from other bacteria have revealed the importance of the ’RR’ dipeptide in Tat 
export (1, 20, 37, 73, 80).  Expression of BlaC(KK) from plasmid pJM117 did not protect the 
∆bla mutants of M. smegmatis and M. tuberculosis from carbenicillin (Table 2.4).  Nitrocefin 
analysis on M. smegmatis whole-cell extracts confirmed that BlaC(KK) was expressed from 
plasmid pJM117 in the ∆blaS background (Fig. 2.5a).  This result further demonstrates that 
M. tuberculosis BlaC is a Tat substrate.   
 
Truncated ‘BlaC can be used as a reporter of Tat export in mycobacteria. 
Since BlaC activity was dependent on the Tat pathway and an intact twin-arginine 
signal sequence, we tested whether truncated ‘BlaC could report on the export of other Tat 
substrates.  Plasmids pJM130 and pJM111, that express ssPlcA-‘BlaC and ssPlcB-‘BlaC 
fusion proteins in which the putative Tat signal sequences of M. tuberculosis PlcA and PlcB 
were fused in-frame and upstream of truncated ‘BlaC (Table 2.3), respectively, were 
electroporated into ∆blaS M. smegmatis and ∆blaC M. tuberculosis.  All the resulting strains 
were β-lactam resistant (i.e. grew in the presence of carbenicillin) (Table 2.4).  This indicates 
that the PlcA and PlcB signal sequences direct export of functional ‘BlaC in M. smegmatis 
and M. tuberculosis.   
 Additional experiments demonstrated that the β-lactam protection observed with the 
ssPlcA-‘BlaC and ssPlcB-‘BlaC fusions was dependent on Tat export.  First, TatA was 
required for the β-lactam resistance as shown by the failure of either ssPlcA-‘BlaC or ssPlcB-
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‘BlaC to protect against carbenicillin when expressed in the M. smegmatis ∆tatA∆blaS 
double mutant (Table 2.4).  Second, a ssPlcB-‘BlaC fusion engineered to have a twin-lysine 
(KK) substitution for the twin-arginines (RR) in the signal sequence (expressed from plasmid 
pJM118) did not protect against carbenicillin when expressed in the ∆blaS and ∆blaC strains 
of M. smegmatis and M. tuberculosis (Tables 3 and 4).  Cell lysates from all these strains 
possessed β-lactamase activity by nitrocefin analysis (Fig. 2.5).  These results reveal a role 
for the Tat pathway and the ‘RR’ motif in PlcB export.  They further demonstrate that ‘BlaC 
can be used as a reporter of protein export by the Tat pathway.   
 
The ‘BlaC reporter does not function with Sec-dependent signal sequences. 
Having demonstrated that native BlaC is a Tat substrate that could report on Tat 
export, we asked whether the ‘BlaC reporter also functions when targeted to the Sec 
pathway.  MPT63/Rv1926c and Antigen-85b/FbpB/Rv1886c are well-characterized secreted 
proteins of M. tuberculosis (35) and both of these proteins have putative Sec signal 
sequences (Table 2.3) (43).  Plasmids pMB228 (ssMpt63-‘BlaC) and pJM109 (ssFbpB-
‘BlaC) were tested in M. smegmatis ∆blaS and M. tuberculosis ∆blaC.  Both ssMpt63-‘BlaC 
and ssFbpB-‘BlaC failed to protect the bla mutants from carbenicillin (Table 2.4).  Nitrocefin 
analysis of whole-cell lysates of ∆blaS M. smegmatis carrying pMB228 (ssMpt63-‘BlaC) 
revealed a very low level of β-lactamase activity, while ∆blaS M. smegmatis carrying 
pJM109 (ssFbpB-‘BlaC) did not exhibit any detectable activity (Fig. 2.5a).  The different 
outcome of testing these ssSec-‘BlaC fusions suggests that, unlike Tat signal sequences, Sec 
signal sequences are unable to promote export of a functionally active ‘BlaC. 
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Discussion 
 
 Here we report the functional characterization of the Tat pathway in mycobacteria.  
Our study shows that deletion of the tatA and tatC genes in M. smegmatis results in slow 
growth on agar medium, hypersensitivity to SDS, and sensitivity to β-lactam antibiotics.  The 
diverse phenotypes we observed suggest that the mycobacterial Tat pathway exports multiple 
substrates.   
Our first attempts to construct tatA and tatC deletion mutants from merodiploid 
single-crossover strains were problematic and suggested that the Tat pathway was essential in 
M. smegmatis.  This was consistent with Transposon Site Hybridization (TraSH) analysis in 
M. tuberculosis which defined tatC as being an essential gene for optimal growth (65).  
However, with extended incubation we recovered deletion mutants of tatA and tatC.   
Currently, the basis of the ∆tat mutant growth defect is not clear.  We hypothesize that 
mislocalization of a Tat substrate involved in nutrient uptake is responsible, since a number 
of M. tuberculosis Tat substrates, predicted by TATFIND, are homologous to periplasmic 
substrate-binding proteins of ABC transporters.  
The M. smegmatis ∆tatA and ∆tatC mutants exhibited identical phenotypes, 
consistent with TatA and TatC being components of the same system.  Research on other 
bacteria suggests that a functional Tat pathway requires a minimum of one TatA and one 
TatC homologue (7, 54).  A mycobacterial ORF with similarity to E. coli TatB and conserved 
residues important to TatB function is present in the M. smegmatis and M. tuberculosis 
genomes (McDonough, Braunstein unpublished results, TubercuList; Institut Pasteur 
[http://genolist.pasteur.fr/TubercuList/]) (32, 81).  However, the role of TatB in mycobacteria 
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remains to be established.  Unlike tatC, tatB of M. tuberculosis was described as non-
essential by TraSH analysis (65).   Furthermore, the mycobacterial tatB is distantly located 
from tatA and tatC in the chromosome.  Instead tatB is located with genes encoding σE and 
potential regulators of σE (sigE, rseA, and htrA).  This has led to the proposal that TatB 
functions in σE regulation, possibly as a specialized component of the Tat translocation 
system (45).   
Some of the phenotypes reported for tat mutants of other bacteria were also exhibited 
by the M. smegmatis ∆tat mutants.  Interestingly, the basis of these tat phenotypes is not 
necessarily conserved.  In E. coli ∆tat mutants, the SDS hypersensitivity phenotype was 
linked to impairment of cell division, as indicated by cell filamentation, and attributed to 
mislocalization of amidases carrying Tat signal sequences (38, 72).  Although the M. 
smegmatis ∆tat mutants were also hypersensitive to SDS, no filamentation, morphological 
defect, or size difference was observed by light microscopy (data not shown).  Furthermore, 
analysis of the protein sequences of putative mycobacterial amidases did not reveal 
recognizable Tat signal sequences.  Consequently, we believe the basis of the SDS sensitivity 
phenotype in M. smegmatis ∆tat mutants differs from that in E. coli.  The drug sensitivity 
phenotype of the M. smegmatis ∆tat mutants also differs from that in E. coli in being specific 
for β-lactams as opposed to a general increase in drug susceptibility due to a defect in the 
integrity of the cell envelope (72). 
Using multiple approaches, we demonstrated that mycobacterial β-lactamases are 
native Tat substrates.  The ∆tatA and ∆tatC mutants of M. smegmatis failed to grow in the 
presence of 50 µg/ml carbenicillin and exhibited a significant reduction in β-lactamase 
activity in the culture filtrate that was similar to the level observed with the β-lactam 
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sensitive ∆blaS β-lactamase mutant.  We further showed that expression of M. tuberculosis 
BlaC in the M. smegmatis ∆blaS background protected against β-lactams in a Tat-dependent 
manner and that protection was dependent on the ‘RR’ dipeptide’ in the twin-arginine motif.  
The latter experiments were performed in both M. smegmatis ∆blaS and M. tuberculosis 
∆blaC strains.   
To our knowledge, BlaS and BlaC are the first examples of Tat-exported β-
lactamases.  Since the Tat pathway exports folded proteins, the Tat-dependent nature of the 
mycobacterial β-lactamases may reflect rapid intracellular folding of the proteins prior to 
export.  Cofactor-bound proteins are a common category of Tat substrates (48), but BlaC and 
BlaS are homologous to cofactorless class-A β-lactamases (25, 29, 44) .  The primary amino 
acid sequences of BlaC and BlaS are only 37% identical which suggests that the Tat-
dependence reflects a common requirement for Tat export as opposed to simple conservation 
among orthologues.  Evaluation of bacterial genome databases reveals that Mycobacterium 
leprae and Mycobacterium fortuitum also have β-lactamases with predicted Tat signal 
sequences, along with a small number of additional non-mycobacterial species including 
Burkholderia cepacia (77), Burkholderia pseudomallei (15), Nocardia asteroides (53), 
Streptomyces clavuligerus (52), and Yersinia enterocolitica (68). 
Because β-lactams target proteins in the cell wall, β-lactamases must be exported to 
protect the cell.  This feature of β-lactamase function was previously exploited in developing 
TEM β-lactamase (TEM Bla) as a genetic reporter of protein export in E. coli and other 
bacteria (14, 49, 69).  Despite the appearance of a Sec-like signal sequence on the native 
TEM Bla, the truncated reporter was shown to work with both Sec and Tat signal sequences 
(69, 74).  In an effort to develop a reporter of protein export that works directly in M. 
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tuberculosis, we tested truncated ‘BlaC and protein fusions in which signal sequences were 
placed in-frame and upstream of ‘BlaC in ∆blaS or ∆blaC mycobacteria for the ability to 
protect against β-lactams.  Of the four ‘BlaC fusions tested, only those with the putative Tat 
signal sequences (ssPlcA-‘BlaC and ssPlcB-‘BlaC) promoted growth on carbenicillin plates; 
the ssSec-‘BlaC fusions (Mpt63 and FbpB) did not.  These results indicate that Tat signal 
sequences can direct export of a functional ‘BlaC reporter but the Sec signal sequences we 
tested cannot.  This suggests that ‘BlaC will be a useful tool for studying the Tat pathway in 
mycobacteria and for identifying exported Tat substrates in M. tuberculosis by selecting 
active ‘BlaC fusions from expression libraries.    
The plasmid pMM7-2 we used to express the ssFbpB-‘BlaC fusion was successful in 
expressing an active exported ssFbpB-‘PhoA alkaline phosphatase fusion in M. smegmatis 
(data not shown).  Thus, it appears that this FbpB signal sequence construct can drive export 
of functional Sec substrates, such as PhoA, but not Tat substrates like BlaC.  Interestingly, 
the signal sequence of FbpB contains consecutive arginines (R13R14L15M16I17) (Table 2.3).  
However, it possesses a region of high hydrophobicity following the R-R-x-φ-φ motif which 
is not characteristic of Tat substrates, and TATFIND did not predict FbpB to be a Tat 
substrate (21).  Our results with the ‘BlaC reporter are consistent with FbpB not being a Tat 
substrate. 
Our inability to detect significant levels of ssSec-‘BlaC fusion proteins by nitrocefin 
analysis of whole-cell extracts may reflect rapid degradation of fusions incompatible with 
export from the cytoplasm, as this is a common fate of non-exported Tat substrates (8, 17).  
An alternate possibility is that the ssSec-‘BlaC fusions are translocated by the Sec pathway in 
an unfolded state and that the resulting exported ‘BlaC is enzymatically inactive due to 
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improper folding.  In this latter scenario ‘BlaC reports on Tat export because it is only 
functional if exported by the Tat pathway.  A precedent for this type of Tat-dependence is the 
export of green fluorescent protein (GFP) by E. coli.  When exported by the Tat pathway 
GFP is active, but when exported by the Sec pathway it is inactive (24, 62, 76).   
We used the nitrocefin assay on whole-cell extracts as a way to assess fusion protein 
expression in carbenicillin sensitive strains (Fig. 2.5).  Interestingly, this analysis also 
revealed substantial cell-associated β-lactamase activity in the ∆blaS strain expressing full 
length BlaC.  This was surprising since our analysis of native M. smegmatis BlaS revealed a 
relatively low level of β-lactamase activity in the wild-type cell extract (Fig. 2.4b).  
Comparison of BlaC and BlaS revealed a potential lipoprotein lipid attachment site at 
cysteine-24 of the BlaC predicted signal sequence (Table 2.3)(41).  Thus, lipid modification 
of BlaC may tether the protein to the cell wall accounting for the different localization of 
exported M. smegmatis and M. tuberculosis β-lactamases.  
Examination of the PlcA, PlcB, and PlcC proteins of M. tuberculosis reveals the 
presence of an N-terminal twin-arginine motif for each enzyme, and empirical evidence in M. 
tuberculosis demonstrates that these proteins are cell wall-localized (39, 58).  There is a 
precedent for phospholipase C proteins being Tat substrates in Pseudomonas aeruginosa 
(79).  Using ssPlcA-‘BlaC and ssPlcB-‘BlaC fusions, we demonstrated Tat-dependence for 
the signal sequences of the M. tuberculosis phospholipase C proteins.  These ‘BlaC fusion 
proteins were active when expressed in a ∆blaS background but not in a ∆blaS∆tatA 
background.  Furthermore, the ‘RR’ dipeptide in the PlcB signal sequence was required for 
the export of an active ‘BlaC fusion as shown using the ssPlcB(KK)-‘BlaC fusion protein.  
Interestingly, PlcA was not identified by the TATFIND program, presumably due to the 
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presence of a negatively charged aspartic acid in the C-terminal region of the predicted signal 
sequence.  In contrast, PlcB lacks this residue and was predicted to be a Tat substrate by 
TATFIND (21).  Our results with the PlcA signal sequence may reflect mycobacterial-
specific properties of Tat signal sequences that are not incorporated into the TATFIND 
algorithm.  Because the ‘BlaC reporter is a native mycobacterial protein dependent on a Tat 
signal sequence and Tat pathway for export, it may be able to identify mycobacterial Tat 
substrates overlooked by a bioinformatic approach. 
Using M. tuberculosis phospholipase C mutants, Raynaud et al. demonstrated the 
contribution of PlcA, PlcB, and PlcC to the full virulence of M. tuberculosis in a mouse 
model of infection (58).  Similarly, a P. aeruginosa ∆tatC mutant unable to export two 
phospholipase C proteins, PlcH and PlcN, is attenuated for virulence (47).  Additional 
bacterial pathogens (Agrobacterium tumefaciens, enterohemorrhagic E. coli O157:H7, and 
Legionella pneumophila) require a functional Tat pathway for full virulence, although the 
exported factors involved are not clearly defined (22, 55, 60).  We expect that the M. 
tuberculosis Tat pathway will also contribute to pathogenesis by exporting virulence factors, 
including Plc enzymes.  M. tuberculosis ∆tat mutants are required to directly test the role of 
the Tat pathway in M. tuberculosis virulence; however, the potential for a M. tuberculosis 
∆tat mutant to exhibit a growth defect in vitro may complicate such analysis.  
Our demonstration of the existence of a functional Tat pathway in mycobacteria 
brings us closer to understanding the protein export systems that function in mycobacterial 
physiology and pathogenesis.  Knowledge of the Tat pathway may also benefit the 
development of novel tuberculosis vaccines.  Recombinant Mycobacterium bovis BCG 
strains with improved secretion capability and/or the ability to export foreign antigens have 
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been proposed as a vaccine strategy (31, 34).  Since the Tat pathway is capable of exporting 
folded proteins it could be the ideal mechanism for secreting highly expressed proteins and 
foreign antigens.  Finally, the ‘BlaC reporter system should serve as a powerful genetic tool 
for studying protein export directly in M. tuberculosis and help us identify the complete set 
of M. tuberculosis Tat-dependent exported proteins.   
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The export-dependent activity of β-lactamase makes this enzyme a useful reporter for 
extracytoplasmic localization of proteins.  Chimeric proteins comprised of signal sequences 
fused to β-lactamase are competent for translocation across the cytoplasmic membrane and 
delivery to the bacterial cell wall where they can protect bacteria from β-lactam antibiotics.  
We previously described the use of the Mycobacterium tuberculosis β-lactamase ‘BlaC as a 
reporter for protein export in mycobacteria.  Unlike β-lactamase reporters described to date, 
export of functional ‘BlaC is dependent on translocation through the Tat pathway.  To gain 
insight into the role the Tat pathway plays in virulence and physiology of M. tuberculosis, we 
utilized the ‘BlaC reporter to identify Tat-exported proteins of M. tuberculosis.  We designed 
M. tuberculosis genomic DNA expression libraries for selection of ORFs fused upstream of 
‘blaC that result in export of the reporter.  We selected for plasmids expressing exported 
‘BlaC fusion proteins in ∆blaS M. smegmatis on media containing the β-lactam antibiotic 
carbenicillin.  Using this approach, we identified 130 carbenicillin-resistant plasmids 
representing a total of ten unique M. tuberculosis ORF-‘blaC fusions.  All ten have predicted 
 69 
N-terminal signal sequences that fit the pattern of a Tat signal sequence, with the exception 
of the predicted oxidoreductase, Rv0063, which lacks a typical twin-arginine motif.  When 
these fusions were tested subsequently in a ∆blaS ∆tatA double mutant of M. smegmatis, all 
failed to promote carbenicillin resistance, indicating that export of the fusion protein was Tat-
dependent.  This work serves to experimentally identify M. tuberculosis sequences that 
promote Tat export and will help better understand the specific features of a Tat signal 
sequence that are important for export by this pathway.  It was then important to confirm that 
the respective full length proteins were Tat-exported.  Analysis of the full length proteins for 
Tat-dependent processing in M. smegmatis indicated that four out of nine proteins showed a 
Tat-dependent effect.  The other five proteins showed no obvious Tat-dependent effect and 
require further analysis to draw a conclusion as to their export specificity.  In these other 
cases, the mature domain of the protein may play a role in the selectivity of export.  We also 
propose that in some of these cases, the full length proteins may require M. tuberculosis-
specific factors for Tat export and processing.  In conclusion, we identified M. tuberculosis 
signal sequences capable of targeting proteins to the Tat apparatus.  The ORFs identified may 
play a collective role in virulence, antibiotic resistance, copper homeostasis, nutrient import, 
and cell envelope metabolism.  Further elucidation of both the functions of these proteins and 
their specificity of export is needed to determine the precise role that the Tat pathway plays 
in these processes. 
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Introduction 
 
Exported proteins of bacteria function in essential cellular processes such as nutrient 
acquisition and cell envelope metabolism.  These surface-exposed and secreted proteins are 
also ideally positioned to interact with other cells and environmental factors.  This protein 
subset includes exported proteins that interact with eukaryotic cells, functioning as virulence 
factors and immunogenic antigens. 
In bacteria, protein export across the cytoplasmic membrane represents the first step 
in the delivery of a large number of proteins to their final location in the cell envelope or 
extracellular space.  The general secretion (Sec) and the twin-arginine translocation (Tat) 
pathways are the best known examples of systems that transport proteins across the 
cytoplasmic membrane via protein channels in the membrane (for reviews, see 23, 49, 55, 
71).  Both systems recognize N-terminal signal sequences of precursor proteins prior to 
transport.  These signal sequences have a charged N-terminal region “N”, a hydrophobic 
region “H”, and a signal peptidase cleavage region “C”.  In most cases, the signal sequence is 
cleaved during or after translocation, liberating the mature exported substrate.  Notable 
exceptions are the Sec-dependent insertion of transmembrane proteins (21) and the Rieske 
Fe/S proteins, in which upon export by the Tat pathway in both plant chloroplasts and 
bacteria the signal sequence is uncleaved and acts as an N-terminal membrane-anchor (2, 22, 
54). 
The Sec and Tat pathways differ in their ability to translocate proteins.  Sec substrates 
are exported in an unfolded state, while Tat substrates are translocated in a folded state.  
Additionally, signal sequences targeted to the Tat apparatus (composed of TatA, TatB, and 
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TatC) carry a consensus motif in the charged N-terminal region called the twin-arginine 
motif, represented as R-R-x-φ-φ (where φ = an uncharged residue) (7, 8).  Although the 
signal sequence as a whole is required for export, the arginine dipeptide is the major targeting 
determinant to the Tat apparatus.  Conservative substitutions of both arginines for lysines, in 
a number of substrates studied to date, prevents the Tat-dependent export of these proteins 
(20, 42, 79).  Interestingly, mutants in which only one of the arginines is replaced with a 
lysine or a glutamine do not always result in a complete block of export (24).  Further, a 
small number of Tat-exported substrates exist in nature that lack the consecutive twin-
arginines (44, 46), and this list is likely to grow as the Tat pathway is further investigated in 
prokaryotes. 
Proteins targeted to the Tat apparatus in E. coli often contain bound cofactors or 
subunits that are incorporated in the cytoplasm.  This process is dependent on the protein 
forming and maintaining a folded conformation prior to export, thus necessitating a pathway 
capable of translocating folded proteins and oligomeric complexes.  In fact, in the absence of 
folding in the cytoplasm, Tat-dependent protein export does not occur, indicating that there is 
a requirement that the protein be folded prior to Tat export (25).  In many cases, Tat signal 
sequence-containing proteins can only achieve a folded conformation with the aid of 
dedicated cytoplasmic chaperones, some of which insert cofactors.  In E. coli, these 
chaperones can be specific to one or a small number of Tat substrates such as DmsD, which 
is involved in maturation of redox enzymes, or can be general in facilitating folding and 
stability of several Tat substrates, such as the DnaK chaperone (43, 56, 60).  It is important to 
mention that not all Tat substrates incorporate complex cofactors.  The Tat-exported 
phospholipase C of Pseudomonas aeruginosa PlcH does not bind a cofactor.  Interestingly, 
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its export is still dependent on a chaperone PlcR (19).  However, with most cofactorless Tat 
substrates, it is not yet clear if cytoplasmic chaperones are required. 
To date, much of the knowledge of Tat-dependent protein export in bacteria has been 
the result of studies in model organisms such as Escherichia coli and Bacillus subtilis (49, 
71).  However, it is becoming increasingly clear that Tat plays a role in exporting virulence 
factors in bacterial pathogens such as Agrobacterium tumefaciens, enterohemorrhagic E. coli 
O157:H7, Legionella pneumophila, Pseudomonas aeruginosa, Pseudomonas syringae, and 
Yersinia pseudotuberculosis (12, 14, 27, 48, 62, 66, 89).  Additionally, the Tat pathway has 
been speculated to function in the pathogenesis of Mycobacterium tuberculosis largely based 
on the proposal that the phospholipase C enzymes, shown to be important to virulence, are 
Tat substrates (53, 61, 63, 67). 
Infection with M. tuberculosis can lead to tuberculosis disease (TB), which causes 1.7 
million deaths each year globally (18).  The development of genetic tools in mycobacteria, as 
well as the availability of the M. tuberculosis genome sequence, has led to increased research 
over the past decade to better understand the molecular physiology of this bacterium and its 
contribution to virulence (10, 16). 
We and others previously demonstrated that the Tat secretion apparatus is dispensable 
in Mycobacterium smegmatis, and ∆tat mutants have pleiotropic phenotypes including slow 
growth on plates (53, 61).  We speculate that the growth defect in ∆tat is due to an inability 
to localize proteins involved in a variety of cellular processes such as nutrient uptake and cell 
wall maintenance.  Additionally, we demonstrated that the major β-lactamase of M. 
smegmatis, BlaS, is a Tat exported substrate.  In a ∆blaS mutant, which cannot grow in the 
presence of β-lactam antibiotics, we were able to functionally complement the ∆blaS 
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mutation with the M. tuberculosis ortholog, BlaC.  Furthermore, BlaC was shown to be 
exported in a Tat- and twin-arginine-dependent manner. 
Recently, Saint-Joanis et al. (67) reported that the tat genes of M. tuberculosis are 
essential.  A viable deletion mutant of the M. tuberculosis tatA and tatC locus could only be 
obtained if a second copy of the respective locus was expressed in trans.  This finding is in 
agreement with global transposon insertion analysis (TraSH) of M. tuberculosis, which failed 
to identify a viable tatC insertion mutant in vitro and therefore categorized this as an 
essential gene (72).  Given the slow growth phenotype we observed with the ∆tat mutants of 
M. smegmatis, the basis for the essentiality of the Tat pathway in M. tuberculosis is not clear.  
The inability to construct a tat mutant of M. tuberculosis makes the identification and 
analysis of putative Tat exported proteins difficult to study directly in the native bacterium.  
Specifically, comparative proteomic approaches are not an option.  Therefore, alternative 
methods are needed to identify and study Tat exported proteins of M. tuberculosis. 
To address this, we developed the BlaC β-lactamase as a reporter for Tat-dependent 
export in mycobacteria.  We showed that the putative Tat signal sequences of M. tuberculosis 
phospholipase C enzymes, but not Sec signal sequences, are capable of driving the export of 
a truncated version of BlaC lacking its signal sequence (‘BlaC), in ∆blaS M. smegmatis and 
∆blaC M. tuberculosis (53).  The export of a functionally active ‘BlaC in the ∆bla 
background promotes growth of the bacteria in the presence of β-lactam antibiotics which 
allows us to select for exported fusions.  Further, this system can be used to test for Tat-
dependent export using the ∆tat mutants of M. smegmatis. 
Here we used ‘BlaC to identify Tat signal sequences of M. tuberculosis using a 
genomic fusion library in which we could select for M. tuberculosis ORFs fused upstream of 
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‘blaC that result in functional export of the reporter.  We identified ten unique Tat signal 
sequences capable of driving the export of ‘BlaC in a Tat-dependent manner in M. 
smegmatis.  In addition to the virulence factor phospholipase C, we identified proteins with 
homology to enzymes that function in carbohydrate and lipid metabolism, copper 
homeostasis, cell envelope maintenance, and nutrient import.  Further, this experimental 
approach led to the identification of a protein that does not fit the typical pattern of what has 
been reported as a Tat signal sequence.  This system proved to be an unbiased approach to 
identify sequences that promote Tat export and may lead to a better understanding of the 
elements required for Tat-specific export.  Because the mature domain must be folded for Tat 
export, it is important to verify that the authentic full length proteins were Tat-exported.  The 
basic question of how often it is that a protein with a functional Tat signal sequence, as 
shown with a reporter, is a true Tat substrate is only just now beginning to be addressed in E. 
coli (87).  Analysis of the full length proteins for Tat-dependent processing in M. smegmatis 
indicated that four out of nine proteins showed a Tat-dependent effect.  The other five 
proteins showed no obvious Tat-dependent effect.  This latter category requires further 
analysis to make a definitive conclusion as to the export of these proteins.  We additionally 
hypothesize that additional M. tuberculosis factors may be required for export and processing 
for some of these cases.  We conclude that the BlaC genetic fusion library is a novel system 
to identify Tat signal sequences without the biases imposed by bioinformatics predictions and 
will be useful for increasing understanding of the elements that define a functional Tat signal 
sequence.  The work so far suggests that four M. tuberculosis full length proteins are 
exported by the Tat pathway in M. smegmatis while more work is required to determine the 
export pathway specificity of the remaining proteins. 
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Materials and Methods 
 
Bacterial strains and culture methods. 
The strains used during this work are listed in Table 3.1.  E. coli strain DH5α was 
used for DNA cloning procedures.  Luria-Bertani (LB) medium (Fisher) was used for 
culturing of E. coli and antibiotics were added at the following concentrations:  150 µg/ml, 
hygromycin B (Roche Applied Science); 100 µg/ml, carbenicillin; or 40 µg/ml, kanamycin 
(Acros Chemicals).  Middlebrook 7H9 or 7H10 medium (Difco; BD Biosciences) was used 
for the culturing of M. smegmatis and M. tuberculosis.  For growth of M. smegmatis, 
Middlebrook medium was supplemented with 0.5% glycerol and 0.2% dextrose.  For growth 
of M. tuberculosis, Middlebrook medium was supplemented with 0.5% glycerol and 1× ADS 
(0.5% bovine serum albumin, fraction V [Roche]; 0.2% dextrose; and 0.85% NaCl).  When 
necessary, media was supplemented with 0.05-0.1% Tween-80 (Fisher).  Antibiotics were 
added to Middlebrook media at the following concentrations:  50 µg/ml, hygromycin B; 
20 µg/ml, kanamycin; or 50 µg/ml, carbenicillin.  L-lysine at 40 and 80 µg/ml was added to 
agar and liquid media, respectively, for growth of M. smegmatis strains PM759 and JM578. 
 
Molecular biology procedures. 
Standard molecular biology techniques were employed as previously described (68).  
The Expand high fidelity PCR system (Roche) was used in all PCR reactions from 
chromosomal DNA and dimethyl sulfoxide at 5.0% was included in select PCR reactions.  
DNA sequencing was performed by either the UNC-CH Automated DNA Sequencing 
Facility (Chapel Hill, NC) or by Eton Bioscience Inc. (San Diego, CA). 
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Table 3.1. Strains used in this study 
 
Strain Description Reference 
E. coli   
  K-12 DH5α F- [φ80d∆lacZM15] ∆(lacZYA-argF) U169 deoR recA1 endA1 hsdR17 
glnV44 thi-1 gyrA96 relA1 
Gibco-BRL 
  TOP10 F- mcrA [φ80d∆lacZM15] ∆(mrr-hsdRMS-mcrBC) ∆lacX74 deoR recA1 
endA1 araD139 ∆(ara, leu)7697 galU galK rpsL nupG 
Invitrogen 
  XL-1 Blue [F' proAB, lacIqZ∆ M15, Tn10(Tetr)] recA1 endA1 gyrA96 thi-1 hsdR17 
supE44 relA1 λ- lac-  
Stratagene 
   
M. smegmatis   
  mc2155 ept-1 (76) 
  MB692 mc2155, ∆tatA (53) 
  JM567 mc2155, ∆tatC (53) 
  PM759 mc2155, ∆blaS1 ∆lysA4 rpsL6 (33) 
  JM578 PM759, ∆tatA (53) 
   
M. tuberculosis   
  H37Rv Virulent (4) 
  PM638 H37Rv, ∆blaC1 (33) 
 
Construction of ‘BlaC reporter libraries. 
Two separate library plasmids were made.  For both, a truncated version of M. 
tuberculosis blaC (referred to as ‘blaC) was amplified from pJM106 by PCR using the 
primers Lib’blaCfor and Lib’blaCrev (Table 3.2). 
(i) Library 1.  The resulting ‘blaC amplicon was ligated into the multicopy mycobacterial 
shuttle vector pMV206.hyg, which had been digested with ClaI and NcoI.  The final plasmid 
product was named pJES113 (Fig. 3.1).  Genomic DNA was isolated from M. tuberculosis 
strain H37Rv as previously described (10), partially digested with AciI and HpaII, and DNA 
fragments of 0.5 to 5.0-kbp were selected.  The genomic digest was cloned into the unique 
ClaI site immediately upstream of ‘blaC in pJES113.  The resulting ligation reaction was 
transformed into chemically competent E. coli XL-1 Blue (Stratagene).  Approximately 
1×106 hygromycin-resistant E. coli transformants were pooled for plasmid DNA isolation 
(Qiagen). 
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Figure 3.1.  Construction of multicopy ‘blaC expression libraries.  See Materials and 
Methods. (A) Library 1 was constructed by ligating ~0.5-5.0 kbp AciI or HpaII restriction 
fragments of M. tuberculosis H37Rv genomic DNA into the ClaI site located on the 
multicopy shuttle plasmid pJES113.  The truncated β-lactamase gene, ‘blaC, lacks a 
promoter, Shine-Dalgarno sequence, start codon, and signal sequence, and therefore depends 
on transcriptional and translational fusion with N-termini of other proteins for the expression 
and export of ‘BlaC. (B) Library 2 was constructed the same way except M. tuberculosis 
PM638 (∆blaC) genomic DNA was ligated into the ClaI site located upstream of ‘blaC on 
the multicopy shuttle plasmid pJM157.  Additionally, pJM157 has the mycobacterial hsp60 
promoter located upstream of the ClaI insertion site, but lacks both a ribosome binding Shine 
Dalgarno site and a start codon.  Both library plasmids carry a selectable hygromycin-
resistance gene (hyg). 
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Table 3.2. Primers used in this study. 
 
Target 
gene 
Oligo name Sequence (5’  3’) Restriction enzyme 
site (5’ extension) 
Source 
Primers used for library construction 
blaC Lib’blaCfor ATCGATCCGGCATCGACAACCTTG ClaI This work 
 
Lib’blaCrev CCATGGCTATGCAAGCACACCGGCAAC NcoI This work 
hsp60 Hsp60for-BstBI ATTCGAACGTGGCGAACTCCGTTGTAG BstBI This work 
 
Hsp60rev2-ClaI TATCGATCGGGGATGAAACGGGGGTC ClaI This work 
Primers used for plasmid construction (HA-tagged constructs) 
plcB PlcBMscIF CGTGGCCATTACCCGCCGACAATTTTTTGC MscI This work 
 PlcBMscF-2 CGTGGCCATTGGGCCTTGCCCCGGACATTTG MscI This work 
 plcBMscF-3 GTCTAGAGTCCGGTGGCATTCGTGGTC XbaI This work 
 plcBXbaF-1 GTCTAGAACCCTTCCCGCTGCGATATCC XbaI This work 
 PlcBHindR CGAAGCTTGACAGAGACCGCTGGGAATCC HindIII This work 
Rv0315 315MscF* CGTGGCCATTCTTATGCCTGAGATGGATCG MscI This work 
 315MscF-2 GTCTAGAAGAACCAGCACGCCGACAAC XbaI This work 
 315HindR CGAAGCTTGAAAGACGCGCACCCAGTCG HindIII This work 
Rv0519c 519MscF CGTGGCCATTCTACGGCGTGGCTGTGCGGG MscI This work 
 519HindR CGAAGCTTTGGACGCCATCCAAGCCAGTT HindIII This work 
lprQ lprQMscF CGTGGCCATTAATAACTCCAGCACCCCCCAG MscI This work 
 lprQHindR CGAAGCTTGCCCACCCGGTCCGTTAGTAG HindIII This work 
ugpB ugpBXbaF-1 GTCTAGAACTCGCTGCAGGTGTTCGATGTG XbaI This work 
 ugpBHindR CGAAGCTTGGCCATGCCCCGCCAGCTTCC HindIII This work 
Rv0063 63MscF AGTGGCCATTGCGCGTGAAATCTCACGCCAG MscI This work 
 63XbaF-1 CTCTAGAACGCCGACGCTTACCTGTGG XbaI This work 
 63HindR CGAAGCTTGGAAGTTCAGCCCGGAGAACA HindIII This work 
Rv0774c 774MscF* CGTGGCCATTATGGCCCGCATGCCAGAGTTG MscI This work 
 774HindR CGAAGCTTGACCTGTGAGCAGCGGCGCGAAC HindIII This work 
Rv0846c 846XbaF GTCTAGAGTTTGGGTGAGCCACATGAC XbaI This work 
 846HindR CGAAGCTTGCAGAATGTAGTCCAGGCGGG HindIII This work 
Rv2843 2843NruF ATCGCGATTCTTAGAGCAGCACCAGTCATC NruI This work 
 2843HindR CGAAGCTTGTATCGACGGGCCTGAAGGCAC HindIII This work 
Primers used for sequence determination 
blaC TnBlaCout* CAGAATGCGAACCGCTCATC n/a This work 
ugpE ugpE-1 CTTGATGCGCAACCACTTTC n/a This work 
plcB plcBmid2 GCGACGGTCGGCGATATGACTTC n/a This work 
Primers used for identification of high frequency ‘blaC fusions 
blaC pMP327F GCTTTGGCGCCTGCCATCT n/a This work 
 blaCfor1 AGATCTGCGCGTCCGGCATCGACAACCTTGC n/a (53) 
 blaCrev AGATCTCCACGAGCCTATGCAAGCACAC n/a (53) 
*primers also used for identification of high frequency ‘blaC fusions 
 
(ii) Library 2.  We constructed a second library vector that carried a constitutive 
mycobacterial promoter upstream of the genomic DNA insertion site.  A fragment carrying 
the promoter and the +1 transcriptional start site from M. tuberculosis hsp60 was amplified 
by PCR from pMV261 using the primers Hsp60for-BstBI and Hsp60rev2-ClaI (Table 3.2).  
The resulting amplicon was ligated into the multicopy mycobacterial shuttle vector pJES113, 
which had been linearized with ClaI.  The final plasmid product was named pJM157 (Fig. 
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3.1).  In contrast to the protocol described above for Library 1, genomic DNA was isolated 
from M. tuberculosis strain PM638 (∆blaC) rather than from the H37Rv wild-type strain.  As 
described above for Library 1, 0.5 to 5.0-kbp AciI and HpaII fragments were cloned into the 
single ClaI site immediately upstream of ‘blaC in pJM157.  The resulting ligation was 
transformed into electrocompetent E. coli DH5α (Invitrogen).  Approximately 8×105 CFU 
were pooled and used to isolate plasmid DNA (Qiagen). 
 
‘BlaC reporter selection assay. 
200 ng of plasmid DNA from either library was electroporated into ∆blaS M. 
smegmatis strain PM759 (33, 58, 59).  The resulting transformation was plated onto 7H10 
agar media without tween, containing 50 µg/ml hygromycin and carbenicillin concentrations 
that ranged from 35-75 µg/ml and incubated at 37°C for a minimum of four days.  
Transformants were streaked for single colony purification on 7H10 media with hygromycin 
and further confirmed as being carbenicillin-resistant by spot test analysis.  Briefly, single 
colonies were resuspended in 500 µl aliquots of 7H9 liquid medium with 0.1% tween.  200 
µl of the suspensions were transferred to empty wells of a 96-well plate and two-fold serial 
dilutions were made in 7H9 with 0.1% tween.  The dilutions were spotted, using a 
multipronged replica-inoculating device, onto 7H10 agar plates containing (i) both 50 µg/ml 
hygromycin and 45 µg/ml carbenicillin, and (ii) 50 µg/ml hygromycin only, and incubated 
for a minimum of three days at 37°C.  Strains were considered for further analysis if they 
resulted in confluent growth on plates containing both hygromycin and carbenicillin in 
comparison to a negative control strain carrying a promoterless and signal sequence-less 
BlaC, which fails to grow on media with carbenicillin (53) (Fig. 3.2). 
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Fig. 3.2.  Spot test confirmation of carbenicillin-resistant ‘BlaC fusions.  A multipronged 
replica plater was used to spot 2-fold dilutions of M. smegmatis on plates with 50 µg/ml 
hygromycin and 45 µg/ml carbenicillin (left) and 50 µg/ml hygromycin alone (right), as 
described in Materials and Methods.  M. smegmatis ∆blaS expressing full length M. 
tuberculosis blaC was used as a positive control for growth on carbenicillin.  M. smegmatis 
∆blaS carrying truncated blaC lacking a promoter and its signal sequence (∆ss) was used as a 
negative control for growth on carbenicillin.  Transformants selected on media containing 
carbenicillin were assayed alongside the controls to confirm or refute the carbenicillin-
resistant phenotype.  A strain was considered sensitive (carbS) if it failed to grow on 
hygromycin/carbenicillin but grew on hygromycin alone (transformant #1 above).  Resistant 
strains (carbR) grew on both antibiotics (transformants #2 and #3 above). 
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Recovery of ‘blaC fusion plasmids. 
Plasmid DNA was transferred from hygromycin-resistant M. smegmatis to E. coli 
DH5α by electroduction (5).  Briefly, a small amount of M. smegmatis was transferred from 
a colony or patch into 20 µl of ice-cold 10% glycerol.  The suspension was mixed by 
vortexing, incubated on ice for 10 minutes, and added to 40 µl of electrocompetent E. coli 
DH5α.  The mixture was transferred to a chilled 0.2 cm gap cuvette and pulsed using 
conditions typical for E. coli electroporation (25-µF, 200 ohms, 2.5 kV).  Immediately, 1 ml 
of LB broth was added to the cuvette and the mixture was transferred to a 1.5 ml centrifuge 
tube.  The tubes were shaken at 37°C for 1 hr. and the mixture plated on LB with 150 µg/ml 
hygromycin.  Hygromycin-resistant E. coli cells were obtained after 16 hours incubation at 
37°C, single colony purified, and plasmid DNA was extracted (Qiagen).  The M. tuberculosis 
genomic DNA insert immediately upstream of ‘blaC was identified by sequencing using the 
primer TnBlaCout (Table 3.2). 
 
Diagnostic PCR analysis of ‘blaC fusions. 
To avoid repeat sequencing of ‘blaC fusions identified at high frequency, we 
performed diagnostic colony PCR on carbenicillin-resistant M. smegmatis.  The primers 
blaCrev and TnBlaCout are specific to the 3’ end of ‘blaC on pJES113 and pJM157, and 
were used as reverse primers in the diagnostic PCRs.  Forward primers used were 
blaCfor1/pMP327F, 315MscF, and 774MscF, and are specific to the 5’ end of blaC, Rv0315, 
or Rv0774c, respectively (Table 3.2). 
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Anti-BlaC antibody. 
A 6× histidine-tagged copy of M. tuberculosis BlaC was expressed from Y49 
pTrcHisB-BlaC in E. coli DH5α (kind gift of Doug Kernodle), and purified by nickel affinity 
chromatography using HIS-Select Nickel Affinity Gel (Sigma) as described previously (88).  
Purified BlaC was eluted from the nickel column with 300 mM imidazole at a concentration 
of 1.3 mg/ml and used to immunize rabbits together with TiterMax Gold adjuvant (Sigma).  
Rabbit immunizations and polyclonal antisera collection was carried out by BioSource 
Custom Immunology Department (Hopkinton, MA). 
 
Immunoblot analysis. 
Whole cell lysates of M. smegmatis strains were prepared as described previously 
(11).  Additionally, whole cell lysates of formalin-killed M. tuberculosis strains were 
prepared as described previously (52).  Triton X-114 partitioning of M. smegmatis whole cell 
lysates was prepared as described previously (34).  Polyclonal BlaC antiserum was used in 
immunoblot analysis at a dilution of 1:10,000 and anti-rabbit peroxidase-conjugated antibody 
was used as secondary antibody (Biorad).  Monoclonal HA antiserum (Covance) was used at 
a dilution of 1:10,000 and anti-mouse peroxidase-conjugated antibody was used as secondary 
antibody (Biorad). 
 
Expression of full length, HA-tagged M. tuberculosis proteins. 
To investigate the export of M. tuberculosis proteins in M. smegmatis and M. 
tuberculosis, we cloned full length M. tuberculosis genes in frame with a sequence encoding 
a hemagglutinin (HA) epitope (YPYDVPDYA), immediately followed by a TGA stop 
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codon.  The resulting C-terminal HA-tagged fusion proteins were expressed from either the 
constitutive hsp60 promoter or the native promoter. 
(i) hsp60 promoter-driven HA fusions.  Oligonucleotide primers were designed to amplify 
full length genes from M. tuberculosis genomic DNA.  Forward and reverse primers were 
designed each with 5’ extension sequences carrying MscI and HindIII restriction sites, 
respectively (Table 3.2).  The resulting PCR product was first cloned into the pCR2.1 cloning 
vector (Invitrogen) and sequenced.  The cloned gene was then digested with MscI and 
HindIII and the appropriate fragment was isolated and ligated into the mycobacterial shuttle 
vector pJSC77 (35) (digested with MscI and HindIII) which carries the hsp60 promoter and 
multiple cloning site upstream of a C-terminal HA tag (Table 3.3).  Due to a MscI site within 
the Rv2843 gene, the strategy was revised in this instance and a NruI site was included 
instead of MscI on the forward primer (Table 3.2). 
(ii) native promoter-driven HA fusions.  Oligonucleotide primers were designed to amplify 
a fragment of M. tuberculosis genomic DNA which included the full length gene of interest 
and upstream sequence containing the putative native promoter.  Forward primers were 
designed each with 5’ extension sequences carrying XbaI and HindIII restriction sites, 
respectively (Table 3.2).  The resulting PCR product was first cloned into the pCR2.1 cloning 
vector (Invitrogen) and sequenced.  The cloned gene and promoter was then digested with 
XbaI and HindIII and the appropriate fragment was isolated and ligated into the 
mycobacterial shuttle vector pJSC77 (digested with XbaI and HindIII) which removes the 
hsp60 promoter (Table 3.3). 
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Table 3.3. Plasmids used in this study. 
 
Plasmid Genotype Description Source 
pCR2.1 bla aph ColE1 TA cloning vector Invitrogen 
pMV206.hyg hyg oriM ColE1 Multicopy mycobacterial shuttle plasmid  
pMV261.kan aph Phsp60 oriM ColE1 Multicopy mycobacterial shuttle plasmid (81) 
pMV306.kan aph int attP ColE1 Single-copy mycobacterial shuttle plasmid  
pJSC77 aph Phsp60 -HA oriM ColE1 HA tag cloned into pMV261 (35) 
pJM106 cat ‘blaC (M. tuberculosis) 
oriV ori2 
Predicted M. tuberculosis ‘blaC mature sequence 
cloned into pCC1 (Epicentre) 
(53) 
pJES112 bla aph ColE1‘blaC (M. 
tuberculosis) 
M. tuberculosis ‘blaC mature sequence cloned into 
pCR2.1 
This work 
pJES113 hyg oriM ColE1‘blaC (M. 
tuberculosis) 
M. tuberculosis ‘blaC mature sequence cloned into 
pMV206.hyg 
This work 
pJM153 bla aph ColE1Phsp60  (M. 
tuberculosis) 
M. tuberculosis hsp60 promoter cloned into pCR2.1 This work 
pJM157 hyg oriM ColE1 Phsp60, ‘blaC 
(M. tuberculosis) 
M. tuberculosis hsp60 promoter cloned into 
pJES113 
This work 
Y49 
pTrcHisB- 
BlaC 
bla Ptrc-blaC (M. 
tuberculosis) ColE1 
E. coli expression vector for M. tuberculosis blaC  (88) 
pJES139 bla aph ColE1 plcB (M. 
tuberculosis) 
M. tuberculosis full length plcB cloned into pCR2.1 This work 
pJSS52 aph oriM ColE1 Phsp60 plcB-
HA 
1.5-kbp MscI/HindIII fragment containing full 
length plcB from pES139 cloned into pJSC77 
This work 
pJM172 aph int attP ColE1 Phsp60 
plcB-HA 
2.0-kbp XbaI/SalI fragment containing Phsp60 plcB-
HA from pJSS52 cloned into pMV306.kan 
This work 
pJSS51 bla aph ColE1 ‘plcB (M. 
tuberculosis) 
M. tuberculosis plcB (no signal sequence) cloned 
into pCR2.1 
This work 
pJM171 aph oriM ColE1 Phsp60 ‘plcB-
HA 
1.4-kbp MscI/HindIII fragment containing plcB (no 
signal sequence) from pSS51 cloned into pJSC77 
This work 
pJM168 bla aph ColE1 Rv0315 (M. 
tuberculosis) 
M. tuberculosis full length Rv0315 cloned into 
pCR2.1 
This work 
pJM169 aph oriM ColE1 Phsp60 
Rv0315-HA 
890-bp MscI/HindIII fragment containing full length 
Rv0315 from pJM168 cloned into pJSC77 
This work 
pJM170 bla aph ColE1 Rv0519c (M. 
tuberculosis) 
M. tuberculosis full length Rv0519c cloned into 
pCR2.1 
This work 
pJM173 aph oriM ColE1 Phsp60 
Rv0519c-HA 
904-bp MscI/HindIII fragment containing full length 
Rv0519c from pJM170 cloned into pJSC77 
This work 
pJM167 bla aph ColE1 lprQ (M. 
tuberculosis) 
M. tuberculosis full length lprQ cloned into pCR2.1 This work 
pJM175 aph oriM ColE1 Phsp60 lprQ-
HA 
1.3-kbp MscI/HindIII fragment containing full 
length lprQ from pJM167 cloned into pJSC77 
This work 
pJM210 bla aph ColE1 Rv0774c (M. 
tuberculosis) 
M. tuberculosis full length Rv0774c cloned into 
pCR2.1 
This work 
pJM211 aph oriM ColE1 Phsp60 
Rv0774c-HA 
913-bp MscI/HindIII fragment containing full length 
Rv0774c from pJM210 cloned into pJSC77 
This work 
pJM212 bla aph ColE1 Rv2843 (M. 
tuberculosis) 
M. tuberculosis full length Rv2843 cloned into 
pCR2.1 
This work 
pJM214 aph oriM ColE1 Phsp60 
Rv2843-HA 
547-bp NruI/HindIII fragment containing full length 
Rv2843 from pJM212 cloned into pJSC77 
This work 
pJM196 bla aph ColE1 Pnative plcB (M. 
tuberculosis) 
M. tuberculosis full length plcB and promoter 
cloned into pCR2.1 
This work 
pJM199 aph oriM ColE1 Pnative plcB-
HA 
2.2-kbp XbaI/HindIII fragment containing full 
length plcB and promoter from pJM196 cloned into 
pJSC77 
This work 
pJM202 bla aph ColE1 Pnative plcA, 
plcB (M. tuberculosis) 
M. tuberculosis full length plcA, plcB, and promoter 
cloned into pCR2.1 
This work 
pJM203 aph oriM ColE1 Pnative plcA, 
plcB-HA 
3.5-kbp XbaI/HindIII fragment containing full 
length plcA, plcB, and promoter from pJM202 
cloned into pJSC77 
This work 
 85 
Table 3.3. (Continued) Plasmids used in this study. 
 
pJM209 aph oriM ColE1 Pnative plcA, 
plcB-FLAG 
3.5-kbp XbaI/HindIII fragment containing full 
length plcA, plcB, and promoter from pJM202 
cloned into pJM208 
This work 
pJM197 bla aph ColE1 Pnative Rv0315 
(M. tuberculosis) 
M. tuberculosis full length Rv0315 and promoter 
cloned into pCR2.1 
This work 
pJM206 aph oriM ColE1 Pnative 
Rv0315-HA 
1.2-kbp XbaI/HindIII fragment containing full 
length Rv0315 and promoter from pJM197 cloned 
into pJSC77 
This work 
pJM198 bla aph ColE1 Pnative ugpE, 
ugpB (M. tuberculosis) 
M. tuberculosis full length ugpE, ugpB, and 
promoter cloned into pCR2.1 
This work 
pJM201 aph oriM ColE1 Pnative ugpE, 
ugpB-HA 
2.4-kbp XbaI/HindIII fragment containing full 
length ugpE, ugpB, and promoter from pJM198 
cloned into pJSC77 
This work 
pJM204 bla aph ColE1 Pnative Rv0063 
(M. tuberculosis) 
M. tuberculosis full length Rv0063 and promoter 
cloned into pCR2.1 
This work 
pJM205 aph oriM ColE1 Pnative 
Rv0063-HA 
1.8-kbp XbaI/HindIII fragment containing full 
length Rv0063 and promoter from pJM204 cloned 
into pJSC77 
This work 
pJM213 bla aph ColE1 Pnative Rv0846c 
(M. tuberculosis) 
M. tuberculosis full length Rv0846c and promoter 
cloned into pCR2.1 
This work 
pJM215 aph oriM ColE1 Pnative 
Rv0846c-HA 
1.8-kbp XbaI/HindIII fragment containing full 
length Rv0846c and promoter from pJM213 cloned 
into pJSC77 
This work 
pMP327 aph PblaC-blaC (M. 
tuberculosis) oriM ColE1 
M. tuberculosis blaC cloned into pMV261 (53) 
pJM113 aph Phsp60-‘blaC (M. 
tuberculosis) oriM ColE1 
’blaC from pJM106 cloned into MscI-linearized 
pMV261 
(53) 
pJM117 aph PblaC-(KK)blaC (M. 
tuberculosis) oriM ColE1 
M. tuberculosis ssblaC(KK) cloned into pMV261 (53) 
 
Bioinformatic identification of putative twin-arginine signal sequences. 
In silico analysis of the M. tuberculosis genome was performed to identify putative 
Tat-exported proteins based on the presence of a predicted twin-arginine signal sequence at 
the N-terminus.  Protein sequences corresponding to the 4056 predicted open reading frames 
(ORFs) of M. tuberculosis H37Rv were obtained from TubercuList (Institut Pasteur 
[http://genolist.pasteur.fr/TubercuList/]) and were entered as query sequences in the 
TATFIND v.1.4 (65) (http://signalfind.org/tatfind.html) and TatP v.1.0 (6) 
(http://www.cbs.dtu.dk/services/TatP/) search algorithms.  The output for TATFIND v.1.4 is 
either “True” or “False” as to the whether a given peptide sequence has a predicted Tat signal 
sequence.  TatP v.1.0 has multiple outputs including (i) potential cleavage site, (ii) potential 
Tat signal peptide but no Tat motif, and (iii) potential Tat signal peptide with Tat motif.  For 
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our analysis, we chose to use the default search criteria RRx[FGAVML][LITMVF] and 
include only those proteins that had both a predicted Tat motif and the predicted components 
of a Tat signal sequence, as described for known bacterial Tat substrates.  Finally, in our in 
silico analysis, we included the predicted Tat exported proteins, as defined by the TigrFAM 
motif (TIGR01409) (41, 74).  This list was obtained directly from the TIGR website 
(http://cmr.tigr.org/tigr-scripts/CMR/GenomePage.cgi?database=ntmt02). 
 
Results 
 
Selection of ‘blaC fusions that promote resistance to carbenicillin in M. smegmatis. 
We previously demonstrated that the predicted twin-arginine signal sequences from 
the cell wall-associated PlcA and PlcB phospholipase C enzymes of M. tuberculosis are 
capable of directing the export of a truncated M. tuberculosis β-lactamase, ‘BlaC lacking its 
native signal sequence (53).  Upon introduction of the PlcA or PlcB signal sequence-‘BlaC 
chimeras into the β-lactam-sensitive strains of M. smegmatis (∆blaS) and M. tuberculosis 
(∆blaC), the strains acquired the ability to grow in the presence of the β-lactam antibiotic 
carbenicillin.  We further demonstrated that the requirements for functional ‘BlaC export in 
M. smegmatis are the presence of (i) a functioning Tat apparatus, and (ii) a Tat-dependent 
signal sequence fused in-frame with ‘BlaC.  This latter requirement was established based on 
the inability of either Tat signal sequences that had a twin-lysine substitution of the twin-
arginine motif or M. tuberculosis Sec signal sequences to promote protection against β-
lactam antibiotics.  Together, this data demonstrates that ‘BlaC can function as a reporter for 
Tat-dependent export in M. smegmatis. 
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We used this reporter in a genetic selection for M. tuberculosis sequences that 
promote Tat export.  We designed reporter libraries to identify M. tuberculosis open reading 
frames (ORFs) that, when fused in frame to truncated ‘blaC, generate fusion proteins that are 
exported by the Tat pathway.  We constructed two multicopy expression vectors, pJES113 
and pJM157, that carry blaC lacking its signal sequence (referred to as ‘blaC), downstream 
of a unique ClaI restriction site (Fig. 3.1).  pJES113 lacked a promoter on the vector and 
pJM157 carried the constitutively active hsp60 promoter on the vector upstream of the ClaI 
site.  We then partially digested M. tuberculosis genomic DNA with the ClaI-compatible 
endonucleases AciI or HpaII, which cut frequently in the chromosome.  Genomic fragments 
between 0.5 and 5.0 kbp were ligated into ClaI-linearized pJES113 and pJM157 to create 
genomic DNA Library 1 and Library 2, respectively.  Libraries 1 and 2 contained plasmids 
from 1×106 and 8×105 pooled E. coli transformants, respectively. 
The reason for using two libraries is that there may be classes of ORFs only 
compatible with one of the vectors.  We hypothesized that gene fusions not expressed in M. 
smegmatis, or missed because the gene was located downstream in a large operon and 
therefore unlikely to contain the native promoter, might be expressed and identified with the 
hsp60 promoter-containing Library 2.  Conversely, gene fusions that were toxic because of 
expression from the hsp60 promoter might be identified by Library 1.  Since the Library 2 
vector lacks the hsp60 Shine Dalgarno sequence, translation of the fusion protein can only 
occur if the native Shine Dalgarno site of an ORF is provided on the genomic insert. 
Both libraries were electroporated into ∆blaS M. smegmatis and transformants were 
plated on 7H10 agar medium containing 45 µg/ml of carbenicillin.  Viable transformants 
were further confirmed as being carbenicillin resistant on 45 µg/ml, as described in the 
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Materials and Methods section and shown in Figure 3.2.  In an attempt to achieve near 
saturation of possible targets, a number of factors were considered in determining the total 
number of CFUs to be plated for each library, as described in greater detail in the Discussion.  
For selection using Library 1, a total of 1×106 CFU were plated, yielding a total of 101 
carbenicillin-resistant colonies.  For selection using Library 2, a total of 8.7×105 CFU were 
plated, yielding a total of 29 carbenicillin-resistant colonies.  Plasmid DNA was isolated 
from carbenicillin-resistant strains and sequenced to determine the identity of the genomic 
DNA insert.  In later rounds of selection, we prescreened carbenicillin-resistant strains by 
colony PCR for specific fusions we picked up at high frequency, to eliminate sequencing 
repeat fusions.  From Library 1, which was constructed with wild-type H37Rv DNA, BlaC 
was identified in 50% of the clones (Table 3.4).  Library 2 was subsequently constructed with 
genomic DNA from the ∆blaC strain of M. tuberculosis, thereby eliminating repeated 
identification of BlaC. 
 
Identification of M. tuberculosis signal sequences that drive the Tat-dependent export of 
‘BlaC. 
We identified ten unique ORF-‘blaC fusions from the two libraries combined (Table 
3.4).  All of the ten M. tuberculosis fusion proteins had predicted N-terminal signal 
sequences that fit the tripartite structure of having a charged “N” region, an uncharged or 
hydrophobic “H” region, and a signal peptidase cleavage “C” region.  An amino acid 
alignment of the identified signal sequences revealed that nine out of ten “N” regions 
contained Tat motifs that followed the R-R-x-φ−φ pattern (Fig. 3.3).  The exception was the 
Rv0063 signal sequence, which lacks the arginine dipeptide, and instead has a glutamine in  
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Table 3.4.  Tat signal sequences identified by ‘BlaC fusion. 
 
Tat signal 
sequence 
Description No. Times 
Identified 
TatP TAT 
FIND 
Tigr 
FAM 
Rv0063 Possible oxidoreductase 1 … … × 
Rv0315 Possible beta-1,3-glucanase precursor 41 × × × 
Rv0483 Probable conserved lipoprotein (LprQ) 2 … … … 
Rv0519c Possible lipase 5 × … × 
Rv0774c Possible lipase; short-chain alcohol 
dehydrogenase family 
12 × × × 
Rv0846c Probable multicopper oxidase 1 × × × 
Rv2068c Class A beta-lactamase (BlaC) 63 × × × 
Rv2350c Phospolipase C (PlcB) 1 × × × 
Rv2351c Phospolipase C (PlcA) 0* × … × 
Rv2833c Probable glycerol-3-phosphate-binding 
lipoprotein (UgpB) 
3 × × × 
Rv2843 Probable conserved transmembrane 
Ala-rich protein 
1 … × × 
*Demonstrated by direct testing only 
 
the position where the second arginine would be (R-Q-T-F-L).  Despite this disparity, the 
Rv0063 sequence otherwise had features typical of a Tat signal sequence (8) (Fig. 3.3a). 
With the aid of signal sequence prediction programs, we identified putative signal 
peptidase cleavage sites in the ten signal sequences (Fig. 3.3a).  Of the ten, five possess a 
predicted cysteine-containing lipobox motif (L-A/S-G/A-C+1) in the C-region (1, 82).  Lipid 
attachment occurs at the conserved cysteine, which is also the first residue of the mature 
protein after signal sequence cleavage by the lipoprotein-specific signal peptidase, LspA (3, 
69).  In E. coli, lipidation is a prerequisite for cleavage of the signal sequence (86).  It is not 
clear whether the above five proteins are true lipoproteins.  In addition, some of the signal 
sequences with lipoboxes also have predicted signal peptidase I cleavage sites near the 
lipobox (Fig. 3.3a). 
Interestingly, we observed that the site of fusion to ‘BlaC always occurred very close 
to the predicted signal peptidase cleavage site of the identified fusions (Fig. 3.3a).  Of the 
fusions we identified, the longest length between a predicted cleavage site and the ‘BlaC  
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A. 
Rv2843   ------MLRAAPVINRLTNRPISRRGVLAGGAALAALGVVSACGESAPKAPAVEELRSPLDQARHDGALAAA-- 
Rv0774c  --------------MMARMPELSRRAVLGLGAGTVLGATSAYAIDMLLQPRTSHA------------------- 
Rv0519c  MLRRGCAGNTDRRGIMTPMADLTRRALLRWGAGAGAGAAGVWAFGALVDPLEPQAAPAPFEPPTAGSSLPTRIS 
Rv0063   -----------------MAREISRQTFLRGAAGALAAGAVFGSVRAT--------------------------- 
UgpB     ------------------MDPLNRRQFLALAAAA--AGVTAGCAG------MGGG------------------- 
PlcB     ---------------------MTRRQFFAKAAAATTAGAFMSLAGPIIEKAYGAGPCP---------------- 
Rv0315   ----------------MLMPEMDRRRMMMMAGFGALAAALP--------------------------------- 
LprQ     ---------MNNSSTPQSQGPISRRLALTALGFGVLAPNVLVACA----------------------------- 
BlaC     ----------------MRNRGFGRRELLVAMAMLVSVTGCARHAS----------------------------- 
Rv0846c  ------MPELATSGNAFDKRRFSRRGFLGAGIASGFALAACASKPTASGAAGMT-------------------- 
consensus                     ..*. ........  ...                                    
 
B. 
 
 
Figure 3.3.  M. tuberculosis Tat signal sequences are capable of driving the export of 
‘BlaC.  (A) Multiple sequence alignment (ClustalW) of the minimum M. tuberculosis 
sequences capable of directing the export of functional ‘BlaC, as demonstrated by our 
libraries.  The amino acid sequence up to the fusion junction is shown.  The arginine(s) of the 
twin-arginine motif for each protein are indicated in blue.  Potential signal peptidase I 
cleavage sites are underlined.  The cysteine residues for Rv2843, UgpB, LprQ, BlaC, and 
Rv0846c are in boldface and indicate the putative site of lipid attachment and cleavage of 
these predicted lipoproteins.  (B) Sequence logo of the set of ten twin-arginine signal 
sequences capable of directing the export of functional ‘BlaC.  The height of each stack 
represents the degree of sequence conservation and the size of each letter is proportional to 
the frequency of the corresponding amino acid in that position. 
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fusion junction was 34 amino acids.  Never did we identify active fusions of ‘blaC to the 
middle or 3’ end of a M. tuberculosis ORF. 
Previous data indicated that the PlcA and PlcB signal sequences were capable of 
exporting a functional ‘BlaC in the ∆blaS background of M. smegmatis but not in a ∆blaS 
∆tatA background (53).  To test whether the fusions identified by the ‘BlaC libraries were 
similarly exported in a Tat-dependent manner, we introduced all the fusion plasmids into 
∆blaS ∆tatA M. smegmatis.  All ten fusions failed to confer carbenicillin resistance to the 
∆blaS ∆tatA strain, even after extended incubation (data not shown).  This indicated that all 
the fusion proteins identified require the Tat pathway for export of functional BlaC. 
 
Bioinformatic identification of putative Tat signal sequences. 
Currently, there are three available bioinformatic algorithms used to predict the 
presence of twin-arginine signal sequences within a given protein sequence.  We applied 
three of these programs, TatP v1.0 (6), TATFIND v1.4 (65), and TigrFAM (TIGR01409) 
(41, 74), to the analysis of the M. tuberculosis H37Rv genome sequence and compared the 
output to the experimental data we obtained with our ‘BlaC library approach (see Materials 
and Methods).  In addition to the ten proteins we identified from the library analysis, we also 
included PlcA in the in silico analysis since we previously demonstrated that a PlcA signal 
sequence-‘BlaC fusion is Tat-exported (53).  Of the 4056 ORFs in the M. tuberculosis 
H37Rv genome (15), 95 are predicted to encode proteins with Tat signal sequences by at 
least one of the three prediction programs.  However, the prediction criteria for the programs 
differs to the extent that there is only limited overlap between the Tat signal sequences 
predicted by all three of the programs.  Of the 95 predicted Tat proteins, only eleven are 
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predicted by all three programs and ten are predicted by two out of three programs (Fig. 3.4a 
and Table 3.4).  Of the signal sequences identified experimentally to direct export of ‘BlaC, 
six were predicted by all three programs (Rv0315, Rv0774c, Rv0846c, BlaC, PlcB, and 
UgpB) and three were predicted by 2/3 programs (Rv0519c, PlcA, and Rv2843) (Fig. 3.4b).  
The Rv0063 signal sequence, which aligns with traditional Tat signal sequences but lacks the 
twin-arginine dipeptide, was only predicted by TigrFAM.  Not surprisingly, when we 
manually changed the Rv0063 input sequence from its native SRQTFLR to SRRTFLR, the 
protein was then predicted to be a Tat substrate by both TatP and TATFIND.  Finally, we 
identified the LprQ (Rv0483) signal sequence in our library, which was not predicted by any 
of the three programs.  This is most likely due to an extended “N” region upstream of the 
twin-arginine motif, which may preclude prediction by the existing programs.  It is likely that 
lprQ is annotated incorrectly.  In the pJM157 library, we obtained a clone in which the 
annotated start codon of lprQ (TubercuList, Institut Pasteur 
[http://genolist.pasteur.fr/TubercuList/]) was absent and the +1 transcriptional start of the 
hsp60 promoter was located 18 bp upstream from a GTG codon which we predict is the 
actual start codon.  The library insert also needs to include the native Shine-Dalgarno site, 
which supports this conclusion.  The corrected LprQ protein, which lacks the N-terminal 14 
amino acids in the annotated sequence, was applied to the TatP and TATFIND servers and 
was then shown to have a predicted Tat signal sequence by TatP but not by TATFIND. 
 
Assessment of signal sequence processing of M. tuberculosis full length proteins. 
The above selection identified M. tuberculosis sequences capable of directing the 
export of ‘BlaC through the Tat pathway in M. smegmatis.  As there is a strict requirement  
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Figure 3.4.  Distribution of predicted and experimentally verified M. tuberculosis twin-
arginine signal sequences. (A) Venn diagram indicating the distribution of M. tuberculosis 
proteins predicted to have N-terminal twin-arginine signal sequences, as gathered by 
bioinformatic analysis using the TATFIND v.1.4, TatP v.1.0, and TigrFAM (TIGR01409) 
algorithms.  The number of proteins predicted by TatP was 46 (29 unique), TATFIND 28 (12 
unique), and TigrFAM 53 (33 unique).  The number of proteins predicted by 2/3 programs 
was 10.  The number of proteins predicted by 3/3 programs was 11. (B) Venn diagram 
indicating the distribution of M. tuberculosis proteins identified by signal sequence fusion to 
‘BlaC among the three prediction programs indicated.  The number of demonstrated proteins 
predicted by 2/3 programs was 3.  The number of demonstrated proteins predicted by 3/3 
programs was 6.  Rv0063 was predicted by TigrFAM only.  LprQ was not predicted by any 
of the programs. 
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for a Tat substrate to fold prior to export (25), we reasoned that these signal sequences were 
responsible for targeting folded ‘BlaC to the Tat translocase.  However, a recent study in E. 
coli indicates that some twin-arginine signal sequences are also able to direct export of 
unfolded reporter proteins via the Sec pathway (87).  This suggests that, in addition to the 
targeting determinants of the signal sequence, the folded state of the mature domain is 
important in determining if a protein will be exported by the pathway it is targeted to.  We 
therefore sought to determine if the authentic full length proteins identified by our selection 
strategy were exported through the Tat pathway. 
We chose to evaluate export of the full length M. tuberculosis proteins by assaying 
for signal sequence processing using immunoblot analysis.  Here, we can look for the 
presence or absence of a smaller molecular weight processed form of the protein 
(approximate 3-4 kDa smaller) under conditions in which Tat export is functioning or not.  
The analysis was carried out in M. smegmatis, where we had the advantage of being able to 
test for Tat-dependent processing using the ∆tat mutants.  We first chose to examine export 
of full length BlaC, since we had previously shown enzymatically that BlaC is exported in a 
∆blaS background, but not in a ∆blaS ∆tatA background, or when a conservative twin-lysine 
substitution was made in BlaC (BlaC[KK]) (53). 
Polyclonal antibodies were generated against truncated BlaC as described in 
Materials and Methods and used to detect BlaC expressed in M. smegmatis in whole cell 
lysates.  The anti-BlaC antibody does not cross react with BlaS of wild-type M. smegmatis 
(data not shown), or with any additional M. smegmatis proteins, as indicated by the absence 
of detectable bands in a ∆blaS strain carrying an empty vector (Figure 3.5, lane 1).  In the 
∆blaS background, which has an intact tat locus, BlaC is present as a predominant band 
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which runs at about 30 kDa.  A minor band of about 33 kDa in size, which is the predicted 
size of full length BlaC is also present.  In the same ∆blaS background, BlaC[KK] is only 
present as the larger of the two bands (Fig. 3.5, lane 4).  Similarly, when BlaC is expressed in 
a ∆blaS ∆tatA background, there is a notable decrease in the detectable amount of the smaller 
band and an increase in the larger band (Fig. 3.5, lane 5).  Together this data suggests that in 
the absence of Tat export, there is a defect in BlaC processing, as observed by the absence or 
reduction of the smaller molecular weight, presumably mature species.  Interestingly, in 
contrast to the complete lack of a processed band for BlaC[KK], we still observed the smaller 
band of BlaC in the ∆blaS ∆tatA strain, albeit at a reduced level.  The reason for this is 
unknown, but may indicate that a small amount of nonfunctional BlaC is being exported by a 
Tat-independent pathway.  It is worthwhile to point out that the ∆blaS ∆tatA strain grows 
slower than the ∆blaS strain due to the loss of tatA (53), and this slower growth may allow 
BlaC to overcome its strict Tat-dependence and interact with other export pathways. 
Finally, it is worth mentioning that a truncated BlaC lacking its signal sequence (∆ss) 
runs as a single band of similar, but not equivalent molecular weight as the processed form 
seen in the adjacent lane (Figure 3.5, lanes 1 and 2).  BlaC is a predicted lipoprotein (82), and 
therefore lipidation of the exported form of BlaC may explain the slower mobility compared 
to the nonlipidated ∆ss form, which lacks the conserved lipobox motif. 
Since we were able to detect Tat-dependent signal sequence processing of BlaC in M. 
smegmatis, we went on to test the remaining nine ORFs identified in the ‘BlaC selection for 
export as evidenced by signal sequence cleavage.  We designed expression constructs that 
carried the full length M. tuberculosis gene fused at the C-terminus to a HA epitope tag.  
These constructs were expressed from either the constitutive mycobacterial hsp60 promoter  
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Figure 3.5.  Tat-dependent processing of BlaC in M. smegmatis.  BlaC was assessed for 
signal sequence processing by immunoblot analysis.  Full length blaC or blaC[KK] was 
expressed from its native promoter in a tat+ strain (∆blaS) or a tat- deletion strain 
(∆blaS ∆tatA) of M. smegmatis.  blaC lacking its signal sequence (∆ss) was expressed from 
the mycobacterial hsp60 promoter.  Bands were detected by immunoblot analysis using anti-
BlaC antibodies.  The presumed precursor (p) and mature (m) forms of select proteins are 
indicated by arrowheads. 
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or their native promoter.  When native promoters were used, they were chosen on the basis of 
information from upstream sequences present in ‘blaC library fusions.  The constructs were 
introduced into wild-type and ∆tat M. smegmatis, and whole cell lysates were separated by 
SDS-PAGE and examined by immunoblot analysis with anti-HA antibodies as described 
above. 
Eight out of nine proteins were detected by immunoblot analysis (Fig. 3.6).  The 
exception was native promoter-driven UgpB, which we failed to detect by immunoblot in 
both M. smegmatis and M. tuberculosis. 
 Of the eight proteins tested, Rv0315, Rv0774c, and Rv2843 showed evidence of a 
Tat-mediated processing event.  This was demonstrated by the presence of a smaller 
molecular weight form in wild-type and reduction of this species in the ∆tatC mutant (Fig. 
3.6).  In a wild-type background, Rv0315 showed three bands equally spaced with about 3-4 
kDa size difference between bands.  The highest molecular weight band is similar in size 
(~34 kDa) to that of the predicted Rv0315 precursor form and is present in both wild-type 
and ∆tatC.  Interestingly, the faster of the two smaller bands is completely absent in ∆tatC, 
whereas the middle band is only reduced in the ∆tatC mutant, suggesting that both smaller 
bands are derived from the precursor form in a Tat-dependent manner.  This may indicate 
that a second processing event is occurring during or after export.  In contrast, Rv0774c and 
Rv2843 are represented as two bands in both wild-type and ∆tatC M. smegmatis; however, 
the smaller band is reduced in quantity in the ∆tatC mutant.  Interestingly, it also appears that 
the overall protein content for these proteins is decreased in the ∆tatC mutant, despite each 
lane being loaded for equal total protein.  We conclude that there is a Tat-dependent effect  
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Figure 3.6.  Assessment of signal sequence processing of M. tuberculosis full length 
candidate Tat substrates.  The proteins indicated were assessed for signal sequence 
processing by immunoblot analysis.  Full length genes were expressed from their native 
promoter (plcB, Rv0063, Rv0315, Rv0846c) or the hsp60 promoter (∆ss-plcB, Rv0519c, lprQ, 
Rv0774c, Rv2843) in a tat+ wild-type strain (mc2155) or a tat- deletion strain (JM567, ∆tatC) 
of M. smegmatis.  Strains were harvested at OD600 = 1.0 for whole cell lysate preparation and 
equal volumes of the lysates were run on an SDS-PAGE gel.  To maximize separation of 
bands, lysates were run on either 8% (Rv0846c, Rv0063, and PlcB), 12% (Rv0315, Rv0774c, 
Rv0519c, and LprQ), or 15% (Rv2843) acrylamide gels based on the size of the targeted 
protein.  For Rv0774c and Rv2843, protein quantitation was performed to ensure that 
equivalent amounts of total protein were loaded between wild-type and ∆tatC strains.  Bands 
were detected by immunoblot analysis using anti-HA antibodies.  The presumed precursor 
(p) and mature (m) forms of select proteins are indicated by arrowheads.  The asterisk 
indicates a putative proteolytic cleavage product for Rv0315.  Native promoter-driven UgpB 
was not detected by anti-HA immunoblot. 
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for these three proteins, although further analysis should be conducted to more definitively 
establish the identity of the Tat-dependent smaller product. 
 Surprisingly, five out of the eight proteins displayed a profile by immunoblot analysis 
in which no differences in size were observed between expression in wild-type or ∆tatC M. 
smegmatis, (ie. no obvious Tat-dependence in M. smegmatis).  Rv0483 (LprQ), Rv0519c, 
and Rv0846c each show two bands in both the wild-type and ∆tat M. smegmatis backgrounds 
(Fig. 3.6).  For LprQ and Rv0519c, the two bands are about three kDa apart and run at the 
expected size of a precursor/mature doublet.  For Rv0846c the bands are close in size and 
until further analysis is performed, we cannot determine whether the smaller of the two bands 
is a potential mature species or a proteolytic degradation product.  Rv0063 and PlcB each 
show only one band in both M. smegmatis backgrounds (Fig. 3.6).  As described in more 
detail in the Discussion, the lack of ∆tat dependence for these five proteins could indicate 
that (i) the protein is exported by both Sec and Tat, (ii) the protein is exported by Sec only, 
(iii) precursor and mature species cannot be resolved on the gel system used, and therefore 
the use of signal sequence cleavage as a readout for export is not adequate, or (iv) the protein 
is not exported by M. smegmatis.  Further experiments are required to determine which of 
these possibilities is occurring. 
 
Analysis of PlcB export in mycobacteria. 
We were interested in establishing that the phospholipase C enzymes are true Tat 
substrates since they are proven virulence factors of M. tuberculosis (63).  The M. 
tuberculosis Plc enzymes are good candidates for being true Tat substrates since 
phospholipase C enzymes are exported by the Tat pathway in a number of bacteria (26, 89).  
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Therefore, we focused subsequent analysis on PlcB to determine its mode of export in 
mycobacteria.  As shown in Figure 3.6, PlcB was present as a single band in M. smegmatis 
whole cell lysates at the predicted precursor size of 57 kDa, regardless of whether the Tat 
pathway was present.  For size comparison, we expressed an HA epitope-tagged form of 
PlcB lacking the predicted N-terminal signal sequence (∆ss).  As expected, the ∆ssPlcB 
migrates faster on the gel compared to the band seen for the full length protein (Figs. 3.6 and 
3.7).  This suggested that the full length protein is most likely unprocessed in both wild-type 
and ∆tat M. smegmatis backgrounds. 
Because M. smegmatis lacks phospholipase C homologs we considered the possibility 
that this nonpathogenic mycobacteria may also lack accessory factors required for PlcB 
export in M. tuberculosis.  To test this possibility, we expressed full length PlcB in M. 
tuberculosis H37Rv and assayed whole cell lysates by immunoblot analysis.  Unlike the 
profile seen in M. smegmatis, PlcB, when expressed in M. tuberculosis, showed two clear 
bands, the larger of the two migrating at the same location as the band seen when full length 
PlcB was expressed in M. smegmatis, and the faster of the two migrating at the same location 
as the ∆ssPlcB band (Fig. 3.7).  This suggests that the PlcB signal sequence is cleaved in M. 
tuberculosis, but not in M. smegmatis.  Interestingly, immunoblot analysis of PlcB expressed 
in slow-growing M. bovis bacillus Calmette-Guérin (BCG) showed the same two bands as 
seen with PlcB in M. tuberculosis (data not shown), despite the lack of Plc homologs in 
BCG.  Experiments are planned to further characterize these findings. 
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Figure 3.7.  The PlcB signal sequence is putatively processed in M. tuberculosis, but not 
in M. smegmatis.  Full length plcB was expressed from its native promoter and plcB lacking 
its signal sequence (∆ss) was expressed from the mycobacterial hsp60 promoter in a tat+ 
wild-type strain (mc2155) of M. smegmatis (M. sm), a tat- deletion strain (∆tatC, JM567) of 
M. smegmatis, or a tat+ wild-type strain (H37Rv) of M. tuberculosis (M. tb).  Bands were 
detected by immunoblot analysis using anti-HA antibodies.  The presumed precursor (p) and 
mature (m) forms of PlcB are indicated by arrowheads. 
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Discussion 
BlaC reporter libraries. 
The goal of this work was to identify the substrates of the M. tuberculosis Tat 
pathway in order to determine the role it plays in virulence.  Because the Tat pathway in M. 
tuberculosis is essential and mutants cannot be made (67), the ways this can be approached 
are limited, preventing the possibility of a direct comparative approach in M. tuberculosis. 
Using reporter fusions to identify exported proteins is a well established strategy.  
This type of selection has been previously employed using the E. coli TEM-1 β-lactamase to 
identify proteins exported by the Sec and Tat pathway in bacteria (13, 57, 75), and has 
recently been used in M. tuberculosis (52). 
We previously reported that BlaC was a Tat-specific reporter (53).  Here, we 
exploited this property in a strategy to identify Tat exported proteins of M. tuberculosis.  To 
date, this represents the first unbiased use of a genetic reporter to identify Tat-exported 
proteins in bacteria.  So far, reporters of Tat export have only been used to confirm Tat 
predictions (70, 84, 87).  Moreover, BlaC has the capacity of being both specific for Tat 
export, and employable in a genetic selection. 
Because of the novelty of the BlaC reporter system, this work can also address two 
basic aspects of Tat biology.  First, this system can identify Tat signal sequences in an 
unbiased way without input from prediction programs.  Second, by subsequent evaluation of 
the full length protein, it can allow us to determine how often it is that a demonstrated 
functional Tat signal sequence is present on a bona fide Tat substrate, or instead is present on 
a protein that is exported by multiple or other pathways.  Both of these issues have only 
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begun to be investigated in E. coli (87), but are likely to be an important issue in 
understanding Tat export of proteins. 
Our data shows that the BlaC reporter is a powerful system to select for Tat-exported 
fusion proteins.  Our proof of concept experiments had been done previously (53).  Here, our 
data with the library reinforces the power of the system: all ‘blaC fusions obtained were in-
frame with an ORF, all unique ‘BlaC fusions identified from the library were exported in a 
Tat-dependent manner, and all but one identified ORF had a twin-arginine motif. 
 Each library was pooled from approximately 1×106 plasmid-containing E. coli.  
Given (i) the 4.4 Mbp size of the M. tuberculosis genome, (ii) a library insert size of 500 bp, 
and (iii) a 1/6 chance of obtaining an in-frame translational fusion between ‘blaC and an 
ORF, we calculated that selecting from a total of 2.4×105 clones was necessary to achieve a 
99% probability of obtaining in-frame ‘blaC fusions with every M. tuberculosis ORF (68).  
Therefore, we constructed the libraries to be sufficiently complex in an effort to achieve near 
saturation of possible targets, and assessed a total of 1.9×106 CFU of M. smegmatis for 
carbenicillin-resistance from both libraries combined.  Analysis of the identified ‘BlaC 
fusions revealed that only the very N-terminus of a protein was fused to ‘BlaC.  On average, 
the fusion junction was 15 amino acids beyond the predicted signal sequence cleavage site.  
Because of the requirement for proper folding prior to export, the most likely explanation for 
this is that extended mature sequence disrupts ‘BlaC folding and therefore prevents export.  
The above calculation did not take into account this unanticipated requirement for a fusion to 
occur near the signal sequence cleavage site.  Therefore, our calculations likely 
underestimate the number of library clones needed to identify all possible targets that can be 
identified using this system. 
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Further, given this observation, we conclude that only genes that have recognition 
sites for the AciI or HpaII endonucleases that are just beyond the signal sequence cleavage 
site and in-frame with that gene will be identified using the ‘blaC libraries described here.  
Therefore, we cannot state that the current analysis using the ‘BlaC reporter is 
comprehensive.  There are proteins predicted to be Tat substrates by Tat signal sequence 
prediction programs that we did not identify by random fusion to ‘BlaC which may be a 
result of the lack of AciI/HpaII restriction sites within 30 amino acids of their predicted 
cleavage site.  Rv2041c is an example of a gene that falls within this category.  Because we 
now realize it would be missed by the library, a direct demonstration of potential Tat 
substrates like Rv2041c is required to determine if they are Tat-exported proteins.  
Alternatively, modification of the ‘BlaC fusion library to circumvent the requirement for 
specific restriction sites near the cleavage site may result in the identification of additional 
Tat-exported proteins. 
In total, we selected 130 carbenicillin-resistant M. smegmatis colonies carrying active 
‘blaC fusions to ten unique genes of M. tuberculosis.  Of the ten, all have predicted signal 
sequences.  Five of these genes encode proteins (Rv0063, Rv0315, Rv0774c, BlaC, and 
PlcB) that have been reported to be secreted or cell wall-associated by proteomics (36, 39, 
50, 63, 73).  Only BlaC and PlcB have demonstrated functions (63, 88). 
Of the ten unique ORFs identified from both libraries, a small number were picked up 
at high frequency.  Using Library 1, which was constructed with wild-type M. tuberculosis 
genomic DNA, we identified BlaC repeatedly.  We suspect many of these plasmids carried 
the blaC gene intact.  This led us to prescreen carbenicillin-resistant isolates by PCR for blaC 
prior to sequencing.  In addition, we designed Library 2 using ∆blaC genomic DNA to avoid 
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identifying BlaC.  We also identified fusions to the Rv0315 signal sequence a total of 41 
times from both libraries, and the length of the N-terminal fusions showed the greatest 
variation ranging from 25 to 53 amino acids.  These were also later prescreened by PCR. 
Five of the ten signal sequences identified from the library are predicted to be 
lipoproteins.  This is not unusual, as several demonstrated Tat-exported proteins in bacteria 
carry putative lipoboxes (92); however, there is a lack of evidence demonstrating that these 
proteins are in fact lipidated and anchored to the membrane.  A link between Tat export and 
lipoprotein processing has yet to be established (71).  BlaC is a good candidate for this 
analysis since it has lipobox and we have shown that it is Tat-exported.  Additionally, we 
have observed that BlaC partitions to the lipoprotein-rich detergent phase when treated with 
Triton X-114, both in M. tuberculosis and M. smegmatis (H.S. Gibbons, unpublished data 
and Supplemental Figure 3.8), and this localization is dependent on its native signal sequence 
in M. smegmatis, suggesting it may be lipidated.  Further analysis is required to determine if 
BlaC is a true lipoprotein. 
 
Analysis of Tat-dependent processing of M. tuberculosis full length proteins. 
We embarked on examination of the export of each of the ten authentic full length 
proteins in M. smegmatis wild-type and ∆tat.  We undertook this analysis since several 
putative E. coli Tat signal sequences were capable of directing export of a reporter to either 
the Sec or Tat pathway, depending on the unfolded or folded state of the reporter (87).  
However, analysis of several of the authentic full length proteins showed them to be exported 
exlusively by Tat.  This suggests that, in E. coli, the export of native proteins that carry twin-
arginine signal sequences may not reflect what is observed when the respective signal 
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sequence is fused to a folded or unfolded reporter enzyme.  For our analysis, full length 
proteins were expressed with a C-terminal HA tag in M. smegmatis and export was assessed 
by looking for evidence of Tat-dependent signal peptide cleavage by immunoblot analysis.  
Four proteins (BlaC, Rv0315, Rv0774c, and Rv2843) showed a Tat-dependent effect, with 
disappearance of smaller bands in ∆tat consistent with export and signal sequence cleavage 
being Tat dependent.  Surprisingly, the remaining five proteins showed no obvious Tat effect, 
with identical immunoblot profiles in both wild-type and ∆tat M. smegmatis backgrounds. 
There are several possible explanations for why we see no Tat-dependent difference 
for these five proteins: (i) The protein may be exported by both Sec and Tat, in which case 
blockage of Tat-export in ∆tat does not affect Sec export of the protein. (ii) The protein may 
be exported by Sec only. (iii) There may be technical problems with the assay and we may 
not be able to distinguish between the precursor or mature form of the protein by 
immunoblot.  In this case, expression of a truncated control lacking a signal sequence should 
help reveal this to be the problem.  Alternatively, another assay can be used. (iv) The full 
length protein is not exported by M. smegmatis.  This is a possibility since we are expressing 
a M. tuberculosis protein in a heterologous system.  At this point, we cannot draw any 
definitive conclusions about these five proteins and further analysis is required to determine 
if the full length proteins identified from our library are exported by Tat, Sec, both, or none 
in M. smegmatis and M. tuberculosis. 
Although there are examples of cross-species export by the Tat pathway (80), a 
number of reports suggest that recognition of a signal sequence by a heterologous host does 
not always occur (9, 77).  In support of this conclusion, we further analyzed PlcB, which 
lacks a M. smegmatis ortholog.  We showed that when PlcB was expressed in its native host, 
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M. tuberculosis, it yielded two species by immunoblot analysis, the faster of the two 
migrating at the same molecular weight as the expected processed PlcB lacking its signal 
sequence.  To prove this is the processed form of PlcB, we would have to demonstrate the 
absence or reduction of the smaller band in a strain defective for export of PlcB, ideally in a 
tat mutant; however, this is not an option.  It is likely that if PlcB is a Tat substrate in M. 
tuberculosis, a KK substitution of the twin-arginine consensus motif would prevent it from 
being exported in M. tuberculosis.  This experiment is underway. We hypothesize that a 
specific factor is necessary for the export of PlcB in M. tuberculosis, which is absent in M. 
smegmatis. 
Although additional experiments are necessary, these preliminary results suggest the 
attractive possibility that PlcB is a M. tuberculosis-specific Tat substrate.  There are a small 
number of examples of Tat substrates shown to require dedicated chaperones for export (43, 
56).  Although the exact function of these chaperones remains to be discerned, proposals for 
how they may work include (i) protecting the Tat substrate from degradation or premature 
delivery to the translocon before folding is complete, (ii) delivering the folded substrate to 
the translocase, or (iii) promoting proper folding (56).  Since some of these functions relate 
to the mature domain of the protein, this may account for why the full-length PlcB and not 
the ssPlcB-‘BlaC failed to be exported by M. smegmatis.  Notably, PlcH of P. aeruginosa 
requires PlcR chaperones for its export (19).  However, there are no obvious PlcR 
homologues in M. tuberculosis. 
Similar to PlcB, we speculated that some of the other proteins we analyzed utilize M. 
tuberculosis-specific chaperones specific to the mature domains of the proteins.  Although 
most previous reports describe dedicated chaperones as mentioned above, there is evidence 
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that DnaK plays a role as a general chaperone in folding of Tat substrates in E. coli (38, 43, 
56, 60).  Like PlcB, we fail to detect a Tat-dependent effect in M. smegmatis for the Rv0063 
and Rv0846 proteins, which lack respective orthologs in M. smegmatis, and are therefore also 
candidates for having a M. tuberculosis-specific chaperone. 
 
Putative functions of the genes identified to date from the BlaC fusion library. 
Here, we provide a more detailed description of the ten genes identified by the 
selection described in this work, specifically in regard to their demonstrated or putative 
functions based on sequence homology and their potential justification for export by the Tat 
pathway. 
BlaC (Rv2068c).  Mycobacteria and a small number of nonmycobacterial species have β-
lactamases with predicted Tat signal sequences.  To date, the only β-lactamases demonstrated 
to be native Tat substrates are BlaS of M. smegmatis and BlaC of M. tuberculosis (53).  In 
this work, we have further shown that BlaC is processed in a Tat-dependent manner.  Due to 
the intrinsic properties of Tat export, it is reasonable to suggest that BlaS and BlaC simply 
fold too quickly in the cytoplasm and are therefore incompatible with export through the Sec 
apparatus (25).  Alternatively, these proteins may bind cofactors or associate with additional 
proteins in the cytoplasm prior to export.  The crystal structure of BlaC was recently 
determined to high resolution and its structure confirmed homology-based hypotheses that 
BlaC is a class A β-lactamase (40, 90).  Although some β-lactamases bind cofactors, Class 
A β-lactamases do not. 
PlcA (Rv2351c) and PlcB (Rv2350c).  We previously demonstrated that the signal 
sequences from the phospholipase C enzymes, PlcA and PlcB, drove the export of the BlaC 
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reporter in a Tat- and twin-arginine-dependent manner (53).  As expected, we selected a 
random PlcB fusion to ‘BlaC from our fusion library that promoted growth on carbenicillin.  
We also predicted we would identify a PlcA fusion; however, we did not.  It is possible that, 
as described above, a random PlcA-‘BlaC fusion was not compatible with our selection due 
to the lack of an appropriately positioned AciI/HpaII site within the plcA gene.  Alternatively, 
it is possible that the libraries were not complex enough.  To date, we have not directly tested 
a ‘blaC fusion to plcC, which lies downstream of plcB, although it is a close homolog to the 
other two genes and has a predicted Tat signal sequence. 
PlcA and PlcB, have been found in subcellular cell wall fractions of M. tuberculosis 
and have been shown to contribute to virulence in mice (63).  Phospholipase C homologs are 
recognized as having potential Tat signal sequences in many bacteria, and may therefore 
represent a category of cofactorless proteins that, for unknown reasons, has adapted to export 
by the Tat pathway (26).  Further, a number of phospholipase C enzymes, including those 
with homology to PlcA and PlcB of M. tuberculosis, are demonstrated Tat substrates (12, 66, 
89). 
The plcABC locus is absent in M. smegmatis and no orthologs to the plc genes exist 
elsewhere on the M. smegmatis chromosome (http://www.tigr.org/).  As mentioned above, 
preliminary evidence suggests that PlcB is processed in M. tuberculosis, but not in M. 
smegmatis and we propose that a chaperone required for export and/or processing of PlcB is 
present in M. tuberculosis, but absent in M. smegmatis. 
Rv0519c and Rv0774c.  Rv0519c and Rv0774c are homologous proteins, sharing 54% 
amino acid sequence identity throughout the length of both proteins, suggesting that the two 
proteins have similar cellular functions.  The ‘BlaC fusions we obtained to Rv0519c were the 
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longest in length, having between 74 to 82 amino acids of the N-terminus of Rv0519c fused 
to ‘BlaC.  Both proteins each have a predicted transmembrane domain at the N-terminus (78) 
that overlaps with the hydrophobic domain of the signal sequence.  Since the signal 
sequences have predicted cleavage sites, it is not clear if these proteins are true membrane 
proteins.  However, Rv0774c is detected in the culture filtrate of wild-type M. tuberculosis 
and is therefore presumably secreted and not an integral membrane protein (50).  Further, 
Rv0774c appears to show a Tat-dependent effect in M. smegmatis, unlike Rv0519c, which 
may further indicate that the proteins are localized differently (Fig. 3.6).  Rv0519c and 
Rv0774c are 69 and 80% identical at the amino acid level to a single ortholog in M. 
smegmatis (Msmeg5851), which has a predicted twin-arginine signal sequence. 
Both Rv0519c and Rv0774c are reported as nonessential genes by TraSH analysis 
(72).  Sequence analysis for both proteins (31, 45) reveals putative domains belonging to 
esterase D and lipase families.  In addition, Rv0519c and Rv0774c show some homology to 
the Ag85 family of mycolyltransferases (FbpA, FbpB, and FbpC) including having 
conserved Ser, Asp/Glu, and His active site residues.  Together, this information has led 
Takayama et al. (83) to propose that these proteins may function as mycolyltransferase 
enzymes, involved in the transfer of mycolic acid from Myc-PL to trehalose 6-phosphate on 
or close to the inner membrane surface. 
Rv0315.  As mentioned above, the Rv0315 signal sequence was identified more times than 
any fusion, except BlaC.  Rv0315 has been identified in two independent analyses of M. 
tuberculosis culture filtrates (50, 73).  Additionally, Dubnau et al. (28) identified Rv0315 
using a promoter trap for genes preferentially expressed by M. tuberculosis in the mouse 
lung, which suggests that its export is important during infection.  Rv0315 shows Tat-
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dependent processing in M. smegmatis.  Rv0315 is 45% and 53% identical at the amino acid 
level to Msmeg5345 and Msmeg0645, respectively.  The latter of the two M. smegmatis 
orthologs has a predicted Tat signal sequence. 
Rv0315 is reported as nonessential by TraSH analysis (72).  The function of Rv0315 
is unknown, although it is a glycosyl hydrolase family 16 member and has homology to 
secreted β-1,3-glucanases of some yeast-lytic actinomycetes, which use these enzymes to 
lyse yeast cells by degrading the β-1,3-glucan components of the yeast cell wall.  Outside of 
the mycobacteria, Rv0315 has 44% amino acid similarity to the demonstrated β-1,3-
glucanase (βglIIA) of the yeast-lytic actinomycete Cellulosimicrobium cellulans (29, 30) 
(Supplemental Fig. 3.9).  βglIIA has consecutive arginines at its N-terminus that align with 
the twin-arginine motif of Rv0315; however, βglIIA is not predicted to be a Tat substrate by 
TATFIND or TatP, and instead has a predicted transmembrane domain where the signal 
sequence cleavage site would be.  Previous analysis of a secreted β-1,3-glucanase of Bacillus 
circulans demonstrated that the enzyme is proteolytically modified post-export, resulting in 
sequential loss of the N-terminus (91).  A similar event in the processing of Rv0315 may 
help to explain the smallest band on the immunoblot seen when Rv0315 is expressed in wild-
type M. smegmatis (Fig. 3.6). 
Rv0846c.  Rv0846c is a predicted lipoprotein with homology to bacterial multicopper 
oxidases and has a putative copper-binding site.  Rv0846c was not included in the 
comprehensive TraSH analysis of M. tuberculosis in vitro (72), and therefore data is not 
available as to whether Rv0846c is essential for in vitro or in vivo growth.  Rv0846c showed 
no obvious Tat-dependence in M. smegmatis and, like PlcB, lacks an ortholog in M. 
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smegmatis, leaving open the possibility that a M. tuberculosis-specific chaperone may be 
involved in Rv0846c Tat export. 
Multicopper oxidases play a critical role in copper homeostasis and iron metabolism 
in bacteria (47).  These are periplasmic enzymes that bind copper in the cytoplasm prior to 
export of the protein, and are therefore often Tat exported.  Its homolog in E. coli, cueO 
(formerly yacK), is a demonstrated Tat-exported multicopper oxidase and is part of a copper-
regulatory operon that has been shown to oxidize a wide variety of substrates including 2,6-
dimethyoxyphenol, enterobactin, and ferrous iron (37, 47, 79).  Due to the presence of an N-
terminal Tat signal sequence and homology to other multicopper oxidases, Rv0846c is a 
good candidate to fulfill this role in M. tuberculosis.  It is also possible that, like other 
multicopper oxidases, Rv0846c may have an additional role in iron import. 
UgpB (Rv2833c).  UgpB of M. tuberculosis is a predicted lipoprotein homologous to 
periplasmic substrate-binding proteins of other bacteria, particularly those involved in 
glycerol-3-phosphate acquisition and uptake via ATP-binding cassette (ABC) transporters.  It 
is categorized as an essential gene in vitro by TraSH analysis (72), which makes it a 
candidate for explaining why the Tat pathway is essential in M. tuberculosis.  UgpB has been 
identified in membrane fractions of wild-type M. tuberculosis by two-dimensional 
electrophoresis (51), which is consistent with it being a membrane-bound lipoprotein.  We 
were not able to express full length UgpB.  Until we overcome this problem, we cannot 
address the issue of full length export.  UgpB is 40% similar to the product of the Rv2041c 
gene, which is also a predicted substrate binding protein of a putative sugar import system 
(Supplemental Fig. 3.10).  We did not identify a Rv2041c-‘BlaC fusion in our library.  As 
mentioned above, we predict that our library does not contain a Rv2041c-‘BlaC fusion 
 113 
protein that is compatible for Tat-export since Rv2041c lacks AciI/HpaII restriction sites 
within 30 bp of the predicted signal peptide cleavage site.  UgpB has low homology (~40% 
similar) to two M. smegmatis proteins, Msmeg5574 and Msmeg0515 that both lack a twin-
arginine signal sequence. 
Recently, Titgemeyer et al. (85) described the Ugp system as one of four putative 
ABC transport systems likely involved in sugar import in M. tuberculosis.  Interestingly, 
protein motif analysis of M. tuberculosis UgpB additionally classifies the protein as a Fe/S 
Rieske subunit of ubiquinol-cytochrome c reductase.  Members of this family of proteins in 
bacteria often have Tat signal sequences for export with the Fe/S group already bound, and 
may additionally be anchored to the membrane by an uncleavable signal sequence (2, 22, 
54). 
LprQ (Rv0483).  Rv0483/lprQ encodes a putative lipoprotein with no predicted function.  
LprQ is 81% similar to Msmeg0929, which has a predicted Tat signal sequence. 
LprQ belongs to the ErfK/YbiS/YcfS/YnhG family of bacterial proteins whose 
function is largely unknown but has members that contain putative peptidoglycan binding 
domains.  Interestingly, immediately upstream of lprQ is Rv0482/murB, which is predicted to 
encode a potential fatty acid desaturase (FAD)-binding enzyme involved in peptidoglycan 
biosynthesis.  The murB and lprQ genes are in the same orientation and separated by only 62 
bp.  It is attractive to speculate that MurB and LprQ interact, perhaps to transfer 
peptidoglycan from MurB to LprQ for export to the cell wall.  Another possibility is that 
MurB acts as a chaperone for LprQ, functioning in the quality control mechanism of cofactor 
insertion and folding of the substrate protein prior to Tat export.  Alternatively, MurB may 
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form a complex with LprQ and use a “piggy-back” mechanism for export through the Tat 
translocase. 
Rv2843.  Like LprQ, Rv2843 encodes a putative lipoprotein with no predicted function.  Of 
the ten genes identified from the ‘blaC library, only Rv2843 and lprQ have orthologs in the 
Mycobacterium leprae genome that are not pseudogenes.  Since M. leprae has undergone 
reductive evolution and consequently has a large number of pseudogenes, the subset of true 
genes are thought to be important for growth in vivo and pathogenesis (17).  Our analysis 
(Fig. 3.6) revealed that Rv2843 shows a Tat-dependent effect in M. smegmatis.  Rv2843 is 
40% similar to Msmeg2623 in M. smegmatis, which has a predicted Tat signal sequence. 
Rv2843 is predicted to encode a 181 amino acid alanine-rich protein with no 
homology outside of mycobacteria.  The protein has two predicted transmembrane domains 
at residues 20-42 and 62-84 (78).  ‘BlaC fusion to Rv2843 occurred at residue 66, although 
the predicted lipoprotein cleavage site is between residues 36 and 37.  At this point it is 
unclear if Rv2843 is an integral membrane protein.  Rv2843 overlaps by 4 bp with Rv2844, 
which is predicted to encode a 162 amino acid alanine-rich protein of unknown function.  A 
transposon insertion in the downstream gene, Rv2844, in a ∆blaC background, yields a strain 
that is hypersusceptible to the β-lactam antibiotic ceftriaxone (32).  Rv2844 does not have a 
predicted N-terminal signal sequence.  Together, this data suggests that the two proteins 
could perhaps interact and function in the export of a cell envelope component that is 
required for β-lactam antibiotic resistance (32).  In this scenario, Rv2844 could be passively 
co-exported, or ‘piggy-backed’, as a complex with Rv2843 through the Tat pathway – a 
mechanism that has been described for some Tat substrates (64). 
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Rv0063.  The identification of an active ‘BlaC fusion to Rv0063 was intriguing since it was 
the only fusion protein that lacked consecutive arginines in the “N” region of the signal 
sequence.  Despite this anomaly, the Rv0063 signal sequence fit the tripartite pattern of a 
typical signal sequence.  Since Rv0063-‘BlaC was exported in a Tat-dependent manner, we 
conclude that the signal sequence of Rv0063 is competent for Tat export.  It joins a small 
number of examples of bacterial Tat signal sequences that do not fit the twin-arginine 
pattern.  This category includes the TtrB subunit of tetrathionate reductase from Salmonella 
enterica, which has a lysine-arginine dipeptide (44) and the Tat-exported prepropenicillin 
amidase from E. coli has an asparagine residue between the two arginines in the Tat motif 
(46).  These examples of non-RR-dependent export by the Tat pathway suggest that 
additional features of the signal sequence are important in targeting.  They may also 
demonstrate the existence of individual Tat substrate characteristics specific to a particular 
organism.  Further identification of the exceptions to this rule may help in identifying these 
additional features. 
In addition to these naturally occurring proteins, Tat-exported proteins with 
conservative substitutions of the RR dipeptide to KK are not exported by the Tat pathway.  
However, a single substitution of one of the arginines is sometimes recognized by the Tat 
apparatus.  Finally, the presence of a glutamine residue in the second position of the Rv0063 
Tat motif is not unprecedented.  In fact, a substitution of the second arginine for glutamine in 
the twin-arginine motif of the E. coli TorA signal sequence did not prevent export of the GFP 
reporter to which it was fused (24). 
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 Rv0063 was identified by Malen et al. (50) in the culture filtrate of M. tuberculosis 
using two-dimensional gel electrophoresis.  Rv0063 is 40% similar to Msmeg1746, which is 
about the same size, but lacks a signal sequence. 
The function of Rv0063 is unknown, although it is has been annotated as a putative 
oxidoreductase based on domain recognition signatures present in the primary amino acid 
sequence, including that of a potential FAD-binding protein.  In this instance, insertion of the 
FAD cofactor may precede targeting and export of Rv0063, and therefore serve as a 
requirement for Tat-dependent export of the folded protein.  Interestingly, MurB, an enzyme 
potentially involved in peptidoglycan synthesis, is in the same family of FAD-linked 
oxidoreductases as Rv0063.  As mentioned above, murB is located immediately upstream of 
the lprQ gene and could act as a chaperone for Rv0063 and/or LprQ prior to Tat export. 
 
Summary. 
The use of a Tat-specific reporter enzyme in conjunction with a genetic fusion library 
has led to the identification of M. tuberculosis proteins having signal sequences capable of 
Tat-export.  In addition to β-lactamase and phospholipase C, we identified eight previously 
uncharacterized proteins with potential functions that include nutrient import, copper 
homeostasis, and cell envelope metabolism.  Further work is required to determine if these 
proteins are exclusively exported by the Tat pathway.  Demonstration of the true functions of 
these proteins and their specificity of export with regard to the Sec and Tat pathways can 
help uncover the overall role that the Tat pathway plays in M. tuberculosis, including its 
potential importance in virulence.  Although we believe the selection strategy described here 
was performed to near saturation, we uncovered unexpected restrictions that may have 
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resulted in the exclusion of some fusion proteins.  A modified library approach or additional 
methods can be applied, thereby allowing the comprehensive identification of Tat-specific 
signal sequences of M. tuberculosis.  Together, this approach can contribute significantly to 
an increased understanding of how the Tat pathway functions in bacteria. 
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Supplemental Figure 3.8.  BlaC is localized to the detergent phase during Triton X-114 
partitioning of M. smegmatis.  Full length blaC was expressed from its native promoter and 
blaC lacking its signal sequence (∆ss) was expressed from the mycobacterial hsp60 promoter 
in the ∆blaS strain of M. smegmatis.  As a control, M. tuberculosis LpqH (19 kDa 
lipoprotein) of was expressed in wild-type M. smegmatis.  French-pressed whole cell lysates 
(W) were partitioned using Triton X-114 into detergent (Tx) and aqueous (Aq) phases as 
described previously (34).  Bands were detected by immunoblot analysis using anti-BlaC or 
anti-LpqH antibodies. 
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Rv0315    1 ---MLMPEMDRRR-----MMMMAGFGALAAALPAPTAWADPSRPAAPAG---PTPAPAAP 
BglIIA    1 MSLPHEPSSPSRRTLTLILAAAAGLALVAAWIVIATRSSPPTSPPTTEGGQVTTPAPNDP 
 
 
Rv0315   50 AAATGG-LLFHDEFDGPAGSVPDPSKWQVSNHRTPIKNPVGFDRPQFFGQYRDSRQNVFL 
BglIIA   61 TAVTPESLAWSDEFDGAAGSAPNPDVWNHETG-------AGGWGNAELQNYTTSRVNSAL 
 
 
Rv0315  109 DGNSNLVLRATRE--GNRYFGGLVHGLWRGGIGTTWEARIKFNCLAPGMWPAWWLS---- 
BglIIA  114 DGQGNLVITALQESDGSYTSARLTTQGNVQPQFGRIEARIQIPRGQ-GIWSAFWMVGANL 
 
 
Rv0315  163 -NDDPGRSGEIDLIEWYGNGTWPSGTTVHANPDGTAFETCPIGVDGGWHNWRVTWNPSGM 
BglIIA  173 PDTPWPTSGEIDIMENVGNAPHEVHGTVHG--PGYSGDNGIMGTYQHPQGWSFADDFHTF 
 
 
Rv0315  222 YFWLDYADGIEPYFSVPATGIEDLNEPIREWPFNDPGYKVFPVLNLAVGGSGGGDP-ATG 
BglIIA  231 GIDWTPGEITWLVDGQEYHRVTTADVGANQWVFDQP---FFLILNVAIGGQWPGNPDATT 
 
 
Rv0315  281 SYPQEMLVDWVRVF----- 
BglIIA  288 PFPQQMKVDYVRVYDNATQ 
 
 
Supplemental Figure 3.9.  Rv0315 of M. tuberculosis is homologous to the secreted β-
(1,3)-glucanase of the yeast-lytic Cellulosimicrobium cellulans.  An alignment of the 
amino acid sequence of Rv0315 and βglIIA of Cellulosimicrobium cellulans using ClustalW 
reveals 44% amino acid similarity over the length of each protein. 
 120 
UgpB       1 --MDPLNRRQFLALAAAAAGVTAGCAGMGGGGSVKSGSGPIDFWSSHPGQSSAAERELIG 
Rv2041c    1 MVNKPFERRSLLRGAGALT--AASLAPWAAGCAADDDDALTFFFAANPDELRPRMRVVN- 
 
 
UgpB      59 RFQDRFPTLSVKLIDAGKDYDEVAQKFNAALIGTDVPDVVLLDDRWWFHFALSGVLTALD 
Rv2041c   58 EFQRRYPDIKVRALLSGPG---VMQQLATFCAGGKCPDVLMAWELTYAELADRGVLLDLN 
 
 
UgpB     119 DLFG----QVGVDTTDYVDSLLADYEFNGRHYAVPYARSTPLFYYNKAAWQQAGLPDRGP 
Rv2041c  115 TLLARDQAFAAELKSDSIGALYETFTFNGGQYAFPEQWSGNFLFYNKQLFDDAGVPPP-P 
 
 
UgpB     175 QSWS---EFDEWGPELQRVVGAGRSAHGWANADLISWTFQGPNWAFGGAYSDKWTLTLTE 
Rv2041c  174 GSWERPWSFAEFLDAAQALTKQGRSGRDRQWGFVNAWVSFYAAGLFAMNNGVPWSVPRMN 
 
 
UgpB     232 P--------ATIAAGNFYRNSIHGKGYAAVAN-----DIANEFATGILASAVASTGSLAG 
Rv2041c  234 PTHLNFDHDGFLEAVQFYADLTNKHKVAPSAAEQQSMSTADLFSVGKAGIALAGHWRYQT 
 
 
UgpB     279 ITASARFDFGAAPLPTGPDAAPACPTGGAGLAIPAKLSEERKVNALKFIAFVTNPTNTAY 
Rv2041c  294 FDRADGLDFDVAPLPIGPRGRAACSDIGVTGLAIAATSR-RKDQAWEFVKFATGPVGQAL 
 
 
UgpB     339 FSQQTGYLPVRKSAVDDASERHYLADNPRARVALDQLPHTRTQDYARVFLPGGDRIISAG 
Rv2041c  353 IGESRLFVPVLRSAIN----SHGFANAHRRVGNLAVLSEGPAYSEGLPVTPAWEKIAALM 
 
 
UgpB     399 LESIG--LRGADVTKTFTNIQKRLQVILDRQIMRKLAGHG 
Rv2041c  409 DRYFGPVLRGSRPATSLTGLSQAVDEVLRNP--------- 
 
 
 
Supplemental Figure 3.10.  UgpB and Rv2041c of M. tuberculosis are homologous.  An 
alignment of the potential sugar transport binding proteins UgpB and Rv2041c using 
ClustalW reveals 40% amino acid similarity over the length of each protein. 
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Mycobacterium tuberculosis is an intracellular pathogen that is able to avoid 
destruction by host immune defenses.  Exported proteins of M. tuberculosis, which include 
proteins localized to the bacterial surface or secreted into the extracellular environment, are 
ideally situated to interact with host factors.  As a result, these proteins are attractive 
candidates for virulence factors, drug targets, and vaccine components.  Here we describe a 
new β-lactamase reporter system capable of identifying exported proteins of M. tuberculosis 
during growth in host cells.  Because β-lactams target bacterial cell wall synthesis, β-
lactamases must be exported beyond the cytoplasm to protect against these drugs.  When 
used in protein fusions, β-lactamase can report on the subcellular location of another protein 
as measured by protection from β-lactam antibiotics.  Here we demonstrate that a truncated 
TEM-1 β-lactamase lacking a signal sequence for export (‘BlaTEM-1) can be used in this 
manner directly in a mutant strain of M. tuberculosis lacking the major β-lactamase, BlaC.  
The ‘BlaTEM-1 reporter conferred β-lactam resistance when fused to both Sec and Tat 
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export signal sequences.  We further demonstrate that β-lactamase fusion proteins report on 
protein export while M. tuberculosis is growing in THP-1 macrophage-like cells.  This 
genetic system should facilitate the study of proteins exclusively exported in the host 
environment by intracellular M. tuberculosis. 
 
Introduction 
 
Tuberculosis is responsible for nearly two million deaths each year (47).  
Mycobacterium tuberculosis, the causative agent of this disease, is an intracellular pathogen 
and the ability of this bacterium to survive and grow in macrophages is essential to its 
virulence.  Multiple processes are likely employed by M. tuberculosis to avoid destruction in 
macrophages.  These include residing in a phagosome that fails to mature into an acidified 
phagolysosome and resisting reactive radicals (as reviewed in 32, 48).  As in other bacterial 
pathogens, M. tuberculosis proteins exported beyond the cytoplasm to the bacterial cell 
envelope (comprised of the cytoplasmic membrane and cell wall) or secreted into the 
environment are ideally positioned to interact with host cell components and promote 
survival in macrophages.  Consequently, exported and secreted proteins make good 
candidates for virulence factors, drug targets for disease intervention, and vaccine antigens. 
Mycobacteria possess two conserved pathways for exporting proteins: the general 
secretion (Sec) pathway and the twin-arginine translocation (Tat) pathway (2, 21, 25, 28, 29, 
35).  These systems recognize precursor proteins synthesized with amino-terminal signal 
sequences and transport them across the cytoplasmic membrane (10, 26).  The proteins 
exported by these pathways can remain associated with the cell envelope or be further 
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secreted by the bacterium.  The signal sequences of Sec and Tat substrates share a similar 
domain structure; however, Tat substrates are distinguished by the presence of the twin-
arginine motif, R-R-x-φ-φ (φ = uncharged residue).  The two pathways also differ in their 
mode of transport.  Sec substrates are translocated across the cytoplasmic membrane in an 
unfolded state, whereas Tat substrates are translocated in a folded conformation.  M. 
tuberculosis also has at least two specialized protein export pathways: the SecA2-dependent 
system and the ESX-1 (ESAT-6) system (3, 15, 18, 30, 40).  Interestingly, both pathways 
appear capable of secreting specific subsets of proteins that lack conventional Sec or Tat 
signal sequences. 
In M. tuberculosis, proteomic and genetic methods have been used to experimentally 
identify proteins exported beyond the cytoplasm (reviewed in (21).  The genetic methods rely 
on reporter enzymes that are fused to M. tuberculosis protein sequences and report on the 
subcellular location of the fusion proteins (4, 8, 12, 23, 46).  Surrogate hosts such as non-
pathogenic Mycobacterium smegmatis or Escherichia coli have been used in most of these 
studies, often because endogenous enzyme activities in M. tuberculosis precluded their use 
directly in the pathogen.  The use of surrogate hosts is a problem for identifying proteins that 
are only exported by pathogenic M. tuberculosis. 
β-lactamase is an export reporter that was not initially employed directly in M. 
tuberculosis because of endogenous β-lactam resistance.  β-lactamase catalyzes the 
hydrolysis of β-lactams, a class of antibiotic that targets cell wall biosynthetic enzymes 
located outside of the cytoplasmic membrane.  Therefore, β-lactamase must be exported 
beyond the cytoplasm to protect the bacterium from the drug.  For this reason, when fused to 
another protein, it can be used as an export reporter with β-lactam resistance as a powerful 
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indicator of export.  We recently reported that a ∆blaC mutant of M. tuberculosis, lacking the 
chromosomally encoded β-lactamase BlaC, is β-lactam sensitive (14).  Further, we showed 
that BlaC is a native Tat substrate and that a truncated ‘BlaC lacking a signal sequence can 
function as a reporter of Tat-dependent export directly in a ∆blaC mutant of M. tuberculosis 
(25).  This was shown by fusing a Tat signal sequence to ‘BlaC and demonstrating that the 
resulting hybrid protein confers resistance to the β-lactam antibiotic carbenicillin in the 
∆blaC background.  Interestingly, the ‘BlaC reporter works with Tat but not Sec exported 
proteins.  Here we expanded the β-lactamase tools that can be used directly in M. 
tuberculosis by demonstrating that the TEM-1 β-lactamase (BlaTEM-1), originally identified 
in a clinical isolate of E. coli (9), functions as an export reporter in the ∆blaC mutant of M. 
tuberculosis.  The ‘BlaTEM-1 reporter has the significant advantage of being compatible 
with both Sec and Tat signal sequences. 
The proteomic and genetic approaches used in previous work for identifying exported 
proteins of M. tuberculosis are limited by their reliance on in vitro grown bacteria.  
Consequently, a potentially interesting collection of proteins only exported or secreted while 
M. tuberculosis are inside host cells are missed.  In this report, we demonstrate that β-
lactamase reporters have the novel capability of identifying M. tuberculosis proteins that are 
exported during intracellular growth in β-lactam treated THP-1 macrophage-like cells.  The 
system we describe will be of significant value for identifying the most interesting category 
of exported M. tuberculosis proteins – those exported during growth in the host environment. 
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Materials and Methods 
 
Bacterial strains, media and growth conditions. 
Escherichia coli DH5α was grown in Luria-Bertani medium (Fisher) supplemented 
with the following concentrations of antibiotics as required: carbenicillin, 100 µg/ml; 
kanamycin, 40 µg/ml.   M. tuberculosis strains H37Rv (WT), PM638 (∆blaC, H37Rv) (14) 
and all derivative strains were cultured in Middlebrook 7H9 medium or on Middlebrook 
7H10 agar medium (Difco; BD Biosciences) supplemented with 10% ADS (0.5% BSA, 
fraction V [Roche]; 0.2% dextrose; and 0.85% NaCl), 0.5% glycerol, and 0.05% Tween 80 
(Fisher).  Antibiotics for mycobacteria were used at the following concentrations: 
carbenicillin, 50 µg/ml; kanamycin, 20 µg/ml. 7H10 plates supplemented with carbenicillin 
lacked tween, as the combination of tween and carbenicillin appeared detrimental to growth 
of fusion-expressing strains. 
 
Construction of ‘blaTEM-1 fusion plasmids. 
 Plasmids used in this study are listed in Table 4.1.  All subcloned PCR products were 
sequenced and determined to be error free.  Sequence encoding the mature domain (lacking 
the N-terminal signal sequence) of E. coli BlaTEM-1 was amplified from pUC19 plasmid 
DNA (Invitrogen) using the following primers: TEMbla1 (5’- 
AGATCTCACCCAGAAACGCTGGTGAAAG) and TEMbla2 (5’- 
GTTACCAATGCTTAATCAGTGAGGCACC).  The resulting PCR product was cloned into 
the pCC1 vector (Epicentre) to generate pJM114.  The ‘blaTEM-1 reporter was subcloned as 
a BglII-BamHI fragment into each of the multi-copy vectors described below.  (i) ∆ss,  
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Table 4.1. Plasmids used in this study 
 
Plasmid Genotype Description Source 
pCC1 cat oriV ori2 CopyControl (single copy) blunt cloning vector Epicentre 
pCR2.1 bla aph ColE1 TA cloning vector Invitrogen 
pMV261.kan aph Phsp60 oriM ColE1 Multicopy mycobacterial shuttle plasmid 41 
pMB219 aph oriM ColE1 Multicopy mycobacterial shuttle plasmid This work 
pMB222 aph Phsp60-ssplcB (M. 
tuberculosis) oriM ColE1 
M. tuberculosis plcB signal sequence in pMV261 
under control of hsp60 promoter 
25 
pMB227 aph Phsp60-ssmpt63 (M. 
tuberculosis) oriM ColE1 
M. tuberculosis mpt63 signal sequence in pMV261 
under control of hsp60 promoter 
25 
pMB228 aph Phsp60-ssmpt63-‘blaC (M. 
tuberculosis) oriM ColE1 
M. tuberculosis ssmpt63-‘blaC in pMV261 under 
control of hsp60 promoter 
25 
pJM109 aph Phsp60-ssfbpB-‘blaC (M. 
tuberculosis) oriM ColE1 
M. tuberculosis ssfbpB-‘blaC in pMV261 under 
control of hsp60 promoter 
25 
pJM111 aph Phsp60-ssplcB-‘blaC (M. 
tuberculosis) oriM ColE1 
M. tuberculosis ssplcB-‘blaC in pMV261 under 
control of hsp60 promoter 
25 
pJM113 aph Phsp60-‘blaC (M. 
tuberculosis) oriM ColE1 
M. tuberculosis ‘blaC (no signal sequence) in 
pMV261 under control of hsp60 promoter 
25 
pJM114 cat oriV ori2 E. coli ‘blaTEM-1 cloned into pCC1 This work 
pJES101 aph Phsp60-ssplcB-‘blaTEM-1 
(E. coli) oriM ColE1 
’blaTEM-1 from pJM114 cloned into pMB222 This work 
pJES102 aph Phsp60-‘blaTEM-1 (E. 
coli) oriM ColE1 
’blaTEM-1 from pJM114 cloned into pMV261 This work 
pJES103 aph Phsp60-ssmpt63-‘blaTEM-
1 (E. coli) oriM ColE1 
’blaTEM-1 from pJM114 cloned into pMB227 This work 
pJES125 bla aph ColE1 M. tuberculosis mpt83 signal sequence and upstream 
sequence cloned into pCR2.1 
This work 
pJES128 aph oriM ColE1 ’blaTEM-1 from pJM114 cloned into BamHI-
linearized pMB219 
This work 
pJES129 aph Pmpt83-ssmpt83-‘blaTEM-
1 (E. coli) oriM ColE1 
M. tuberculosis mpt83 signal sequence and upstream 
sequence from pJES125 cloned into pJES128 
This work 
 
‘blaTEM-1. ‘blaTEM-1 was digested from pJM114, end-filled with Klenow and cloned into 
MscI cut pMV261.  The resulting plasmid, pJES102, contains the ‘blaTEM-1 reporter  
without a fused signal sequence cloned downstream of the hsp60 promoter.  (ii) ssplcB-
‘blaTEM-1. The ‘blaTEM-1 fragment was subcloned into BamHI cut pMB222.  The 
resulting plasmid, pJES101, contains an in-frame fusion of DNA encoding the signal 
sequence of PlcB/Rv2350c (ssplcB) to ‘blaTEM-1 under the control of the hsp60 promoter.  
(iii) ssmpt63-‘blaTEM-1.  The ‘blaTEM-1 fragment was subcloned into BamHI cut pMB227.  
The resulting plasmid, pJES103, contains an in-frame fusion of ssmpt63 (Rv1926c) to 
‘blaTEM-1 under the control of the hsp60 promoter. (iv) ssmpt83-‘blaTEM-1. DNA 
encoding the signal sequence and the first 31 amino acids of the mature M. tuberculosis 
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Mpt83 (Rv2873) protein along with the native mpt83 promoter (20) was amplified from M. 
tuberculosis genomic DNA using the following primers: mpt83HindIIIF (5’- 
CAAGCTTCGTCGGATCCGTGGTAGGGGATGTC) and mpt83HindIIIR (5’- 
CAAGCTTCGGGGTCAGCCATTGCCGCCGTGG) and cloned into the pCR2.1 vector 
(Invitrogen) to generate pJES125.  A HindIII fragment from pJES125, carrying ssmpt83 and 
upstream genomic sequence, was cloned into HindIII cut pJES128 (Table 4.1).  The resulting 
plasmid, pJES129, contains an in-frame fusion of ssmpt83 to ‘blaTEM-1 under the control of 
the native mpt83 promoter (Pmpt83). 
 
Protein quantification by immunoblot. 
 Whole cell lysates of M. tuberculosis strains were prepared as described previously 
(2) with the following modifications.  M. tuberculosis cultures were grown in 5 ml volumes 
to mid-exponential phase.  The cultures were washed twice and resuspended in PBS 0.02% 
Tween 80.  An equal volume of 10% formalin was added to the washed cultures, which were 
then incubated at room temperature for 1 hour with frequent mixing by inversion.  The 
formalin fixation step was necessary to kill M. tuberculosis before further processing.  
Bacteria were then harvested by centrifugation at 3000 RPM, washed once in PBS 0.02% 
tween to remove residual formalin, and bead-beaten lysates were then obtained from each 
sample.  Protein concentration for each lysate was measured using a bicinchoninic acid 
protein quantification kit (Pierce).  Lysates were boiled for 10 minutes, subjected to SDS-
PAGE and immunoblots were performed using standard conditions.  Primary antibodies 
specific for BlaTEM-1 were used at a concentration of 1:5000 (QED Biosciences), and 
horseradish peroxidase-conjugated anti-mouse secondary antibodies were used at a 
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concentration of 1:20,000.  Bands were visualized using Western Lightning 
Chemiluminescent Reagent Plus (PerkinElmer) and quantified using ImageJ Image 
Processing and Analysis software (http://rsb.info.nih.gov/ij/).  Whole cells lysates with the 
highest level of expression were diluted to enable direct comparison of all hybridization 
signals on a single blot.  The comparative quantification was determined by measuring pixel 
density of an equal area for each blotted lysate in duplicate.  Signal intensity per µg of whole 
cell lysate loaded was determined and is reported as the amount relative to protein detected in 
the ‘BlaTEM-1 expressing strain. 
 
Macrophage infections. 
THP-1 cells were maintained in RPMI (Gibco)/10% heat inactivated fetal calf serum 
(FCS) at 37 °C and 5% CO2.  To prepare THP-1 monolayers for infection, cells were 
centrifuged at 300 g, washed once in RPMI, then resuspended in RPMI /10% FCS at a 
concentration of 1 × 106 cells/ml.  Cells were seeded into 8-well tissue culture slides at 2 × 
105 cells/well and treated with phorbol myristate acetate (PMA) at a final concentration of 50 
ng/ml for 48 hours. 
M. tuberculosis was grown to mid-exponential phase OD600 of 0.5-1.0.   Immediately 
prior to infection, the bacterial culture was pelleted, washed once in PBS containing 0.05% 
Tween 80 (PBS-Tw), and resuspended in an equal volume of PBS-Tw.  The culture was then 
briefly sonicated to break up clumps of bacteria, diluted in RPMI/10%FCS medium and 
added to the THP-1 monolayer at MOI = 0.1. 
THP-1 monolayers were infected with M. tuberculosis strains for 4 hours at 37 °C 
and 5% CO2.  Overlaying medium was then removed, the monolayers were washed 3 times 
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with RPMI to remove non-cell associated bacteria, and triplicate wells were lysed and plated 
to determine uptake (day 0 time-point).  The infected monolayers were then overlaid with 
RPMI/10% FCS, or RPMI/10% FCS supplemented with carbenicillin and maintained at 
37°C and 5% CO2.  At 3 days post infection, the overlying medium was replenished with 
RPMI/10% FCS media or media supplemented with carbenicillin, as appropriate.  On days 1, 
3 and 5 post-infection, triplicate wells for each infection were washed to remove antibiotic 
and lysed with 0.05% SDS.  The resulting lysates were diluted and plated on 7H10 agar to 
enumerate intracellular bacteria during the course of infection.  On day 0 and day 5 of the 
infection, cell lysates were also plated on 7H10 agar supplemented with 50 µg/ml 
carbenicillin.  This demonstrated that selection of spontaneous β-lactam resistant mutants did 
not occur during the course of infection.  To determine the appropriate carbenicillin 
concentration necessary to kill intracellular bacteria, THP-1 infection experiments were 
performed with a range of antibiotic concentrations (Fig. 4.4b).  Carbenicillin at 1 mg/ml was 
determined to be the lowest concentration of antibiotic that caused optimal killing of 
sensitive intracellular M. tuberculosis and was used in subsequent experiments. 
 
Results 
 
'BlaTEM-1 is exported by Sec and Tat signal sequences in M. tuberculosis. 
β-lactamase is an ideal reporter for protein export because it must be localized 
beyond the bacterial cytoplasmic membrane to effectively protect the bacterium from β-
lactam antibiotics.  Therefore, it can be used in protein fusions to identify proteins that are 
extracytoplasmic.  An attractive feature of a β-lactamase reporter is that a selection for β-
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lactam resistant colonies can be performed, as opposed to a more labor-intensive screen.  In 
the past, we showed that the endogenous β-lactamase of M. tuberculosis BlaC can function 
as a reporter of export exclusively by the Tat pathway when expressed in the β-lactam 
sensitive ∆blaC mutant of M. tuberculosis or ∆blaS mutant of M. smegmatis (25).  Since the 
Sec pathway is likely responsible for the majority of protein export in M. tuberculosis, we 
were interested in utilizing a β-lactamase reporter that additionally works with Sec exported 
proteins.  For this reason, we tested the E. coli TEM-1 β-lactamase (BlaTEM-1) which has 
been used in other bacteria to report on proteins exported by Sec, Tat, Type II and Type III 
secretion systems (5, 7, 37, 39). 
A series of multi-copy kanamycin-marked ‘blaTEM-1 plasmids were constructed and 
electroporated into the ∆blaC mutant of M. tuberculosis (Fig. 4.1).  The resulting kanamycin 
resistant strains were tested for the ability to grow in the presence of 50 µg/ml of the β-
lactam carbenicillin. When the truncated 'blaTEM-1 reporter without a signal sequence was 
expressed in the ∆blaC mutant of M. tuberculosis, the strain remained carbenicillin-sensitive.  
In fact, no colonies of the strain expressing the truncated ‘BlaTEM-1 grew on agar 
containing carbenicillin even after extended incubation (Figs. 4.1 and 4.2).  However, 
expression of a hybrid protein comprised of a Sec signal sequence from Mpt63, a well-
established secreted protein of M. tuberculosis (17, 24), fused to 'BlaTEM-1 (ssMpt63-
‘BlaTEM-1) protected the ∆blaC mutant from carbenicillin, as was evident by the ability of 
this strain to grow on carbenicillin agar plates (Figs. 4.1 and 4.2).  We similarly tested a 
fusion protein in which the Sec signal sequence of a proven cell wall-associated lipoprotein, 
Mpt83 (16), was fused to ‘BlaTEM-1.  This construct also conferred β-lactam resistance to 
∆blaC M. tuberculosis (Fig. 4.1).  Of note, the ssMpt83-‘BlaTEM-1 fusion protein also  
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Fig. 4.1.  Schematic representation of signal sequence-‘BlaTEM-1 fusion constructs.  
Mycobacterial shuttle plasmids were designed to encode fusion proteins of M. tuberculosis 
peptide sequence (open boxes) with a truncated ‘BlaTEM-1 protein (gray boxes) lacking its 
native signal sequence.  The hatched boxes indicate plasmid-derived peptide sequence that is 
present as a result of the cloning process.  The constructs were driven off the constitutive M. 
tuberculosis hsp60 promoter for (a) pJES102/‘blaTEM-1, (b) pJES103/ssmpt63-‘blaTEM-1, 
and (d) pJES101/ssplcB-‘blaTEM-1.  The native M. tuberculosis promoter located upstream 
of the mpt83 operon was used to drive expression of (c) pJES129/ ssmpt83-‘blaTEM-1 
(promoters indicated by arrows).  Signal peptidase cleavage sites are indicated by arrowheads 
and by the AxA/G recognition motif for PlcB and Mpt63, and the LAGC lipobox recognition 
motif for Mpt83.  Diagram not to scale; ss, signal sequence. 
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included the first 31 amino acids of the mature Mpt83 protein as well as the native mpt83 
promoter which is reported to be active at very low levels in vitro (16, 34).   
Finally, we tested the signal sequence of PlcB, a proven cell wall-associated 
phospholipase C, for the ability to promote export of enzymatically active ‘BlaTEM-1 (19, 
31).  PlcB has a predicted Tat signal sequence, and the ssPlcB-‘BlaTEM-1 fusion also 
allowed ∆blaC M. tuberculosis to grow in the presence of carbenicillin (Fig. 4.1).  
To determine whether the ssPlcB-'BlaTEM-1 fusion was exported by the Tat 
pathway, it was tested in ∆blaS M. smegmatis and in a ∆tatA ∆blaS M. smegmatis double 
mutant (25) in two independent experiments.  When the ssPlcB-'BlaTEM-1 fusion protein 
was expressed in ∆blaS M. smegmatis, 92% of colonies were carbenicillin resistant.  
However, when the same construct was expressed in the ∆tatA ∆blaS mutant only an average 
7% of colonies were carbenicillin resistant indicating that the Tat pathway functions in the 
export of this fusion protein.  To show that a functional Tat pathway was not required for 
export of the Sec signal sequence-'BlaTEM-1 fusion, we similarly evaluated export of 
ssMpt63-'BlaTEM-1.  When expressed in ∆blaS and the ∆tatA ∆blaS mutants, ssMpt63-
'BlaTEM-1 conferred carbenicillin resistance to 90% and 95% of colonies, respectively.  This 
indicated, as expected, no role for the Tat pathway in exporting a Sec signal sequence-
'BlaTEM-1 fusion.  
In each example where a M. tuberculosis signal sequence (Sec or Tat) was fused to 
‘BlaTEM-1, ∆blaC M. tuberculosis was protected from β-lactam attack.  To demonstrate that 
the inability of the ‘BlaTEM-1 reporter lacking a signal sequence to protect against 
carbenicillin was due to lack of export, as opposed to lack of expression, whole cell extracts 
of  ‘BlaTEM-1 expression strains were prepared and assayed for cell-associated β-lactamase.   
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Fig. 4.2.  'BlaTEM-1 does not provide β-lactam-resistance to ∆blaC M. tuberculosis.  
Plasmids encoding the indicated 'blaTEM-1 fusions were electroporated into M. tuberculosis 
∆blaC.  The resulting strains were then plated on 7H10 plates supplemented with either 
kanamycin and 0.05% tween or kanamycin and carbenicillin without tween.  Plates were 
inspected for growth following 21-25 days of incubation. Not shown are colonies expressing 
ssMpt83-‘BlaTEM-1 and ssPlcB-‘BlaTEM-1; growth on plates containing carbenicillin for 
these strains was similar to that conferred by ssMpt63-‘BlaTEM-1. 
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To test for enzyme activity, we used the chromogenic β-lactam nitrocefin, which turns red 
following cleavage by β-lactamase (27).  During a 15 minute incubation the nitrocefin was  
hydrolyzed by all strains expressing ‘BlaTEM-1 constructs, while ∆blaC M. tuberculosis 
demonstrated no activity, similar to PBS alone (data not shown).  Importantly, β-lactamase 
activity was detected with the truncated ‘BlaTEM-1 reporter lacking a signal sequence.  In 
fact, the lysate from the ‘BlaTEM-1 strain converted nitrocefin to the red product almost 
instantaneously and faster than any other strain tested.  We similarly detected β-lactamase 
activity in whole cell lysates of ∆blaC M. tuberculosis expressing the 'BlaC reporter lacking 
its native signal sequence.   
We also compared the level of each ‘BlaTEM-1 fusion protein present in whole cell 
lysates from the respective M. tuberculosis strains by immunoblots with antibodies specific 
for BlaTEM-1.  This revealed a wide variation in the amount of ‘BlaTEM-1 protein produced 
by the different strains (Fig. 4.3).  The non-exported ‘BlaTEM-1 expressed off the hsp60 
promoter (Phsp60) was the most abundant protein detected.  Phsp60 is considered a relatively 
strong promoter and is, therefore, present on many mycobacterial shuttle vectors (42).  In 
comparison, the Phsp60 driven ssPlcB-‘BlaTEM-1 and ssMpt63-‘BlaTEM-1 were expressed at 
lower levels (59% and 0.9% of the level of the non-exported ‘BlaTEM-1 construct, 
respectively).  Since mpt83 is expressed at relatively low levels in vitro we expected the 
ssMpt83-‘BlaTEM-1 fusion to be weakly expressed (16, 34, 38).  In fact, it was nearly 
undetectable by immunoblot, present at only 0.4% of the amount of non-exported ‘BlaTEM-
1 construct.  The bands detected on the immunoblot are in general agreement with the 
predicted molecular weight of the expressed proteins.  ‘BlaTEM-1, lacking a signal 
sequence, has a predicted size of 28 kDa.  Since whole cell lysates were analyzed in these  
 145 
 
 
Fig. 4.3. ‘BlaTEM-1 fusion proteins are detected at different amounts in M. tuberculosis 
whole cell lysates.  Protein present in whole cell lysates (WCL) from each of the indicated 
∆blaC strains were separated by SDS-PAGE and immunoblotted using primary antibody 
specific for BlaTEM-1.  Comparative signal was quantified by measuring pixel density of an 
equal area for each blotted lysate in duplicate.  Average signal intensity per µg of WCL is 
reported as the amount relative to protein detected in the ‘BlaTEM-1 expressing strain.  Due 
to the different amounts of protein in each strain, it was necessary to load dilutions of the 
‘BlaTEM-1 and ssPlcB-‘BlaTEM-1 expressing lysates so that signal from less abundant 
protein fusions could be simultaneously detected.  There was no detectable signal with the 
WCL from the ∆blaC mutant carrying empty pMV261 plasmid. 
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experiments it is possible to see processed protein and/or uncleaved cytosolic precursor, 
which may explain the larger sized ssPlcB-‘BlaTEM-1 product.  The signal sequences of  
PlcB and Mpt63 would add approximately 3 and 4 kDa, while the Mpt83 signal sequence and 
fused portion of the mature protein would add approximately 11 kDa, if left intact.   
These observations suggested that even though ‘BlaTEM-1 does not promote growth in 
the presence of carbenicillin, a significant amount of β-lactamase was produced and 
accumulated within the bacterium.  Together, our results indicated that in ∆blaC M. 
tuberculosis 'BlaTEM-1 must be exported to confer protection against β-lactam antibiotics, 
that β-lactam resistance can be used to report on export, and that this reporter can be 
exported by Sec or Tat signal sequences and is compatible with different levels of 
expression. 
 
The ∆blaC mutant of M. tuberculosis is sensitive to β-lactams during intracellular 
growth in human THP-1 cells. 
β-lactam antibiotics can be used for clinical treatment of intracellular pathogens such 
as Listeria monocytogenes (33), and have been shown to reduce the population of 
phagocytosed Staphylococcus aureus (1).  This indicates that β-lactams can enter 
macrophages and inhibit intracellular growth of some bacteria.  The ∆blaC mutant of M. 
tuberculosis is sensitive to β-lactams in vitro, and we set out to test if this mutation also 
makes M. tuberculosis susceptible to β-lactams during growth in host cells. 
Intracellular growth of the ∆blaC mutant was not previously evaluated; therefore, we 
first tested the ability of this mutant to grow within human monocytic THP-1 cells.  THP-1 
cells were infected at a MOI of 0.1 with either the ∆blaC mutant or the virulent parental 
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H37Rv strain.  After a four hour period of infection, the THP-1 monolayer was washed to 
remove non-cell associated bacilli and fresh media was added back.  Growth over a five day 
period was assessed by plating of infected host cell lysates for viable bacilli.  The ∆blaC 
mutant showed no difference in intracellular growth when compared to H37Rv (Fig. 4.4a).  
Of note, we confirmed that M. tuberculosis does not grow in the THP-1 culture medium as 
previously reported (49). 
To determine if the ∆blaC mutant was sensitive to β-lactams during intracellular 
growth, THP-1 cells were infected with ∆blaC M. tuberculosis and, following the washes to 
remove extracellular bacilli, media containing different concentrations of carbenicillin was 
added to the infected monolayers.  After five days incubation, the infected monolayers were 
washed to remove carbenicillin and lysed to plate for viable bacilli.  In the absence of 
carbenicillin, the ∆blaC mutant grew in THP-1 cells as previously seen.  However, as the 
concentration of carbenicillin during the intracellular growth period increased, growth of the 
mutant diminished.  At carbenicillin concentrations of > 0.8 mg/ml substantial killing of the 
mutant was observed (Fig. 4.4b).  These results indicated that the ∆blaC mutant is sensitive 
to β-lactam antibiotics during intracellular growth, and it suggested that the β-lactamase 
reporters could be used to study protein export during intracellular growth.  Additional 
experiments showed that a concentration of 1 mg/ml carbenicillin was sufficient to achieve 
significant killing of the ∆blaC mutant of M. tuberculosis in THP-1 cells, and this 
concentration was used in all subsequent experiments. 
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Fig. 4.4.  The ∆blaC mutant of M. tuberculosis does not have a growth defect and is 
sensitive to β-lactam antibiotic in human THP-1 macrophage-like cells.  (a) THP-1 cells 
were seeded into 8 well chamber slides, and triplicate wells were infected with either WT 
H37Rv or ∆blaC M. tuberculosis at a MOI of 0.1 bacilli per macrophage.  At 4 hours (Day 
0), 1, 3 and 5 days post infection, infected wells were washed, lysed, and plated for 
intracellular bacteria.  Error bars represent standard error of the mean of c.f.u. in triplicate 
wells. (b) THP-1 cells were infected with ∆blaC M. tuberculosis as in (a).  Following a 4-
hour uptake period, wells were washed and indicated concentrations of carbenicillin were 
added to infected wells.  Infected cells were lysed and plated at 4 hours (Day 0) and 5 days 
post infection to enumerate intracellular bacteria. Dashed line represents average intracellular 
CFU at 4 hours post infection.  Error bars represent standard error of the mean of 
quadruplicate wells combined from two replicates. 
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Export of β-lactamase protects intracellular ∆blaC M. tuberculosis from β-lactam 
antibiotics. 
A reporter system that works with intracellularly growing M. tuberculosis would be 
of great value for identifying exported proteins that are expressed and exported only during  
infection.  Having shown that the ∆blaC mutant was sensitive to β-lactams during 
intracellular growth, we tested if β-lactamase could be used to report on protein export by M. 
tuberculosis growing in host cells.  We tested fusion proteins expressing the ‘BlaC and 
‘BlaTEM-1 reporters for the ability to protect the ∆blaC mutant in β-lactam treated THP-1 
cells.  In each experiment we compared an exported fusion protein to the truncated reporter 
alone.  To test the ‘BlaC reporter, which works with Tat exported proteins only, THP-1 cells 
were infected with the M. tuberculosis ∆blaC mutant expressing ssPlcB-‘BlaC or ‘BlaC only.  
Media with or without 1 mg/ml carbenicillin was added and the course of infection was 
monitored over a five day period.  In the absence of carbenicillin, both strains grew in THP-1 
cells during the course of the experiment.  However, in the presence of carbenicillin, the 
strain expressing the truncated reporter alone did not grow and was reduced 10-fold over five 
days while the strain expressing the exported ssPlcB-‘BlaC  fusion protein was protected 
from carbenicillin and grew normally (Fig. 4.5a). 
The ‘BlaTEM-1 fusions were similarly tested.  When THP-1 cells were infected with 
∆blaC M. tuberculosis expressing either the exported ssMpt63-‘BlaTEM-1 or the ‘BlaTEM-1 
reporter alone, only the strain expressing ssMpt63-‘BlaTEM-1 fusion grew in THP-1 cells in 
the presence of carbenicillin.  The non-exported ‘BlaTEM-1 strain was sensitive to the β-
lactam and was reduced in number 10-fold (Fig. 4.5b).  Similarly, ∆blaC M. tuberculosis 
exporting ssMpt83-‘BlaTEM-1 fusion was able to grow in carbenicillin treated THP-1 cells,  
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Fig. 4.5.  M. tuberculosis signal sequences fused to ‘BlaC and ‘BlaTEM-1 protect 
intracellular bacilli from β-lactam antibiotics.  THP-1 macrophage like cells were infected 
in triplicate wells with (a) M. tuberculosis ∆blaC expressing either ssPlcB-‘BlaC or ‘BlaC, 
(b) M. tuberculosis ∆blaC expressing either ‘BlaTEM-1 or ssMpt63‘BlaTEM-1 or (c) M. 
tuberculosis ∆blaC expressing ‘BlaTEM-1or  ssMpt83-‘BlaTEM-1.  Infected cells were then 
left untreated or treated with 1 mg/ml carbenicillin (carb).  Wells were washed, lysed and 
plated 4 hours (d 0), 1, 3 and 5 days post infection.  Each experiment was replicated 3 times 
in the case of (a) and (b), and 4 times in (c), with similar results. 
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while the non-exported ‘BlaTEM-1 construct did not confer resistance to the ∆blaC mutant 
(Fig. 4.5c).  
These experiments demonstrated that both the Tat specific ‘BlaC reporter and the 
more permissive ‘BlaTEM-1 reporter can report on protein export while M. tuberculosis is  
growing in β-lactam treated host cells. The use of β-lactamase reporters with intracellular M. 
tuberculosis represents a powerful tool for the study and identification of proteins exported 
during growth in host cells. 
 
Discussion 
 
The exported proteins of M. tuberculosis have been the subject of research attention 
for some time.  This stems from the well-established fact that the majority of bacterial 
virulence factors and antigens are proteins exported out of the cytoplasm to the bacterial cell 
envelope or secreted out from the bacterium (13).  In fact, there is a growing list of M. 
tuberculosis exported and secreted proteins shown to contribute to virulence or to 
development of a host immune response (21).  Genetic reporters have proven to be powerful 
tools for identifying these extracytoplasmic proteins.  The construction of a β-lactam 
sensitive ∆blaC mutant of M. tuberculosis opened the door for using β-lactamases as 
reporters of protein export directly in M. tuberculosis.  The ‘BlaC reporter can be used as a 
Tat specific reporter while the ‘BlaTEM-1 reporter, shown here, can work with Sec or Tat 
signal sequences.  An advantage of β-lactamase reporters is that they can be used to select for 
exported fusion proteins, as opposed to more labor intensive screening.  In addition, we 
showed here for the first time that resistance to β-lactam antibiotics can be used to report on 
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protein export during intracellular growth of bacteria.  Even in more genetically tractable 
bacterial pathogens, the identification of proteins exported or secreted from within host cells 
is a challenge.   
Because β-lactams target cell wall modifying enzymes, β-lactamases must be 
exported in order to protect against these drugs.  This export requirement was previously 
exploited with fusion proteins expressed in E. coli and other bacteria grown in vitro (5, 22).  
Here we showed that BlaTEM-1 can also report on protein export directly in ∆blaC M. 
tuberculosis.  The three M. tuberculosis signal sequences tested in our study are from well-
established secreted or cell-wall associated proteins.  Mpt63 (Rv1926c, 16kDa protein) has a 
predicted Sec signal sequence and is one of the four most abundant M. tuberculosis proteins 
secreted into culture media during in vitro growth (17).  Mpt83 (Rv2873) is a glycosylated 
lipoprotein (16, 43) that is exported to the cell wall of M. tuberculosis.  Mpt83 has a 
predicted Sec signal sequence with a lipoprotein signal peptidase (LspA) cleavage site and 
the requisite conserved cysteine for lipid modification.  PlcB (Rv2350c, phospholipase C) is 
a cell wall associated protein of M. tuberculosis shown to function in virulence (19, 31).  
Unlike Mpt63 and Mpt83, PlcB has a predicted Tat signal sequence including a twin-arginine 
motif (11).  Signal sequences from all three of these proteins were able to promote export of 
a fused ‘BlaTEM-1 reporter on the basis of production of β-lactam resistance.  Notably, the 
ssMpt83-‘BlaTEM-1 fusion protein was expressed from the native mpt83 promoter and the 
fusion protein included the predicted signal sequence plus 31 amino acids of the mature 
Mpt83 protein.  This demonstrated the ability of the reporter to work with different strength 
promoters and extended protein sequences.  It is important to note that even though variable 
levels of fusion protein were detected in M. tuberculosis whole cell lysates as determined by 
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immunoblot, each exported fusion provided sufficient protection against 50 µg/ml 
carbenicillin while the most abundant ‘BlaTEM-1 without an export signal did not confer β-
lactam resistance.   
Previously, we showed that the PlcB signal sequence is able to drive export of 
functional ‘BlaC in a Tat- and RR-dependent manner (25).  In E. coli the ‘BlaTEM-1 reporter 
works with both Sec and Tat signal sequences (5, 39).  The Sec and Tat pathways appear 
essential in M. tuberculosis (2, 35, 36).  Therefore, to investigate the mode of export of the 
ssPlcB-‘BlaTEM-1 fusion protein it was tested in M. smegmatis ∆blaS and in a M. smegmatis 
∆tatA ∆blaS double mutant.  A 93% reduction in β-lactam resistant colonies was observed in 
the M. smegmatis ∆tatA ∆blaS double mutant.  Thus, the Tat pathway is involved in the 
export of ssPlcB-‘BlaTEM-1, although other export pathways participate as well.  The signal 
sequence of PlcB may be promiscuous in targeting the Tat or Sec pathway for export 
depending on the folded or unfolded nature of a fused reporter element.  Similar results were 
recently shown for some predicted Tat signal sequences in E. coli (45).  
In addition to working with the Sec and Tat pathways, the‘BlaTEM-1 reporter has 
been used with type II and type III secretion systems of Gram-negative bacteria (7, 37).  
Since substrates of the type III secretion system lack conventional N-terminal signal 
sequences, it remains possible that the ‘BlaTEM-1 reporter will also work with non-
conventional exported proteins of M. tuberculosis. 
An interesting category of exported proteins that has been largely overlooked are 
those proteins only expressed and/or exported during the course of infection.  We 
hypothesize that these are proteins exclusively exported in the host environment including 
virulence factors and protective antigens.  Further, only a small number of the exported M. 
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tuberculosis proteins identified in vitro have ever been directly investigated during 
intracellular growth in host cells (21).  For most of these studies, immunomicroscopy was 
used to localize the proteins in M. tuberculosis infected macrophages, which required 
development of suitable antibodies.  We reasoned that if β-lactam antibiotics can reach 
intracellular ∆blaC M. tuberculosis, β-lactamase reporters should additionally work during 
intracellular growth.  β-lactam antibiotics do not normally accumulate in eukaryotic cells; 
however, antibiotics of this class freely diffuse in and out of host cells (44), and β-lactam 
antibiotics are used to treat some intracellular bacterial infections (33).  More specifically, β-
lactams reach intracellular Staphylococcus aureus and Listeria monocytogenes and prevent 
growth of these organisms in THP-1 cells (1, 6).  Here we showed that ∆blaC M. 
tuberculosis in THP-1 cells was also susceptible to carbenicillin.  Thus, BlaC is responsible 
for M. tuberculosis resistance to β-lactam antibiotics during intracellular growth, indicating 
that the chromosomal blaC is a key factor preventing the use of β-lactams to treat M. 
tuberculosis infection. 
When the set of exported β-lactamase fusion proteins was tested for the ability to 
protect ∆blaC M. tuberculosis from β-lactam treatment during intracellular growth, all 
exported fusions conferred resistance.  In contrast, the truncated non-exported β-lactamase 
reporters were not protective.  These experiments demonstrated the effectiveness of both 
‘BlaC and ‘BlaTEM-1 reporters to identify M. tuberculosis sequences that drive export of 
each reporter during growth within host cells.  Because the ssMpt83-‘BlaTEM-1 fusion was 
expressed from the native promoter, our results indicate that Mpt83, a protein of unknown 
function, is expressed and exported during intracellular infection.  This result is consistent 
with the reported induction of mpt83 in macrophages (38) . 
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Several approaches have described proteins exported by M. tuberculosis in vitro, but 
a different suite of proteins may be exported during infection of the host.  The intracellular β-
lactamase reporter system we describe represents a new genetic tool for studying protein 
export in M. tuberculosis.  It can be used to directly test the intracellular export of a protein 
of interest.  We also hope to use it in combination with multiple rounds of infection and 
selection of β-lactam resistant clones from a M. tuberculosis fusion library.  This should 
serve to identify the most interesting category of proteins; namely, those that are exported 
during intracellular growth and missed by alternative methods. 
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CHAPTER 5 
 
DISCUSSION 
 
 
 Tuberculosis (TB) is responsible for 1.7 million deaths each year and remains a 
global health problem despite the existence of anti-mycobacterial therapies (53).  Several 
major factors contribute to the continued existence of this disease such as the lack of an 
effective vaccine, the increased development of active TB in individuals with AIDS, and the 
emergence of drug resistant strains of Mycobacterium tuberculosis (27).  These problems can 
be addressed by achieving a greater understanding of the mechanisms that M. tuberculosis 
uses to cause disease.  Specifically, further insight into the means by which M. tuberculosis 
interacts with the host may lead to the development of better vaccines, diagnostics, and anti-
mycobacterial therapies with the ultimate goal of combating TB. 
We are interested in how protein export pathways of M. tuberculosis contribute to 
virulence.  In bacterial pathogens, protein export pathways play important roles in 
transporting virulence factors and immunogenic antigens to their proper external location to 
enable interaction with the host (11).  The protein export pathways of M. tuberculosis have 
only begun to be studied (21, 25).  Knowledge of these pathways and their exported 
substrates is important in determining their contribution to virulence and could lead to new 
disease intervention and prevention strategies. 
 The Tat pathway was first described in the thylakoid membranes of plant chloroplasts 
and subsequently in bacteria as a novel means of transporting folded proteins across 
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membranes (2, 38, 40, 44, 51).  Since then, a large amount of work, conducted primarily with 
E. coli, has contributed to a basic understanding of the unique properties of Tat export (23, 
39).  More recently, the Tat pathway has begun to be investigated in other bacterial species 
(23).  From these analyses, it is clear that specific properties of Tat export are conserved 
between unrelated bacteria.  However, bacteria-specific differences also exist.  For example, 
some Gram-positive bacteria with a functioning Tat pathway lack a tatB ortholog (9), which 
is an essential component of the Tat translocase in Gram-negative bacteria (41).  Finally, the 
studies also reveal that the Tat pathway is involved in virulence of some bacterial pathogens 
and may represent a unique means of localizing important virulence factors (3, 5, 10, 22, 32, 
35, 50).  Investigation of Tat-export in other bacteria and identification of the cognate 
exported substrates may help to uncover novel properties of Tat-export and help pinpoint 
elements that are conserved or unique to specific groups or families of bacteria. 
The work presented in this dissertation dealt with the initial characterization of the 
Tat pathway in mycobacteria.  We hypothesized that like other bacterial pathogens, M. 
tuberculosis utilized the Tat pathway for the export of a subset of folded proteins including 
virulence factors.  Additionally, we sought to use the information obtained from our analyses 
to better understand the basic properties of Tat export in bacteria.  Here, we discuss the 
contribution of this work to (i) determining a role for the Tat pathway in M. tuberculosis 
physiology and pathogenesis, (ii) better understanding the properties of Tat export in 
bacteria, and (iii) exploiting the ability of the mycobacterial Tat pathway to export folded 
proteins of interest. 
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Determining a role for the Tat pathway in M. tuberculosis pathogenesis and physiology.
 The Tat pathway is important for the virulence of several bacterial pathogens and in 
some cases has specifically been shown to export virulence factors (3, 5, 10, 22, 32, 35, 50).  
It has become clear that the phospholipase C enzymes, which are virulence factors in many 
bacteria, are commonly Tat-exported proteins (9).  This is true in Pseudomonas aeruginosa 
where ∆tat mutants fail to export two phospholipase C enzymes critical for virulence (50).  
The phospholipase C enzymes of M. tuberculosis are cell-wall associated virulence factors 
with predicted twin-arginine signal sequences (33).  We hypothesized that the Tat pathway 
was involved in the export of the phospholipase C virulence factors and therefore is likely to 
be important to virulence.  In addition, there may be other proteins exported by the Tat 
pathway that contribute to the virulence of M. tuberculosis. 
In Chapter 2, we presented data that demonstrated the functionality of the Tat 
pathway, by making tat mutants, in the genetic model system Mycobacterium smegmatis.  
We showed that deletion of the predicted components of the Tat translocase resulted in slow 
growth and hypersensitivity to SDS (26).  This latter phenotype is suggestive of a loss in 
function due to the mislocalization of one or more proteins involved in cell envelope 
metabolism.  We further showed that the chromosomally-encoded β-lactamases of M. 
smegmatis and M. tuberculosis were Tat-exported proteins.  Notably these had predicted Tat 
signal sequences. 
We initially planned to investigate the Tat pathway in M. tuberculosis using ∆tat 
mutants.  However, the tat genes proved to be essential in M. tuberculosis (36, 42).  It is 
probable that one or more proteins exported by the M. tuberculosis Tat system are required 
for in vitro growth.  Several predicted Tat substrates were previously identified as essential 
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for in vitro growth by TraSH analysis (42) and are therefore likely candidates for 
contributing to the essential nature of a tat mutant.  Also, since M. tuberculosis is a slow 
grower, it is conceivable to think that a growth defect similar to that seen in ∆tat M. 
smegmatis (26), would result in a M. tuberculosis strain that takes significantly longer to 
grow on plates than the wild-type.  The inability to obtain tat mutants in M. tuberculosis 
makes comparative studies between mutant and wild-type unfeasible.  Therefore, alternative 
methods were needed to investigate the M. tuberculosis Tat pathway. 
To gain insight into the contribution that Tat export plays in M. tuberculosis 
physiology and pathogenesis, we designed a strategy to identify the Tat-exported substrates 
of M. tuberculosis in a M. smegmatis background.  To do this, we developed the native β-
lactamase of M. tuberculosis, BlaC into a reporter for export by the Tat pathway.  M. 
tuberculosis BlaC represents the first example of a genetic reporter specific for Tat export 
that can be used directly in a selection on agar plates.  This can be a powerful method to 
identify Tat exported proteins in other bacterial systems.  This idea is discussed in the next 
section. 
We demonstrated that the twin-arginine signal sequences of M. tuberculosis 
phospholipase C (Plc) enzymes were capable of directing export via the Tat pathway (26).  
This data demonstrated these Plcs have functional Tat signal sequences and is consistent with 
them being exported by the Tat pathway.  In turn, this would mean that Tat export 
contributes to virulence.  However, ultimately we must demonstrate that the full length 
authentic Plc enzymes are true Tat-exported proteins.  This analysis is underway and is 
discussed further in the following section. 
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Other than phospholipase C, we identified additional M. tuberculosis ORFs with 
signal sequences capable of directing the export of the BlaC reporter.  These proteins have 
homology to lipases, substrate binding proteins, and redox proteins (see Chapter 3 
Discussion); however, they have yet to be characterized in M. tuberculosis.  Until their 
function is determined, it is unclear if they play a role in virulence.  In addition, there may be 
other proteins exported by the Tat pathway that we have not identified due to limitations of 
our reporter system; therefore, alternative methods may be required to identify these proteins, 
as described in the next section. 
A limitation of the library approach we employed is that it relied on in vitro growth 
conditions.  We hypothesize that there is a subset of proteins that are exclusively exported by 
M. tuberculosis while the bacteria are inside macrophages and are therefore likely to be 
important for pathogenesis.  This subset of proteins would not have been identified in the 
library selection described in Chapter 3.  In Chapter 4, we describe the first-ever use of a β-
lactamase reporter of export with intracellularly growing bacteria (24).  We showed that the 
∆blaC mutant of M. tuberculosis was susceptible to carbenicillin while growing inside 
macrophages.  Further, we showed that a PlcB signal sequence fusion to BlaC was exported 
and protected ∆blaC M. tuberculosis from carbenicillin inside macrophages.  Thus, there is 
potential to adapt the ‘BlaC reporter and BlaC expression library, described in Chapter 3, in 
M. tuberculosis for the selection of strains that export BlaC fusions during bacterial growth 
in macrophages.  This would be a novel means of identifying proteins exported exclusively 
in infection, and would be an important step in determining the role of the Tat pathway in the 
virulence of M. tuberculosis. 
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The Tat pathway is present in many bacteria, but it is not in mammalian cells.  Thus, 
the Tat apparatus is a potential target for novel drug development.  Our finding that the Tat 
pathway may be involved in the export of the Plc virulence factors suggests that inhibition of 
Tat export in M. tuberculosis would prevent localization of phospholipase C enzymes and 
result in an attenuation of virulence similar to that described with a ∆plcABC mutant.  
Furthermore, since the Tat pathway is essential for in vitro growth, we speculate that 
inhibition of Tat export by a specific drug would result in a bactericidal effect in vivo. 
 
Better understanding of the properties of Tat export in bacteria 
We undertook an unbiased experimental approach to identify M. tuberculosis proteins 
with functional Tat signal sequences.  Using a random BlaC fusion library, we identified M. 
tuberculosis Tat signal sequences that drove export of the reporter by the Tat pathway.  Most 
analyses of Tat export are based on initial bioinformatic prediction of Tat signal sequences 
(46, 48).  Since the dataset of Tat-exported proteins from which these programs are created is 
biased towards a small number of prokaryotes (1, 34, 43), the programs may be limited in 
their ability to predict true substrates in mycobacteria.  In fact, we showed in Chapter 3 (Fig. 
3.4) that there was very little overlap between the outputs of three Tat signal sequence 
prediction programs when applied to the M. tuberculosis genome, thus strengthening this 
claim.  The data obtained from our analysis was not dependent on bioinformatic analysis, and 
therefore represents an unbiased approach with potential to provide new information that 
could be used to better understand Tat-export in bacteria.  Here, we present an overview of 
this information and provide speculation of the roles that both the signal sequences and 
mature domains of the identified proteins might play in Tat export.  We propose that specific 
 168 
chaperones or additional factors may be required for export of Tat-substrates in M. 
tuberculosis.  Finally, we conclude with the idea that BlaC can be used as an easy-to-assay 
reporter for Tat-dependent export in other bacteria. 
Using the BlaC reporter library, we identified ten signal sequences that drove the Tat 
export of a functional BlaC.  These signal sequences fit the pattern of typical Tat signal 
sequences described to date, specifically with respect to the consensus twin-arginine motif.  
Interestingly, most of the proteins we identified were predicted by at least two of the 
bioinformatic programs described in Chapter 3.  This suggests that the sequence elements 
predicted by all three programs may be the best indicators of Tat export and could be used to 
either improve the current programs or to design programs better suited for mycobacteria and 
related bacteria.  The Rv0063 signal sequence was an exception to this rule since it lacked a 
twin-arginine dipeptide, making it at least the third reported example of a non-RR signal 
sequence in bacteria (17, 19).  At this point in time, we do not know if the atypical motif of 
Rv0063 is specifically required for mycobacterial Tat export, or instead is a general, but rare 
property of Tat export in bacteria.  Our analysis shows that an unbiased experimental method 
can provide new information on functional signal sequences.  Below, we discuss ways in 
which we might identify additional Tat signal sequences using the BlaC reporter, which 
could yield more examples of Tat signal sequences with atypical Tat motifs. 
 Although we were successful in identifying Tat-exported fusion proteins using the 
BlaC reporter, we encountered an unexpected limitation to our strategy that may have 
prevented us from selecting additional fusions.  As described in Chapter 3, we only obtained 
fusions of BlaC immediately downstream of the predicted signal sequence cleavage site of an 
ORF.  This suggests that inclusion of the mature domain of a protein when fused to the ‘BlaC 
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reporter prevents export.  A likely explanation for this is that the foreign sequence disrupts 
the folding of BlaC and prevents its functional export by the Tat pathway.  It also suggests 
that some ORFs might not be identified using our current library approach.  The overlooked 
ORFs would be those that lack restriction sites positioned to generate in-frame ‘blaC fusions 
near the cleavage site.  One way to address this problem would be to directly construct 
individual BlaC fusions to predicted Tat signal sequences and demonstrate export using the 
selection strategy we described.  However, as we demonstrated in Chapter 3, a more 
comprehensive and unbiased approach might result in the identification of Tat signal 
sequences that do not fit the pattern of a typical Tat signal sequence.  Since this is a category 
of proteins we are interested in identifying, an unbiased approach is preferable.  An alternate 
approach would be to design a new library in which obtaining an in-frame fusion is not 
dependent on the presence of appropriately positioned restriction sites within an ORF.  This 
could be achieved with a library constructed from random fragments of sonicated genomic 
DNA upstream of the ‘blaC reporter to be used in the same selection described in Chapter 3.  
This can potentially result in a more random and complex fusion library.  With this approach, 
we would expect to select for fusions to the ORFs described in Chapter 3, in addition to new 
ORF fusions, thus expanding our list.  Furthermore, we could perform the selection directly 
in M. tuberculosis to potentially identify fusion proteins that are not compatible with the M. 
smegmatis Tat system. 
In a recent study in E. coli, a subset of Tat signal sequences show specificity to the 
Tat translocase, while others are promiscuous and can direct export of a reporter through 
either the Sec or Tat translocase (48).  Because export is dependent on the folded state of a 
protein (8), it is not surprising that the mature domain is a factor in determining whether a 
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given protein can be exported by the Tat apparatus.  This study also brings up the question: 
how often is it that a protein with a functional signal sequence is a true Tat substrate?  To 
address this issue in mycobacteria, we showed preliminary analysis of export of the authentic 
full length proteins encoded from nine of the ten ORFs identified from the library.  Using 
signal sequence processing as a readout for export, we detected a Tat-dependent effect for 
full length BlaC, Rv0315, Rv0774c, and Rv2843 by immunoblot.  The remaining five 
proteins showed no obvious Tat-dependent difference.  As described in Chapter 3, the lack of 
∆tat dependence for these five proteins could indicate that (i) the protein is exported by both 
Sec and Tat, (ii) the protein is exported by Sec only, (iii) precursor and mature species cannot 
be resolved on the gel system used, and therefore the use of signal sequence cleavage as a 
readout for export is not adequate, or (iv) the protein is not exported by M. smegmatis.  For 
this last possibility, we cannot exclude the possibility that the C-terminal HA tag is 
preventing the proper folding and/or targeting of the full length protein to the export 
apparatus.  Specific analyses to address these possibilities are ongoing and more work needs 
to be done before we can make a conclusion. 
The possibility of the authentic protein being a Sec substrate could be explored by 
assessing precursor processing when Sec export is inhibited.  Guo et al. (14) developed a 
method in which expression of a target gene is reduced in response to increased levels of a 
transcriptional repressor specific to that target gene.  This method has been applied in M. 
smegmatis to demonstrate that expression of the essential secA1 gene is downregulated in 
response to addition of the repressor (14).  This strain can be used as a background for the 
introduction of our existing full length constructs.  Here, we can utilize this method to 
potentially demonstrate Sec-dependent export of the full length proteins that show no Tat-
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dependent effect.  Specifically, we would look for evidence of a processing defect 
(accumulation of precursor) in response to decreased secA1 expression.  Finally, we can also 
deplete SecA1 in a ∆tat background to better demonstrate if a protein is exported in a truly 
Sec-dependent manner.  The demonstration that a protein with a functional Tat signal 
sequence is exported by the Sec pathway suggests that the full length M. tuberculosis protein 
is unfolded in M. smegmatis and further work will be necessary to determine if this is 
indicative of the authentic protein in its native host. 
Another factor that may help explain why some full length M. tuberculosis proteins 
fail to show Tat-dependence is the lack of an accessory factor in the M. smegmatis model 
required for export.  Chaperones have been described in a small number of bacteria and in 
these cases, are required for folding of a precursor protein prior to export by the Tat pathway 
(15, 30).  Of these few reported examples, most function in insertion of cofactors into the 
precursor protein (28).  In contrast, the PlcR protein of P. aeruginosa is an example of a 
chaperone that is not involved in cofactor insertion but is still required for efficient folding of 
the PlcH phospholipase C prior to export (6).  We demonstrated that full length PlcB may be 
processed in slow-growing M. tuberculosis and M. bovis BCG, but not in fast-growing M. 
smegmatis suggesting that M. tuberculosis-specific factors may be required for the export of 
full length PlcB.  We are currently testing a full length PlcB mutant in which the twin-
arginine dipeptide was substituted with twin-lysines.  If PlcB is exported by the Tat pathway 
in M. tuberculosis, as our data suggests, we hypothesize that the PlcB[KK] protein would be 
defective for export and would therefore only be present as an uncleaved precursor form.  
The PlcB data suggests that additional M. tuberculosis factors may be required for the export 
of several other full length proteins that failed to show processing in M. smegmatis.  Future 
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work may focus on the identification and characterization of specific accessory factors or 
chaperones that contribute to Tat export in M. tuberculosis.  To date, no examples of Sec or 
Tat chaperones have been identified in M. tuberculosis, and therefore, this finding might be 
significant in better understanding the requirements for export in mycobacteria. 
It is well established that only folded proteins are compatible for export by the Tat 
pathway and unfolded proteins are incompatible for export (8).  To date, a number of Tat-
specific reporters that fold prior to export have been described, including green fluorescent 
protein (GFP), which can be detected by fluorescence analysis in the periplasm (37, 47).  In 
addition, Posey et al. (31) have shown that an E. coli Tat signal sequence fusion to GFP is 
exported in a Tat-dependent manner in M. smegmatis by screening.  Recently, the use of GFP 
as a reporter for Tat export was enhanced by the addition of a small C-terminal tag (SsrA) 
that targets the GFP fusion proteins for degradation by the cytoplasmic ClpXP machinery (7).  
Using this approach, only exported fusion proteins escape degradation and accumulate in the 
periplasm where they can be detected by fluorescence analysis.  The addition of the SsrA tag 
is a marked improvement of this system; however, flow cytometric screening is required for 
the identification of exported GFP-SsrA fusion proteins. 
Our approach was to utilize the M. tuberculosis BlaC as a reporter for Tat-export.  
The use of a β-lactamase selection assay eliminates labor intensive screening and allows us 
to perform a simple assay for the presence or absence of viable colonies on agar media with 
carbenicillin.  This is a classic approach to identifying exported proteins in bacteria (4, 29, 
45, 46), although not in a Tat-dependent manner.  However, until recently, it had not been 
performed directly in mycobacteria due to the presence of endogenous β-lactamase activity 
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(12, 49).  We were able to circumvent this problem by using ∆bla mutants of M. smegmatis 
and M. tuberculosis, which are sensitive to β-lactam antibiotics (12). 
Many of the existing Tat-dependent reporters have been used successfully in a variety 
of bacterial hosts (20, 31, 52).  We speculate that BlaC can be utilized as a reporter for Tat 
export in other bacteria, and given the above-mentioned advantages it has over existing 
reporters, would be an effective means for identifying Tat-exported proteins.  This would be 
especially useful in E. coli, where using an easy-to-assay unbiased approach to identify Tat-
exported proteins has not been performed and therefore might result in the identification of 
atypical Tat signal sequences.  As mentioned earlier, this information may uncover novel 
properties of Tat export, such as a relaxed requirement for the RR dipeptide, therefore 
contributing to understanding of Tat biology overall.  Finally, the use of this reporter in other 
pathogens might result in the identification of Tat-exported virulence factors.  Since it 
appears that phospholipase C enzymes are a category of Tat-exported virulence factors (9, 
35, 50), it is conceivable that other subsets of virulence factors may rely exclusively on the 
Tat pathway for export. 
 
Exploiting the ability of the mycobacterial Tat pathway to export folded proteins of 
interest 
The export of heterologous proteins in bacteria has been exploited for a variety of 
purposes, and until recently, was accomplished mainly by export through the Sec translocase 
(13).  However, many proteins proved to be incompatible for export by the Sec pathway due 
to strict folding requirements.  Because of its ability to export folded proteins, the Tat 
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pathway may be a useful alternative to this problem, especially when exporting foreign (non-
native proteins) and therefore has important implications in biotechnology. 
Here, we present two ways in which the mycobacterial Tat pathway might be utilized 
in the export of folded proteins.  First, large-scale efforts to construct better TB vaccines 
include development of recombinant strains of the existing vaccine (rBCG) in an attempt to 
produce a lasting immune response (16).  Export of large amounts of immunogenic antigens 
by the Tat pathway may be an effective means of localizing the proteins where they can 
interact efficiently with the host.  By this rationale, the use of polyvalent rBCG strains has 
been proposed as a method to provide protection against other diseases (18).  In this instance, 
the ability to efficiently export foreign proteins, which may fold in the bacterial cytoplasm, 
may rely on the Tat pathway. 
Second, the overexpression of proteins in bacteria for purification and other analyses 
is often hampered by problems such as protein insolubility.  These problems can sometimes 
be overcome by directing the secretion of the protein, and may be further improved by export 
through the Tat apparatus (13).  This might be an important option in the purification of 
mycobacterial proteins, especially if expression directly in mycobacteria is desired.  These 
two methods represent novel means of utilizing the Tat pathway in mycobacteria for the 
improved export of proteins and may be the foundation for many innovative studies to come. 
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